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ABSTRACT OF THE DISSERTATION
MODULATING ADIPOGENESIS: KEY ROLE OF RAS-RELATED PROTEIN
RAB5 AND ITS EFFECTORS
by
Yongjun Huang
Florida International University, 2018
Miami, Florida
Professor Alejandro Barbieri, Major Advisor
The formation of adipocytes is a complicated process in which insulin and IGF1 signaling pathways and numerous transcription factors control the conversion of
precursor cells to mature fat cells. The Rab5 protein acts as a rate-limiting protein
during receptor-mediated endocytosis by switching between a GDP-bound
inactive form and a GTP-bound active form. The inactivation and activation of
Rab5 are regulated by several Rab5 GTPase activating proteins (GAPs) and Rab5
guanine nucleotide exchange factors (GEFs), respectively.
This dissertation demonstrated that the activity of the small GTPase Rab5 and
its regulators are essential for the differentiation of 3T3-L1 pre-adipocytes.
Specifically, it showed that Rab5 activation is detrimental to the differentiation
process. The overexpression of a dominant-negative Rab5:S34N mutant, but not
an active counterpart (Rab5:Q79L), stimulated the differentiation of 3T3-L1 preadipocytes. Consequently, the expression of Rab5:S34N increased the expression
of two adipogenic-specific transcriptional factors, PPARγ and C/EBPα. siRNAmediated depletion of Rab5 inhibited the differentiation of 3T3-L1 pre-adipocytes,
vi

providing further evidence for the requirement of Rab5 in the process of
adipogenesis.
A dramatic decrease of the Rab5-GTP level is also observed during the
differentiation of 3T3-L1 pre-adipocytes. Consistent with these observations, I
found that the expression of Rab5 GEFs (i.e., RIN1, Rabex-5, and RAP6), which
increased the GTP-bound form of Rab5, blocked the differentiation process. In
contrast, the expression of Rab5 GAPs (i.e., RN-tre and RabGAP-5), which
decreased the GTP-bound form of Rab5, stimulated differentiation of 3T3-L1 preadipocytes.
I also found a novel interaction between the VPS9 domain of the Rab5 GEFs
and the activated insulin receptor. This interaction is specific since the VPS9
domain did not interact with the catalytic inactive mutant of the insulin receptor and
the Rab5 GAPs (no VPS9 domain) did not bind to the activated insulin receptor.
The data point out that a reduction on the GTP-bound form of Rab5 is required
for the rapid differentiation of 3T3-L1 pre-adipocytes, identifying Rab5 inactivation
as an important contributor of adipogenesis. Also, these observations suggest a
novel cellular mechanism of Rab5 activity in the adipogenesis process in
connection with the insulin receptor, the Rab5 GAPs, and the Rab5 GEFs.
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CHAPTER I
I. Introduction
Adipose tissue includes a diversity of cell types, including endothelial cells,
blood cells, fibroblasts, pre-adipocytes, and macrophages, with mature adipocytes
as the main cell type.
Adipogenesis is an insulin receptor-driven signaling cascade that promote
pre-adipocytes to differentiate into mature (brown and white) adipocytes through
the participation of some key transcription factors (Lowe et al., 2011). Specifically,
adipogenesis is a programmed and highly-regulated process that requires factors
like peroxisome proliferator-activated receptor γ (PPARγ) and other transcription
factor families, including CCAAT/enhancer-binding proteins (C/EBPs), signal
transducers and activators of transcription (STATs), and Kruppel-like factor (KLF)
proteins (Ali et al., 2013).
On the other hand, the intracellular membrane trafficking of the insulin
receptor is an extremely complex process during which the receptor encounters
its adaptor proteins as well as a variety of enzymes. One of them, the small
GTPase Rab5, acts as a rate-limiting protein and governs the early stage of insulin
receptor-mediated endocytosis. How this cellular process is regulated by the small
GTPase Rab5 and its effectors during adipogenesis is not clearly understood. The
specific roles of these intracellular factors, including the transcription factors, Rab5,
and Rab5 regulators, their targets and the corresponding signaling events will be
described. Thus, the working hypotheses and specific aims are proposed and
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discussed on the basis of the current knowledge and the information provided in
this chapter.

I.1 Adipogenesis: the mystery of obesity
Along with the development of the society and the more comfortable and
convenient accessibility of food source, obesity, as one of the most severe global
health problems, receives attention all around the world. Meanwhile, adipogenesis
has been extensively studied in the past four decades because of the increase in
the number of obese people.
I.1.1 Obesity: a global health problem
I.1.1.1 Obesity in history and modern life: from a symbol of beauty to
the threaten of health
Obesity is a medical condition in which excessive fat is formed and
accumulated in the body with a body-mass index (BMI) ≥30kg/m2 (Haslam &
James, 2005). Rather than be treated only as a metabolic disorder, obesity
nowadays has been recognized as a multifactorial disease. Type 2 diabetes, high
blood pressure, osteoarthritis, stroke, congenital disabilities, and menstrual
disorders are related to the increase of body weight (Haslam & James, 2005).
Besides, animal and human data show that high glucose/fat food consumption
sabotage the appetite control by impairing hippocampal-dependent memories,
which suggests obesity is a threat to the central nervous system (Morris et al.,
2015). What is more, the comorbidities not only reduce life expectancy and
increase the economic burden of the society, but also are associated with
2

increased incidence and mortality of multiple types of cancers, including liver,
colon, bladder, endometrium, and breast cancer (Ezzati et al., 2004; Giovannucci
et al., 2010)
Obesity is derived from the Latin word obesitas. The ancient Greeks and
Egyptians were the first ones on record to recognize obesity as a medical disorder
(Heitmann et al., 2012). In the 6th century B.C., an Indian surgeon Sushruta
related obesity with diabetes and heart disorders (Dwivedi & Dwivedi, 2007).
During the Middle Ages and the Renaissance (~1300 A.D. to 1700 A.D.), obesity
was a sign of wealth and prosperity and the symbol of beauty, not only in Europe
but also in Asian (Bloomgarden, 2003). The values towards beauty can be
represented by the artistic works at that time, such as the Portrait of Alessandro
del Borro, a Tuscan nobleman and soldier, who fought in the wars against Ottoman
Empire, was painted as a confident and over obese man; the Madonna with the
Christ Child and St. John the Baptist, in which Madonna and Jesus were
represented as overtly obese woman and child; and the Venus at a Mirror and the
Woman at the well, in which women were drawn as overweight (Ferrucci et al.,
2010). During the 19th century, both height and weight of human bodies increased
in the developed world, which was believed to be associated with the efficient and
sufficient access to food and accumulated society wealth as a result of the
Industrial Revolution (Caballero, 2007). However, it happened quite recently
(around the 1980s) that obesity attracted the sight of the public and started being
extensively studied by researchers, and it was only until the 20th century that
obesity was recognized to associate with mortality increase (Eknoyan, 2006).
3

Since the beginning of the 20th century, public’s view towards ideal body weight
and the relationship between obesity and wealth changed dramatically. The
change is supported by the data that the height of pageant winners of Miss
American increased less than 2%, but the trend of BMI decreased from 22 to 17.5,
which even belongs to the range of undernutrition defined by the World Health
Organization (WHO) (Rubinstein & Caballero, 2000).
Nowadays, increasing evidence demonstrates that obesity is becoming a
global disease. According to the National Health and Nutrition Examination Survey
(NHANES), in the U. S., during 1999-2002, 86.3% and 84.2% of men and women
who were diagnosed as diabetes were obese or overweight with 53% and 58% of
them being obese, respectively (Report, 2004). Studies also found that nearly 29%
of the world population was overweight or obese in 2013, and nearly two out of
three of the obese population lived in developing countries (Mckay, 2014). What is
worse, the data of Behavioral Risk Factor Surveillance System (BRFSS) from 1990
to 2008, show that obesity prevalence increased by 33% and severe obesity
prevalence increased by 130%. Researchers predicted that by the year 2030, 42%
of the population will be obese with a severe obesity (BMI≥40kg/m2) prevalence of
11% (Finkelstein et al., 2011).

I.1.1.2 Adipose tissue: not only a fat storehouse
Obesity, as the name implies, always happen with the symptom of a gain of
body weight. The gain of body weight, however, mostly attributes to the increase
in the mass of adipose tissue.
4

Adipose tissue is loose connective tissue containing adipocytes, which are
also the dominant component of adipose tissue; stromal vascular fraction (SVF),
which includes adipocyte precursors, mesenchymal stem cells (MSCs), and
endothelial precursor cells; and immune cells such as adipose tissue macrophages
(Riordan et al., 2009). The MSCs resemble fibroblasts morphologically and have
the capacity to differentiate into adipocytes, chondrocytes, myocytes and
osteocytes under proper stimulation (Zuk et al., 2001). The endothelial precursor
cells are capable of stimulating angiogenesis either directly or indirectly by
secreting insulin-like growth factor 1 (IGF-1), hepatocyte growth factor 1 (HGF-1),
and vascular endothelial growth factor (VEGF) (Rehman et al., 2004; Sumi et al.,
2007). The adipose tissue macrophages are responsible for the production of the
majority of tumor necrosis factor alpha (TNF-α), which affects glucose
homeostasis in adipocytes, promotes lipolysis and inhibit lipogenesis, and has
been shown to relate with insulin resistance and type 2 diabetes (Cawthorn & Sethi,
2008). Three types of adipocyte precursors, preadipocytes, the CD34+/CD31- cell
population, and the human multipotent adipose tissue-derived stem cells, were
found in the SVF of human adipose tissue (Symonds, 2012). These adipocyte
precursors, which have the capacity to differentiate into adipocytes, resident in
adipose tissue during adult life, undergo self-renewal to produce adipocytes, and
allow the adipose tissue to expand as much as 15-fold as a result of a constant
excess of fat intake (Symonds, 2012).
Researchers mainly focused on the regulation of lipolysis and lipogenesis
since adipose tissue was only considered to be an energy storage organ in the
5

past. They started realizing the importance and complexity of adipose tissue in the
recent 20~25 years when adipose tissue was widely and extensively studied
because of the increasing prevalence of obesity. Adipose tissue is crucial and
multifunctional in the body. It is 1) the primary energy storage site, where excessive
fat that surpasses the requirement of body will be stored; 2) the insulating layer,
which reduces heat loss and maintains the body temperature; 3) the protect and
support structure of some organs; 4) an endocrine organ that secretes numerous
endocrine mediators, including hormones (adipokines), cytokines, and lipids; 5) an
immune organ that helps in the removal of debris and apoptotic cells, and the
maintenance of tissue homeostasis (Mraz & Haluzik, 2014; Vegiopoulos et al.,
2017).
However, the functions of adipose tissue have been found to be different
and, to some extent, harmful to obese individuals. Adipose tissue changes
histologically, functionally, and metabolically in the obese microenvironment. In
obese patients, most adipose depots visibly expand in size, adipocytes increase
in numbers and sizes, while the proportions of other types of cells also changed.
Specifically, the expanded volume of adipose tissue and increased adipocytes cell
number are principally the result of the reduced removal rate of triacylglycerol
(TAG), the main component of fat in adipocytes (Arner et al., 2011). Additionally,
excessive accumulation of fat leads to an increase of number and activity of some
immune cells, such as macrophages, but a decrease of some others (Cildir et al.,
2013). The elevated number of macrophages increases the secretion of TNF-α in
both adipose tissue and the circulatory system, which is related to insulin resistant
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in vitro (Plomgaard et al., 2005). Besides, adipose tissue of obese patients has
relatively reduced blood vessels and neural structure, which form a hypoxic
microenvironment in adipose tissue, and are thought to be responsible for insulin
resistant of obese patients (Coppack, 2005). In response to the hypoxia stress,
adipocytes activate the p38 mitogen-activated protein kinases (p38 MAPKs) and
the Jun N-terminal kinases (JNKs), which correlate with glucose uptake and insulin
sensitivity (M. Bluher, 2013). The dysregulated secretion of TNF-α, hypoxia
microenvironment, and the stress-induced changes in signaling pathways attribute
to an obesity-induced specific type of inflammation named chronic low-grade
sterile inflammation. This type of inflammation is characterized by the increase of
immune factors in the circulatory system and the absence of clinical signs of
inflammation. It is also believed to play a crucial role in the development of insulin
resistance in obese individuals (Medzhitov, 2008; Oliver et al., 2010). Overall,
adipose tissue is crucial for energy control and the homeostasis of the human body.
Its dysfunction in obese patients is the leading cause of the obesity-related
diseases.

I.1.1.3 White, brown, and beige: different colors with different
functions?
The two functionally distinct types of adipose tissue found in mammals are
classified as the white adipose tissue (WAT) and the brown adipose tissue (BAT),
where the white adipocytes and the brown adipocytes cluster, respectively. It is
generally believed that under specific situations, the white adipocytes undergo a
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“browning” process and gain the features of brown adipocytes. These whiteoriginal brown adipocytes are named beige, or brite adipocytes. However,
evidence also shows that the beige cells could be a distinct type of adipocytes
which arise from unique precursor cells that are different from the white or brown
(J Wu et al., 2012). The introduction of this dissertation will only focus on
discussion of the universally brief of beige origin.
The WAT, taking up the majority of the adipose tissue, could be found both
subcutaneously and viscerally, and is one of the most abundant tissues in the
human body. The abnormal expansion/hypertrophy of WAT is the dominant factor
to contribute to the weight gain and dysfunction of adipose tissue during obesity
progression because of the fact that the WAT is poorly vascularized with relatively
rare neural structures (Vazquez-Vela et al., 2008). White adipocytes, the main
component of WAT, manage the primary functions of WAT, such as rapid
accumulation and release of fatty acids, lipogenesis, lipid storage, and regulation
of insulin sensitivity (Symonds, 2012). Adipocytes arise from the mesoderm during
fetal development (Enerback, 2009). The development of white adipocytes, for a
long time, is believed to derive from a myogenic factor 5 (Myf5)-negative lineage
(Timmons et al., 2007). However, developmental studies challenged the view by
providing evidence of the existence of Myf5-positive precursors in WAT (Figure 1).
The mature white adipocytes are round-shaped cells variable in size from 25μm to
200μm. They contain a single giant lipid droplet in the cytoplasm and a flattened,
peripherally located nucleus (Table 1). The content and function of mitochondria
are one of the main differences between the white and brown adipocytes.
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Mitochondria in white adipocytes are, like in other tissues, the main source of ATP,
thin and spindle in shape, and though variable, still relatively few in numbers (Table
1). The dysfunction of mitochondria could cause the imbalance between
production and decomposition of reactive oxygen species (ROS), which is thought
to play a role in the metabolic dysregulation of obesity (Cedikova et al., 2016).
The BAT was thought to only exist in infants and small animals to defend
cold temperature and maintain body temperature in the past (Rothwell & Stock,
1979). But it has been found to locate in supraclavicular, paravertebral, and neck
regions and been suggested to play a potential role in the treatment of obesity in
the past three decades. As the name of BAT implies, the brown adipocytes
comprise the main portion of it. The brown adipocytes, derive from the Myf5positive cell lineage, are relatively smaller (size from 15μm to 60μm) polygonal
cells with multiple scattered lipid droplets in the cytoplasm and a round,
eccentrically, yet not peripherally, located nucleus (Table 1). Mitochondria in brown
adipocytes are bigger and contain more cristae than the ones in white adipocytes.
These mitochondria have unique elliptical shape, exist in the cytoplasm with
enormous numbers, and exclusively express a transmembrane protein,
uncoupling protein 1 (UCP1) (Figure 1). Together with high vascularization, the
cytochromes of numerous mitochondria give the BAT the visible brown color
(Table 1). Unlike the WAT whose regulation is principally controlled by insulin, the
BAT is primarily innervated by the sympathetic nervous system (SNS), which
responses to energy defect or increased energy expenditure, via activating of
numerous-expressed β3-adrenergic receptors (β3-AR) on the membrane of
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mature brown adipocytes (Table 1). The activation of β3-AR enhances the
expression of UCP1 and hormone-sensitive lipase (HSL), and eventually promotes
lipolysis and thermogenesis (Geerling et al., 2014).

Figure 1. Origins and characteristics of white and brown adipocytes.
The white adipocytes are predominantly derived from Myf5- cells while the brown
adipocytes are derived from Myf5+ cells. Mature white adipocytes are round
shaped cells containing a single giant lipid droplet in the cytoplasm, few
mitochondria, and a flattened, peripherally located nucleus. Mature brown
adipocytes are polygonal cells with multiple scattered lipid droplets in the
cytoplasm, and a round, eccentrically, yet not peripherally, located nucleus. Brown
adipocytes contain more mitochondria, which are bigger in size and have more
cristae than the ones in white adipocytes.
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Table 1. Similarities and diversities of white, brown, and beige adipose
tissue.
(Barneda et al., 2013; Cedikova et al., 2016; Kajimura et al., 2015; Saely et al.,
2012; Sanchez-Gurmaches et al., 2012; Seale et al., 2008; Szentirmai & Kapas,
2017; Vargas et al., 2015).
Features
Development

White
Mesenchymal
stem cell;
Predominantly
Myf-negative
precursor cells

Brown
Mesenchymal
stem cell;
Myf-positive
precursor cells

Beige
Mesenchymal
stem cell;
Predominantly
Myf-negative
precursor cells

Develop time

Primarily after
birth

At neonatal stage

Upon WAT
development

Vasculature

Poorly developed
Few capillaries

Highly developed

N/A

Nervous structure

Poor innervation

High innervation

N/A

Cell shape

Round

Polygonal

Round

Cell size

25μm ~ 200μm

15μm ~ 60μm

Variable
depending on
stimulation

Nucleus

Flattened,
peripherally
located

Round,
eccentrically
located

Depend on
stimulation

Lipid droplets
(LDs)

One giant LD

Multiple small
LDs

Multiple variable
sized LDs

Mitochondria

Few
Thin and spindle

High amount
Large and
elliptical or round

Variable
depending on
stimulation

UCP1 expression

Undetectable

High

Variable
depending on
stimulation

Endoplasmic
reticulum

Normal amount

Poor

Depend on
stimulation

Main function

Fat storage

Thermogenesis

Adjust to cold
exposure;
thermogenesis

Location

Subcutaneous
and visceral

Cervical,
supraclavicular,
paravertebral

Within WAT

Role in obesity

Positive

Negative

Negative
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The discovery and study of beige (or brite) adipocytes came up quite
recently when researchers observed the trans-differentiation of brown-like
adipocytes from white adipocytes in WAT depots after chronic cold exposure
(Barbatelli et al., 2010). The first usage of the term “beige” to define the brown-like
white adipocytes, to my knowledge, was in the comments to a published paper
discussing de novo recruitment of brown adipocytes in 2010 (Vegiopoulos et al.,
2010; Ishibashi & Seale, 2010). The trigger of the browning process has not been
fully elucidated but appears to be affected by the excitement of the SNS, levels of
hormones, the tension of physical exercises, and time and extent of cold exposure
(Poekes et al., 2015). Many studies support the decisive role of β3-AR in white
adipocyte browning (Bartness & Ryu, 2015). But controversial views came up
towards the necessarily of the activation of β3-AR, either by the norepinephrine or
the β3-adrenergic agonist, in the browning process. The passive role of β3-AR is
supported by evidence that the β3-AR is dispensable for the browning process (de
Jong et al., 2017). Since the beige cells are transdifferentiated from the white
adipocytes, it is predictable that they share some features in morphology and
function with the white adipocytes, such as sharing the same precursors as well
as the same locations (Table 1). Upon the browning process, the beige cells will
show intermediate features between the two types of adipocytes and generally
transform towards the brown ones. The changes include increased expression of
UCP1 in mitochondria, increased number but decreased size of lipid droplets and
mitochondria, increased sensitivity of β3-AR, increased innervation and
vascularization (Table 1). Recently, the beige cells attract a broad interest from
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scientists as a result of its exercise- and temperature-inducible characteristics.
More will be discussed in the next unit.

I.1.1.4 Current therapies of obesity: a long way to go
As one of the most severe and prevalent diseases raised recently, variable
treatments towards obesity are offered for obese patients to choose from. Basic
strategies of weight control include diet to control the total intake of calories,
physical activities/exercises to consume energy, and behavior change/lifestyle
therapies (Kushner, 2014). Multiple drugs, such as phentermine, orlistat, lorcaserin,
and certain combinations such as phentermine/topiramate, functioning as either
appetite suppressors or lipogenesis inhibitors, have been approved by the Food
and Drug Administration (FDA) for the treatment of obesity. The most effective
treatment for obesity may be bariatric surgery. However, only severe patients or
patients with severe complications should be considered as surgery candidates.
The decision to undergo surgery must be made on the basis of a comprehensive
assessment evaluating both risks and benefits (Mechanick et al., 2013). As a
consequence of the low patient compliance with physical therapies, unavoidable
side effects of current medicines, restrict applicability of surgery, researchers and
doctors are still looking for effective and safe ways to treat obesity.
Several studies have been done to detect the potential possibility of
recruiting and activating the BAT and beige cells in obese patients for weight
control because of the negative role of BAT and beige in obesity. Gene transgenic
mice with ablated BAT were associated with insulin resistance and non-insulin13

dependent diabetes mellitus, reduced rate of energy consumption, and
considerable obesity even with a regular diet (Hamann et al., 1988). Besides,
human studies showed that the BAT activity is negatively related with BMI and
body fat percentage, but

was positively

associated with

cold-induced

thermogenesis (Vijgen et al., 2011; van Marken Lichtenbelt & Daanen, 2003).
Though some in vitro studies showed that activating β3-AR promotes lipolysis and
thermogenesis of both brown and beige adipocytes as described above, the usage
of β3-AR agonists for obesity treatment received disappointing results in humans
so far (S Qian et al., 2015).
Bone morphogenetic protein 4 (BMP-4) agonist and BMP-4 inhibitors have
recently been recommended as a potential medicine or drug target, respectively,
for obesity treatment. An animal study showed that BMP-4 transgene mice
exhibited a reduced WAT mass, decreased number of white adipocytes, and
increased beige cells and SVF (SW Qian et al., 2013). Conversely, the BMP-4knockout mice had depressed UCP-1 expression, decreased mitochondria size,
and increased lipogenesis along with diminished insulin sensitivity (SW Qian et al.,
2013). Human studies showed that silencing of Gremlin-1, a potent BMP-4 inhibitor,
dramatically increased both beige and BAT markers, while the silencing of chordin
and chordin-like-1, a BMP-4 binding protein, markedly reduced adipogenesis
markers, such as peroxisome proliferator-activated receptor-gamma (PPARγ) and
fatty acid binding protein 4 (FABP4) (Gustafson et al., 2015). However, since
BMPs have a broad range of functions not only on adipocytes but also on
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angiogenesis and bone formation, the usage of BMP agonists on obese treatment
needs to be intensely studied before being used on humans.
Other factors like IGF-1, fatty acids, glucocorticoids, macrophage colony
stimulating factor, and prostaglandins, have been identified as stimulators of the
adipogenesis process (MacDougald & Mandrup, 2002). While some other factors,
such as proteins from the Wnt family, transforming growth factor beta (TGF-β),
interleukin 1 (IL-1), TNF-α, and epidermal growth factor (EGF), all showed
inhibitory role in adipogenesis (MacDougald & Mandrup, 2002). However, it is
difficult to use these intracellular or extracellular factors as targets since the
stimulation or inhibition of them could result in complex cellular and systematic
responses.
Quite recently, Gomisin N, a physiological lignan extracted from Schisandra
chinensis, showed inhibitory effects on pre-adipocyte differentiation (Jang et al.,
2017). But whether this lignan functions appropriately in vivo and whether it will
induce severe side effect in the human body remain unknown.
In summary, to find a thorough and secure treatment for obesity still requires
more lab work and clinical tests to be done.

I.1.2 Process of adipogenesis in vitro: the lipids factory under precise
regulation
Adipogenesis is the formation of mature adipocytes differentiated from
fibroblast-like pre-adipocytes. Thus, when considering obesity from a molecular
level, the essential cause could be viewed as a result of the formation and
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accumulation of adipocytes both subcutaneously or/and viscerally. Besides,
adipogenesis is a continuously happened normal physiological process that not
only store lipids for energy expenses, but also regulate body metabolism and
homeostasis.
The highly-controlled process of adipocyte differentiation, especially the
white adipocyte differentiation, has been extensively studied in the past 30 years.
Two types of in vitro experimental models have been used. One is the preadipocyte cell lines, such as the 3T3-L1 and the 3T3-F442A cell line, which is
isolated from the Swiss 3T3 cell line. These pre-adipocyte cell lines only have the
ability to differentiate into adipocytes. The other is the multipotent stem cell lines,
such as the C3H10T1/2 cell line from C3H mouse embryonic stem cell precursors
and the adipose-derived stem cells from human adipose tissue. These multipotent
cell lines have the potential to commit to different lineages, including adipose, bone,
and muscle lineage (Moreno-Navarrete & Fernández-Real, 2012).
To achieve a successful differentiation into mature adipocytes, morphology,
transduction of signals, and protein expression of the pre-adipocytes change
dramatically through a regulated process. All mature adipocytes are characterized
by the existence and accumulation of big lipid droplets (comparing to other type of
cells) in the cytosol, high expression of adipogenic transcription factors (such as
PPARγ and CCAAT/enhancer-binding proteins (C/EBPs)) and adipogenic markers
(such as acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), and fatty acid
binding protein 4 (FABP4)). However, the stimulation of differentiation and the
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adipogenesis process for the three types of adipocytes – the white, brown and
beige cells – are not the same.

I.1.2.1 Lipids and lipid droplets in adipocytes
Lipid droplets (LDs) are lipid-rich cellular organelles that can be found in all
eukaryotic organisms and even some prokaryotic cells (Grant & Donaldson). The
formation of lipid droplets in the cytosol, with a variable range from less than 1μm
to more than 100μm, is the main characteristic of mature adipocytes (Suzuki et al.,
2011). Thus, it is of great importance to understand the structure and metabolism
of the LDs (Figure 2).
In adipocytes, LDs are observed as round structures under the microscope.
The lipid droplets are isolated from other organelles and the aqueous intracellular
environment by a monolayer of phospholipid embedded or adhered by several
types of proteins, including the perilipin (Plin) family proteins (Plin1~5), the cell
death-inducing DFF45-like effector (Cide) family proteins (Cidea, Cideb, Cidec),
adipose triglyceride lipase (ATGL), and some membrane-trafficking proteins
(Barneda et al., 2013; Guo et al., 2009). The Plins stabilize the lipid droplets and
govern lipolysis. The Cides regulate the size of LDs. The adipose triglyceride lipase
hydrolyzes the first fatty acid of triacylglycerol (TAG) to start lipolysis. Membranetrafficking proteins, such as the Rab proteins, govern the fission and fusion of
vesicles, deliver proteins to different cellular compartments, and regulate the signal
transduction. With the phospholipid layer surrounded, the hydrophobic core of LDs
in white adipocytes are predominately made up of triacylglycerols (TAGs) (Figure
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2.A). Thus, the formation and growth of LDs require the production and
transportation of the core lipids (mainly TAGs with a small amount of sterol esters),
the surface phospholipid monolayer and the lipid-related proteins. Several models
have been proposed to describe the life cycle of LDs, but none of the models was
successfully and sufficiently supported by current data. The following introduction
will build on studies conducted on 3T3-L1 pre-adipocytes cell line in vitro or/and
mice/human adipose tissue in vivo.
Generally, the life cycle of the LDs starts with fatty acids. The fatty acids
can diffuse into the cell through fatty acid transporter (FAT, CD36) or fatty acid
transport proteins (FATPs, especially the FATP1) that are located on the cell
membrane. The fatty acids can also be synthesized through de novo lipogenesis
that takes place in the cytoplasm (Figure 2.B). De novo lipogenesis normally
contributes about 20% of the total adipose TAG formation. But this de novo
lipogenesis process is able to provide all necessary fatty acids for adipogenesis
process (Strawford et al., 2004; JM Collins et al., 2011). The fatty acid transport
protein type 1 (FATP1) is highly expressed on the membrane of both WAT and
BAT initially (Schaffer & Lodish, 1994). Though insulin stimulation does not change
the expression of FATP1, it facilitates the translocation of FATP1 to the plasma
membrane from an intracellular compartment in the 3T3-L1 pre-adipocytes (Stahl
et al., 2002). During de novo lipogenesis, palmitate (C16:0) is constructed by
continuously adding malonyl-CoA to acetyl-CoA (Figure 2). Two key enzymes are
involved in the process: ACC and FAS (JM Collins et al., 2011). First, acetyl-CoA,
an intermediate product of glycolysis, is carboxylated into malonyl-CoA by ACC
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(Wakil & Abu-Elheiga, 2009). Acetyl-CoA carboxylase (ACC) is a complex
multifunctional biotin-containing enzyme system that performs the carboxylation
reaction through two steps: 1) ACC acts as a biotin carboxylase in an ATPdependent manner; 2) ACC acts as a carboxyl transferase to transfer the carboxyl
group from biotin to acetyl-CoA to form malonyl-CoA (Gurr et al., 2016). Next, the
condensation reaction is conducted by FAS to form 16-carbon palmitate using
acetyl-CoA and malonyl-CoA as substrates (Currie et al., 2013). The FAS is a giant
multifunctional enzyme system formed by homodimer of two identical monomers
(Berg et al., 2015). Each monomer has seven covalently linked catalytic sites,
which are divided into three domains, to produce palmitate (Chirala & Wakil, 2004).
The chemically inert FAs, either diffuse into the cell or be generated endogenously,
need to bind to cytosolic FABP4 and be esterified with CoA. The esterification is
an ATP-dependent two-step reaction conducted by acyl-CoA synthetase (ACS) —
to enter the bioactive pool in the form of fatty acyl-CoA (FA-CoA) that binds to the
acyl-CoA-binding protein (ACBP) (Figure 2.B). Fatty acid binding protein 4 (FABP4)
belongs to the FABP family and is highly expressed in adipocytes. It is a ~15 kDa
small protein, which acts as intracellular lipid carrier and transporter, to regulate
lipid trafficking and targeting (Furuhashi et al., 2014).
The majority of TAGs are generated through the glycerol 3-phosphate (G3P)
pathway at the endoplasmic reticulum (ER) membrane where the synthesis
process is conducted by enzymes either permanently or transiently located (Pol et
al., 2014). More specifically, the TAGs are formed and deposited between the
leaflets of the ER membrane (Kohlwein et al., 2013). As the triose sugar backbone
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of

TAG,

G3P

is

mainly

generated

through

3

metabolic

processes:

1) gluconeogenesis, in which dihydroxyacetone phosphate is reduced to G3P by
G3P dehydrogenase during glycolysis, 2) phosphorylation of glycerol via glycerol
kinase, and 3) glyceroneogenesis, in which G3P is formed from nonglycerol/glucose precursors, such as pyruvate, amino acids, and lactate (Reshef
et al., 2003). Gluconeogenesis can be upregulated in obese individuals since the
activity of G3P dehydrogenase from lean individuals is only half of that from the
morbidly adipose tissue of obese individuals (Swierczynski et al., 2003). Under
insulin stimulation, the PPARγ-mediated increased expression and activity of
glycerol kinase allow glycerol to be a direct source of G3P (Guan et al., 2002).
However, by using the tritium ([3H2]0) to track body water, glyceroneogenesis was
found to be the quantitatively dominant source of G3P in adipose tissue of rats
(Nye et al., 2008).
Triacylglycerol synthesis is the esterification of the alcoholic groups of G3P
in a row. Several reactions happen successively and are conducted by specific
enzymes, including G3P acyltransferase (GPAT), 1-acylglycerol-3-phosphate
acyltransferase

(AGPAT),

phosphatidate

phosphohydrolase

(PAP),

and

diacylglycerol acyltransferase (DGAT) (Figure 2.B). First, GPAT and AGPAT
transfer acyl groups to G3P stepwise. Then PAP catalyzed the dephosphorylation
reaction, and DGAT converts the generated diacylglycerol (DAG) to TAG
(Saponaro et al., 2015). DGAT is one of the most important enzymes in the process.
The expression and activity of DGAT can be upregulated by both insulin and
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glucose. However, the deletion of DGAT in adipocytes leads to depleted DGAT
activity, TG synthesis, and LD formation (Harris et al., 2011; Meegalla et al., 2002).

Figure 2. Structure and formation of lipid droplets (LD) in adipocytes.
A. LD structure. LD is observed as round structure with a hydrophobic core mainly
made up of TAGs. LD is surrounded by a monolayer of phospholipid embedded or
adhered by several types of proteins, including the Plins, the Cides, ATGL, Rab5,
and Rab18. B. Formation of LDs. Fatty acids from the diet were either transported
into adipocytes through FAT and FATP located on the plasma membrane or
synthesized de novo in the cytosol from acetyl-CoA. The inert fatty acids will be
activated by ACS to form FA-CoA. Then on the membrane of ER, TAG will be
synthesized using G3P and FA-CoA as substrates via a chain of reactions
mediated by GPAT, AGPAT, PAP, and DGAT.
(ACBP: acyl-CoA-binding protein; ACS: acyl-CoA synthetase; AGPAT: 1acylglycerol-3-phosphate acyltransferase; ATGL: adipose triglyceride lipase; Cide:
cell death-inducing DFF45-like effector; DAG: diacylglycerol; DGAT: diacylglycerol
acyltransferase; ER: endoplasmic reticulum; FA-CoA: fatty acyl-CoA; FAT: fatty
acid transporter; FATP: fatty acid transport protein; G3P: glycerol 3-phosphate;
GPAT:
glycerol
3-phosphate
acyltransferase;
PAP:
phosphatidate
phosphohydrolase; Plin: perilipin; TAG: triacylglycerol.) (JM Collins et al., 2011;
Ehehalt et al., 2006; Garrett & Grisham, 2017; Pol et al., 2014; Gurr et al., 2016;
Fujimoto & Parton, 2011)
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Though it is widely believed that the TAGs are synthesized between the
leaflets of the ER membrane, how the neutral lipids and LD-associated proteins
are assembled, how and whether the mature LDs separate from the ER membrane
remain incompletely understood (Hashemi & Goodman, 2015). The exact
pathways of LDs expansion and how much each possible pathway contribute to
LDs expansion also remain unclear. Nevertheless, it is widely accepted that LDs
can grow in size. One possibility is that the neutral lipids and phospholipids were
transported to the LDs through LD-ER contact sites (Yang et al., 2012). The
assumption was supported by electron and immunoelectron microscopy data
showing that the small LDs (around 1μm in diameter) were surrounded by several
layers of ER (Heid et al., 2014). Another possibility is that the neutral lipids and
phospholipids were synthesized directly on the LDs membrane. This scenario is
supported by localization of neutral lipids synthesis related proteins – such as
GPATs, AGPATs, and DGATs – and phospholipid related proteins – such as
CTP:phosphocholine cytidylyltransferase (CCT) – on the LDs membrane (Guo et
al., 2008; Wilfling et al., 2013). Fusion of smaller LDs into bigger LDs also seems
to contribute to the growth of LDs. The fusion event is rare in normal conditions but
happens quite often in the 3T3-L1 pre-adipocytes upon insulin treatment (Guo et
al., 2008; Ariotti et al., 2012).
In summary, the formation of LDs is a multistep process that is conducted
by a series of enzymes whose expression and activity can be regulated by
extracellular stimuli – such as insulin and glucose.
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I.1.2.2 Insulin, dexamethasone, 3-isobutyl-1-methylxanthine: the three
musketeers
As is mentioned above, adipocyte differentiation is a highly regulated and
complicated process in which numerous hormones, proteins, and signaling
pathways function together and successively. Commonly, scientists mimic the
trigger of pre-adipocyte differentiation by adding a hormone combination
containing insulin, dexamethasone (DEX), and 3-isobutyl-1-methylxanthine (IBMX)
in vitro. These three “musketeers” work together to help d'Artagnan – the preadipocytes – undergoing a regulated differentiation process. Though how exactly
these hormones regulate adipogenesis is not fully explored, some basic functions
will be discussed below.
Insulin is a major regulator of cell metabolism and also the most potent
hormone among the three “musketeers” to initiate adipogenesis (Klemm et al.,
2001). It is a hormone secreted by B cells of the pancreas and performs its function
of regulating carbohydrate metabolism by activating the insulin receptors (IRs) and
the IGF receptors (IGFRs) located on the plasma membrane (details of the IR, the
IGFR, the insulin signaling pathways, and how the pathways affect adipogenesis
will be discussed later in another section). The human circulating (biological active)
insulin is a monomer made up of two chains: an A chain with 21 amino acids and
a B chain with 30 amino acids (De Meyts, 2004). In general, insulin alters body
metabolism by affecting glucose transport and glycolysis, fatty acids and TAG
synthesis, the rate of protein synthesis, and the expression of adipocyte
differentiation-associated proteins (Dimitriadis et al., 2011).
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The capability of insulin to govern the transportation of glucose, which is
essential for adipocyte differentiation as the source of energy and TAGs, mostly
relays on its regulatory role towards the glucose transporter type 4 (GLUT4). The
GLUT4, an insulin-sensitive glucose transport protein, is uniquely expressed on
the plasma membrane of adipocytes (James et al., 1988). Under the normal state
(without insulin stimulation), only a small portion of GLUT4s are found on the cell
surface, while the majority of GLUT4s stay on specific intracellular compartments–
the specialized GLUT4 storage vesicles (GSVs)–which locate peripherally close to
the plasma membrane (Leto & Saltiel, 2012). Insulin augments the cell surface
GLUT4 of adipocytes by increasing exocytosis of the GSVs and decreasing
endocytosis of GLUT4 on the plasma membrane (Czech & Buxton, 1993; Jhun et
al., 1992). These GLUT4 transporters were endocytosed into the cell through both
clathrin-mediated endocytosis and the cholesterol-dependent endocytosis (Lajoie
& Nabi, 2010). During internalization, small GTPases (e.g., Rab5), guide the
GLUT4-containing vesicles towards the cell interior (Huang et al., 2001). Upon the
stimulation of insulin, several intracellular signaling cascades are initiated,
including the extracellular signal regulated kinase (Erk)1/2 signaling cascade, and
the phosphatidylinositide 3-kinase (PI3K)/Akt signaling cascade (Zarich et al.,
2006). However, the former cascade has been found to be unimportant for glucose
transportation (Lazar et al., 1995). Instead, the insulin signaling pathway
significantly increases the exocytosis of GSVs by controlling the activation states
of small GTPases via activating the PI3K/Akt signaling cascade (Leto & Saltiel,
2012). Once is recruited and activated, Akt phosphorylates and inactivates two
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GAPs, the AS160 – for vesicle translocation, and the RAL–GAP complex (RGC) –
for vesicle targeting (Leto & Saltiel, 2012). Thus, insulin is able to regulate glucose
uptake by increasing the GLUT4 level and the duration of GLUT4 remains on the
plasma membrane. Besides, studies also show that the 3T3-L1 pre-adipocytes,
once they reach confluence, become more sensitive to insulin stimulation. Under
the pre-confluent state, the cell surface GLUT4 level of 3T3-L1 cells was increased
by 70% upon insulin stimulation; while under confluent state, the surface
transporter level of 3T3-L1 cells was increased by 270% upon insulin stimulation
(Govers et al., 2004).
Dexamethasone is a synthetic glucocorticoid that performs an antiinflammatory role in the body. It triggers the differentiation of primary MSCs into
osteocytes and adipocytes in vitro. With either an increased concentration of DEX
in media or an extended incubation time with DEX, the MSCs prefer adipogenic
differentiation than osteogenic differentiation (Yin et al., 2006). 3-isobutyl-1methylxanthine (IBMX) is one of the most potent and competitive, non-specific
inhibitor of phosphodiesterases that enhance the intracellular cyclic adenosine
monophosphate (cAMP) and activate protein kinase A (PKA) (Schroeder et al.,
2012). Since the PKA signaling pathway is required for the transcriptional
activation of PPARγ, IBMX performs a regulatory role in the gene expression
during differentiation. A study has shown that treatment of IBMX on the 3T3-L1
cells does not drive the pre-adipocytes towards adipogenic differentiation. But that
did not represent a final fate of the pre-adipocytes. Indeed, treatment of DEX on
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IBMX pre-treated cells followed by an additional 48 hours of IBMX treatment
triggered the differentiation process (Pantoja et al., 2008).
In conclusion, the three hormones, insulin, DEX, and IBMX, ensure the 3T3L1 pre-adipocytes to enter and complete the differentiation process properly.
Insulin promotes the adipogenesis process by regulating the GLUT4 levels on the
plasma membrane and the sensitivity of the cells to respond to insulin stimulation.
Dexamethasone, in combination with IBMX, increase the expression of PPARγ,
C/EBPδ, and C/EBPβ, which are important adipogenic transcription factors for
adipocyte differentiation (Cao et al., 1991).

I.1.2.3 Adipogenesis in vitro: the mitotic clonal expansion phase and
the morphological change/terminal differentiation phase
As is mentioned above, two different kinds of in vitro models are used in the
study of adipocyte differentiation: the pre-adipocyte cell lines and the multipotent
stem cell lines. Some cell types undergo a proliferative phase called the mitotic
clonal expansion (MCE) phase before terminal differentiation, while some other
cell types directly enter the differentiation phase. Here, I will discuss the 3T3-L1
(pre-adipocyte cell line) adipogenesis process.
In the process of 3T3-L1 pre-adipocytes differentiation, insulin action,
glucose uptake, lipid transportation and synthesis, transcription factors (e.g.,
PPARγ and C/EBPα), cell cycle proteins (e.g., CDK2 (Cyclin-dependent kinase 2),
cyclin D1 and retinoblastoma (Rb)), adipocyte-associated proteins (e.g., ACC and
FAS), and activation of signaling cascades (e.g., the insulin signaling pathway) are
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required (Koppen & Kalkhoven, 2010). Before hormone activation, the preadipocytes stop proliferation once they reach cell confluence. The treatment of
hormone cocktail (combination of insulin, DEX, and IBMX) will trigger the cells to
enter the fate of differentiation, which includes two phases: the MCE phase and
the morphological change/terminal differentiation phase (Figure 3). The former
phase consists of two rounds of post-confluence mitosis, and the latter phase,
including the transition to a round cell shape from an elongated cell shape and to
contain large globules of fat in the cytoplasm, is the morphological change of preadipocytes into adipocytes, (Figure 3).
In the MCE phase (usually occupies the first 48 hours after hormone
treatment), a group of cell cycle proteins are periodically expressed and degraded
to ensure proliferation through mitosis. Cyclin D1 is a protein expressed
periodically in the G1 phase of the cell cycle, and it is required for the transition
from G1 phase to S phase. cAMP elevates the expression of cyclin D1 during the
first few hours of adipogenesis, which is induced by IBMX and insulin (Fox et al.,
2008). CDK2 belongs to a family of protein kinases that regulated the cell cycle.
The expression of CDK2 is required during the G1/S transition because of its
catalytic role in the cyclin-dependent protein kinase complex (Peng et al., 2016).
Retinoblastoma is phosphorylated by the cyclin-dependent protein kinase complex,
which promotes transcriptional activation of the cell cycle required genes to drive
the cells enter S phase (Berthet et al., 2006).
Meanwhile, adipogenic specific proteins (e.g., C/EBPs and PPARγ) are
regulated transcriptionally, which will be discussed in the next section.
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Figure 3. The process of adipogenesis.
Pre-adipocytes are fibroblast-like elongate-shaped cells with a round, centrally
located nucleus. Upon the stimulation of hormone cocktail (combination of insulin,
IBMX and DEX), pre-adipocytes undergo a ten-day process of differentiation
named adipogenesis. Two phases are involved in this process. The clonal
expansion phase, which happens in the first 48hs of adipogenesis, allows preadipocytes to go through two cycles of mitosis to quadruple the cell. In the latter
terminal differentiation phase, lipid droplets will be generated, accumulated, and
fused in the cytoplasm and eventually form a large lipid vacuole. (Rosen &
Spiegelman, 2000)
I.1.2.4 The adipogenic markers: C/EBPs (C/EBPα, C/EBPβ, and
C/EBPδ) and PPARγ
A series of changes happen simultaneously and successively in
transcriptional level during adipogenesis (Figure 4). The C/EBP family members
share the characteristics of C-terminal leucine zipper domain for dimerization and
a DNA-binding domain for transactivation activity. Three of the family members,
C/EBPα/β/δ, have established roles in adipogenesis. During the first 24 hours after
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hormone treatment, a transient, fast, and dramatic accumulation of C/EBPβ and
C/EBPδ will appear within the MCE phase (Figure 4). The expression of C/EBPβ
is critical for adipogenesis, which is supported by a study showing that mouse
embryo fibroblasts from C/EBPβ (–/–) mice never enter the MCE phase and cannot
differentiate into adipocytes (Tang et al., 2003). Once is hyperphosphorylated by
the mitogen-activating protein kinase (MAPK) and glycogen synthase kinase 3β
(GSK-3β), C/EBPβ acquires its DNA-binding activity and transactivate both
C/EBPα and PPARγ (Tang et al., 2005). Though C/EBPβ appears within 2 hours
after hormone induction, it only gains DNA-binding activity after a long lag when
the cells enter S phase during the mitotic clonal expansion phase (MCE) (Figure
4). An in vivo study shows that newborn C/EBPβ(–/–)·δ(–/–) mice does not
accumulate droplets, and ependymal fat pad weight of adult C/EBPβ(–/–)·δ(–/–)
mice is significantly reduced (Tanaka et al., 1997). The growth of C/EBPδ deficient
pre-adipocytes are dramatically depressed under hormone induction (Hishida et
al., 2009). However, the overexpression of C/EBPβ, not C/EBPδ, is sufficient to
induce adipogenesis, which indicates a regulatory, but less important role of
C/EBPδ in adipogenesis (Yeh et al., 1995). The expression of C/EBPβ and
C/EBPδ both peak shortly after hormone induction and experience a sudden
decrease together with the expression of low levels of C/EBPα and PPARγ.
C/EBPα and PPARγ can then initiate the expression of each other in a positive
feedback loop, perform proliferation inhibition activity, regulate adipogenic genes
and proteins, and remain continuously elevated during adipogenesis (Figure 4).
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Figure 4. The regulation of transcription factors during adipogenesis.
A transient and dramatic increase of C/EBPβ and C/EBPδ takes place within the
first 2 hours after hormone treatment and experience a sudden decrease at the
end of the mitotic clonal expansion (MCE) phase. The expression of these two
transcription factors transactivates both C/EBPα and PPARγ, which initiate the
expression of each other in a positive feedback loop, when the cells cease the
MCE phase. (Ramji & Foka, 2002; Rosen et al., 2002).
The two key transcription factors, C/EBPα and PPARγ, emerge and
dramatically increase in the second wave (the C/EBPβ and C/EBPδ are the first
wave) of adipogenic transcription factors during the development of all types of
adipose cells. A genomic study shows that PPARγ binds to 5299 genomic regions,
where over 60% are also found to be bound by C/EBPα in the 3T3-L1 preadipocytes (Lefterova et al., 2008). Another study reports C/EBPα to be
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responsible for insulin-sensitive glucose transport and the regulation of several
adipogenic related proteins, such as diacylglycerol acyltransferase 1 and 2
(DGAT1/2) and ACC (Olofsson et al., 2008; Z Wu et al., 1999). Interestingly,
PPARγ expression is necessary and sufficient to induce adipogenesis even in the
lack of C/EBPα in mouse embryonic fibroblasts. In concordance, C/EBPα itself is
not able to induce adipogenesis in the absence of PPARγ (Rosen & MacDougald,
2006). The expression of the dominant negative mutant of PPARγ reduced the
mRNAs of several adipogenic key enzymes – GLUT4, insulin receptor, and
C/EBPα – in mature adipocytes (Tamori et al., 2002). So far, no other transcription
factors have been found to successively induce adipogenesis in the absence of
PPARγ, which indicates the importance and unique role of PPARγ in this process.
Peroxisome proliferator-activated receptor gamma (PPARγ) exists in two isoforms,
PPARγ1 and PPARγ2. The former one is more ubiquitously expressed while the
latter one is exclusively expressed in adipocytes. Nevertheless, both isoforms are
highly induced during adipogenesis (Siersbaek et al., 2010).
In summary, the expression of PPARγ and C/EBPα is induced by C/EBPβ
and C/EBPδ when the hormone-treated pre-adipocytes cease the MCE phase.
Both PPARγ and C/EBPα are essential for the differentiation of pre-adipocytes.
However, only PPARγ plays a unique and indispensable role in the differentiation
process.
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I.2 The receptor-mediated endocytosis
I.2.1 Endocytosis
All types of cells require fuel for metabolism. Eukaryotic cells, including the
adipocytes, have the most complicated systems to communicate with the
environment around them. Cells respond to changes and stimuli in the extracellular
environment to mediate signal transduction, build interior trafficking structures, and
secrete hormones to the extracellular environment (Alberts et al., 2007). To
complete these missions, eukaryotic cells developed a high-efficient internal
membrane trafficking system to transfer proteins (such as cell-surface receptors)
between different membrane structures and to take up solutes, particles, or
macromolecules from the external environment. By the process of exocytosis, the
cells deliver proteins, hormones, and lipids either to the plasma membrane or the
extracellular environment. Through the contrary process named endocytosis, the
cells internalize certain particles/macromolecules by surrounding them with an
area of the plasma membrane, removing the plasma membrane from the cell
surface to form a vesicle structure, and delivering the vesicle structure to different
intracellular compartments in an energy-consuming manner (Cooper, 2000).
Compartments, such as the ER and Golgi apparatus, in the exocytosis process
have recognizable shapes and certain localizations. In contrast, compartments in
endocytosis process exist as vesicles that are usually isolated from large cellular
structures. As a result, two endocytic compartments, the early endosomes and the
late endosomes, are distinguished by their localization and time of formation during
the endocytic process (Kornilova, 2014). Endocytosis can generally be divided into
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three stages. First, the cargos (solutes, particles, and macromolecules) are
internalized into the cell with part of the plasma membrane as intracellular vesicles.
Second, the internalized vesicles are sorted and delivered to the early endosomes
and then to different intracellular membrane compartments. At last, the cargos will
reach the final destination, either the lysosome to be degraded or the plasma
membrane to be reused (Sahay et al., 2010).
There are multiple pathways for the solutes, particles, and macromolecules
to enter the cells. Endocytosis has been broadly classified as phagocytosis and
pinocytosis (Cooper, 2000). These two categories can be distinguished by the size
of material been internalized and also by the dependence of phagocytosis on actin
polymerization as a key step in particle ingestion (J Liu & Shapiro, 2003). The
process of taking large particles (generally larger than 250 nm in diameter), such
as cell debris, bacteria or even another cell, is named phagocytosis (Doherty &
McMahon, 2009). Specific cell types, such as macrophages, monocytes, and
neutrophils are well-known “professional phagocytes” that wipe out foreign
material (bacteria and pathogens) as part of the immune system. The uptake of
fluids and solutes (such as vitamins, some ions, and cholesterol, which are
generally less than 150 nm in diameter), together with the macromolecules (such
as transmembrane receptors, ion-channels, and cell-surface transporters) that
they bind to, is called pinocytosis (Cooper, 2000). Different from phagocytosis that
usually occurs in phagocytotic cells, pinocytosis exists in all cell types. At least two
classifications of pinocytosis have been proposed: one considers the material been
engulfed into the cell; the other one emphasizes on the proteins that participate in
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the process of endocytosis (Sahay et al., 2010). The former one classified
pinocytosis as receptor-mediated endocytosis, adsorptive endocytosis, and fluidphase endocytosis (Khalil et al., 2006). The fluid-phase endocytosis can occur by
either

micropinocytosis

(vesicles

less

than

0.1

μm

in

diameter)

or

macropinocytosis (vesicles between 0.5 μm to 5 μm in diameter) (Kruth et al.,
2005). The latter one can further classify pinocytosis into two types: clathrindependent endocytosis, also known as clathrin-mediated endocytosis (CME), and
clathrin-independent endocytosis (Sahay et al., 2010).

I.2.2 Mechanism of receptor-mediated endocytosis: how the initial signal
is implemented – magnification V.S. quenching.
I.2.2.1 The ligands and the receptor tyrosine kinases: the soulmates
Receptor-mediated endocytosis (RME), which is characterized by selective
uptake of specific macromolecules followed by internalization of ligand-receptor
complexes, generally occur through a clathrin-dependent process (Lodish et al.,
2016). The categories of macromolecules been internalized through RME are 1)
peptide signaling growth factors, cytokines, and hormones, such as EGF, FGF,
and insulin; 2) cell metabolism-related macromolecules, such as transferrin and
low-density lipoprotein (LDL); 3) toxins, such as Clostridium perfringens Iota and
Clostridium botulinum C2; 4) viruses, such as measles virus (through Nectin 4
receptor) and Rubella virus (through myelin oligodendrocyte glycoprotein, MOG);
5) bacteria, such as Listeria monocytogenes (through E-cadherin and Met) and
Yersinia pseudotuberculosis (β1-integrins) (Backovic & Rey, 2012; Cossart &
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Helenius, 2014; Gibert et al., 2011; Kornilova, 2014). I will only discuss the entry
of macromolecules from the first category in this chapter.
Receptor-mediated endocytosis is controlled and regulated by a large
number of specialized proteins to mediate fission and fusion of phospholipid
membranes, engulfment of ligands and ligands binding proteins (the receptor
tyrosine kinases, RTKs), movement and directing of ligand-receptor complexes
containing vesicles towards different cellular structures (Doherty & McMahon,
2009). The process of RME starts with the binding of the macromolecules and
specific RTKs, which are a group of cell-surface receptors that consist of 58
receptors divided into 20 subfamilies (Critchley et al., 2018). Receptors and ligands
come in matched pairs. Each RTK only recognizes one or a few specific ligand(s),
for instance, the insulin receptor (IR) specifically identifies insulin and insulin-like
growth factors (IGFs), the epidermal growth factor receptor (EGFR) binds to EGF
and transforming growth factor α (TGF-α), and fibroblast growth factor receptor 4
(FGFR4, from the FGFR family) has high affinity to several ligands, including FGF1, 2, 4, 6, 8, 9, 16, 17, 18, and 19 (Lodish et al., 2016; Tiong et al., 2013).
Meanwhile, a ligand can be picked up by only one or a few receptor(s), e. g., insulin
can be recognized by both the IRs and the IGF receptors (IGFRs), FGF-1 can
binds to FGFR1/2/3/4 (Sorkin & Puthenveedu, 2014; Tiong et al., 2013).
However, the binding affinities between different ligands towards the same
receptor or different receptors with the same ligand are quite diverse. In summary,
despite the fact that one RTK can recognize one or several ligand(s) and one
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ligand can bind to different RTKs with vary affinities, the bindings between ligands
and RTKs are of high specificity and precision.

I.2.2.2 The internalization of ligand-receptor complexes: engulfment
does not mean suppression
The binding of RTKs with specific ligand(s) will form the ligand-receptor
complexes, which will be internalized into the cell with part of the plasma
membrane where the RTKs locate through RME (Figure 5.B). The responsiveness
of cells to the extracellular signal molecules depends on the number of ligandreceptor complexes formed on the plasma membrane. Thus, the endocytosis of
these complexes, which alters the distribution and concentration of RTKs on the
plasma membrane, regulates the long-term homeostasis and sensitivity of the cell
to specific ligands(s) (Lodish et al., 2016).
Once the RTKs recognize the extracellular signal and form the ligandreceptor complexes, the area of the plasma membrane that contains these
complexes will be pinched off as clathrin-coated pits (Figure 5). The internalization
process requires the participation of two proteins, the adaptor protein 2 (AP2) and
clathrin. The former one, AP2 complex, which is formed by 4 subunits (the large α
and β2 subunits, the medium-sized μ2 subunit, and the small-sized σ2 subunit) as
a heterotetrameric structure, serves as bridges between the plasma membrane,
RTK, and clathrin (Higgins & McMahon, 2002) Park, 2014 #1013). Knockout of
AP2 in mice is embryonic lethal, indicating the crucial role of AP2 in embryonic
development and cell homeostasis (Park & Guo, 2014). The latter one, clathrin,
36

has a triskelion structure with three clathrin heavy chains (CHC) stretched out from
a central vertex that is made up by three tightly associated clathrin light chains
(CLC) (Conner & Schmid, 2003; Royle, 2006). Knockout of the CHC in Hela cells
results in diminished growth rate and impaired endocytosis (Hinrichsen et al.,
2003). To form the clathrin-coated pits, the first step is to “mark” the transmembrane receptors – the majority of which are RTKs – to be internalized. The
marking is accomplished when cytoplasmic-located specific motifs of RTKs
become exposed because of structural change under ligand binding (Pearse et al.,
2000). The well-characterized motifs include the tyrosine-based YXXΦ/NPXY
motif and the dileucine-based [D/E]XXXL[L/I] motif (X is any amino acid, and Φ is
a bulky hydrophobic amino acid, e.g., leucine, isoleucine, methionine, valine, and
phenylalanine) (Bonifacino & Traub, 2003). The AP2 complex interacts with
phosphatidylinositol-4,5-bisphosphate

(PIP2)

and

phosphatidylinositol-3,4,5-

triphosphate (PIP3) through its α subunit and μ2 subunit. The interactions between
the AP2 complex and PIP2/PIP3 are responsible for its localization on the plasma
membrane (BM Collins et al., 2002). The AP2 complex also recognizes the
exposed YXXΦ/NPXY motif through the μ2 subunit and the [D/E]XXXL[L/I] motif
through μ2 and/or β2 subunit (Bonifacino & Traub, 2003). After binding to motifs
located on the RTK, the AP2 complex undergoes a large conformational change
from a locked state to an open state (Park & Guo, 2014). In the open state, AP2
complex recruits clathrin to the plasma membrane through the “hinge” domains of
its large α and β2 subunits and promotes the self-assembles of clathrin to build
cage-like structures/lattice (Park & Guo, 2014). Hence, the curvature of the
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membrane region that contains ligand-receptor complexes, the AP2 complexes,
and the recruited clathrin is called the clathrin-coated pit. Through the action of
other factors, such as endophilin and dynamin, the clathrin-coated pit further
curves into the cell and finally will pinch off from the cell membrane (Figure 5.B).
The mature pits – the pits dissociate entirely from the cell membrane – will
be uncoated and fuse to an early endosome where the ligand-receptor complexes
are sorted to lysosomes to be degraded or recycled back to the plasma membrane
to be reused (Figure 5.B). The ratio between the recycled receptors and degraded
receptors varies. For instance, the insulin receptors in the 3T3-L1 pre-adipocytes
are efficiently recycled upon insulin stimulation at a concentration of 100ng/ml
(Marshall, 1985). High concentration of EGF (over 100ng/ml) promotes the
degradation of EGFR while low concentration of EGF (lower than 50ng/ml) favors
recycling of EGFR (Sigismund et al. 2008).
The role of RME involves both the rapid internalization of receptors following
ligand binding and the subsequent sorting of the internalized ligand-receptor
complexes (Goh & Sorkin, 2013). Thus, RME plays an essential role in controlling
the functional activities of the RTKs.
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Figure 5. The tyrosine kinase domain of RTKs and receptor-mediated
endocytosis.
A. The tyrosine kinase domain of RTKs contains a smaller N-lobe and a bigger Clobe. The cleft between the two lobes permits a specific site for ATP binding. B.
Receptor tyrosine kinases are activated by binding with specific ligands followed
by the formation of ligand-receptor complexes. The activated RTKs interact with
AP2, which links to the plasma membrane and recruits clathrin. The ligandreceptor complexes then clustered on the plasma membrane to form a growing
curved clathrin-coated pit. The mature pit then buds off from the plasma membrane
and becomes the clathrin-coated pit (CCP). The CCP will be uncoated in the
cytosol and the uncoated vesicle will be delivered to early endosomes (EEs) to
fuse with them. Some ligand-receptor complexes remain intact while some ligands
dissociate from the receptors when reaching the early endosomes. The ligands
and some of the receptors will be sorted to late endosomes and eventually,
lysosomes to be degraded. However, some of the receptors will be recycled to the
plasma membrane. (Sorkin & Puthenveedu, 2014; Casem, 2016; Kirchhausen et
al., 2014; Cooper, 2000; Lemmon and Schlessinger, 2010).
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As is mentioned above, the RME mediates the internalization and sorting of
the RTKs. It is believed that the primary role of RME is to terminate the RTK
signaling through ubiquitination and degradation upon vesicle sorting. However,
several studies showed that the internalized ligand-receptor complexes continue
functioning and mediate the full biological functions of the RTK signaling (von
Zastrow & Sorkin, 2007). In other words, instead of just functioning as a delivery
station, the endosomes that contain ligand-receptor complexes may also function
as active signaling sites (Irannejad et al., 2015). For instance, activated EGFR has
been found to co-localize with endosomes and downstream signaling molecules,
including the adaptor protein – Src homology and collagen protein (Shc, Src stands
for Rous sarcoma oncogene cellular homolog), the Ras guanine nucleotide
exchange factor (GEF) – son of sevenless (SOS), and the docking protein – growth
factor receptor-bound protein 2 (Grb2) – in vivo (Di Guglielmo et al., 1994). Besides,
the internalized non-phosphorylated EGFR-ligand complex, which is induced by
reversible inhibitors, could be activated in endosomes upon inhibitor wash-out and
were able to perform its biological function by recruiting downstream signaling
molecules (Pennock & Wang, 2003). Furthermore, the tropomyosin receptor
kinase A (TrkA) receptors, once internalized upon nerve growth factor (NGF)
binding, localize on the endocytic vesicles, remain phosphorylated, and are
associated with phosphoinositide phospholipase C (PLC-γ1), which acts as an
essential intracellular signaling transduction enzyme that catalyzes the formation
of inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (Grimes et al., 1996). The
TrkA-NGF complexes were also shown to move from the distal axon to the
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neuronal cell body to carry the signal from the cell periphery to the nucleus (Cosker
& Segal, 2014). Researchers also observed an accumulation of activated insulin
receptors in the intracellular compartments in the presence of insulin (Kublaoui et
al., 1995).
In summary, the RTKs are internalized into the cell in the form of ligandreceptor complexes through clathrin-mediated endocytosis. The engulfed
receptors, in some cases, are not degraded immediately. Instead, these receptors
appear to remain activated and functional in endosomal compartments after
internalization.

I.2.2.3 The small GTPase Rab proteins in the receptor-mediated
endocytosis: the logistic company to control the delivery
As is mentioned above, common procedures of RME include the budding
of clathrin-coated pits from the plasma membrane into the cell, movement of
vesicles in the cytosol, targeting of the vesicles to specific destinations, and
eventually the fusion of vesicles to subcellular structures (Gonzalez & Scheller,
1999). Numerous of proteins, including the Rab (Ras-related GTP-binding protein)
family proteins, participate and act in the RME process to ensure the internalization,
targeting, and fusion to take place precisely. The Rab proteins are a group of small
GTPases (~20-30 kDa) belonging to the Ras superfamily and take part in the
process of membrane trafficking (Grosshans et al., 2006). Over 70 Rab proteins
are found to function in intracellular transport and are classified into 6 groups
based on their function in different components of intracellular membrane
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trafficking, such as vesicle budding, delivery, fusion, and localization of certain
proteins on different membrane domains (Stenmark, 2009). Mutations and
abnormal expression of Rabs have been found to relate with many diseases. For
instance, mutations on the Rab27a gene are responsible for the Griscelli syndrome
(Menasche et al., 2000). The G19V mutation of Rab38 leads to the HermanskyPudlak syndrome (Loftus et al., 2002). Rab25, which belongs to the Rab11
subfamily, is elevated expressed and has an oncogenic function in ovarian, breast,
prostate, bladder, and gastric cancer (S Wang et al., 2017). Rab23, a negative
regulator of the hedgehog signaling pathway that predominantly locates on the
plasma membrane, has increased expression in hepatocellular carcinomas,
diffuse-type gastric cancer, and follicular adenoma type of thyroid tumors (Evans
et al., 2003; Lim & Tang, 2015).
The Rab proteins function as molecular switches as they can be “turned off”
to their GDP-bound form (inactive form) by GTPase activating proteins (GAPs) and
“turned on” to their GTP-bound form (active form) by guanine-nucleotide exchange
factors (GEFs) (G Li, 2015). By recycling between the two forms, the Rab proteins
govern the receptor-mediated endocytosis by regulating membrane trafficking
system, specifically, by recruiting Rab effector proteins to specific sites of the
intracellular membrane structures. Every Rab protein has its unique localization on
distinct membrane compartments to control the specificity of membrane structures
and directionality of membrane trafficking (Zhen & Stenmark, 2015).
The Rab proteins can be found both in the cytosol and on membrane
structures. The Rab GDP dissociation inhibitor (GDI) specifically recognizes the
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GDP-bound Rabs. Thus, GDI solubilizes the Rabs and removes inactive Rabs
from membrane structures (Figure 6). The GDI displacement factor (GDF), which
locates on the donor membrane, initiates the recruitment of Rabs by dissociating
the GDI from Rabs and inserting the Rabs into the membrane of intracellular
compartments (Figure 6). To gain the membrane association ability, Rabs require
post-translational modification of two cysteine residues located on or near the Cterminal (Leung et al., 2006). The Rab proteins are then activated by a group of
membrane-bound proteins named guanine nucleotide exchange factors (GEFs)
(Figure 6). The activated GTP-bound Rabs then recruit several specific Rab
effectors to facilitate vesicle budding, vesicle movement/delivery, and vesicle
tethering (Muller & Goody, 2018). For instance, Rab1 and Rab2 are found on ER
and cis-Golgi to regulate ER-Golgi and Golgi-ER trafficking, respectively; Rab5 is
found to locate on early endosomes, clathrin-coated vesicles, and the plasma
membrane to mediate vesicle budding and early endosome fusion; Rab7 is found
on late endosomes to regulate late endosome trafficking (Stenmark & Olkkonen,
2001). Then the activated GTP-bound Rabs are converted to the inactive forms
through hydrolysis of GTP, which is mediated by another group of proteins termed
GTPase activating proteins (GAPs). As an end, the inactivated Rabs will be
removed from the acceptor membrane by the GDIs to enter the cytosol.
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Figure 6. Rab GTPases cycle.
Rab GTPases exist both in cytosol and on membrane. GDF, which locates on the
donor membrane, displaces GDI and inserts Rabs onto the donor membrane.
GEFs, which also locate on the donor membrane, replace the GDP to GTP to
activate Rabs. Activated Rabs can recruit specific Rab effectors to mediate
different membrane trafficking processes. The activated GTP-bound Rabs are
converted to the inactive forms through hydrolysis of GTP, which is mediated by
GAPs. Then GDIs specifically recognize the GDP-bound Rabs and thus solubilize
the Rabs and remove inactive Rabs from the acceptor membrane. (GDI: Rab GDP
dissociation inhibitor; GEF: guanine nucleotide exchange factor; GAP: GTPaseactivating protein; GDF: GDI displacement factor). (G Li, 2015; Zhen & Stenmark,
2015)
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In conclusion, the small GTPase Rab proteins perform their functions in the
RME process by switching between their active and inactive forms and recruiting
specific Rab effectors to certain membrane compartments.

I.2.3 Structure of the receptor tyrosine kinases
The human genome encodes 58 RTKs divided into 20 subfamilies, and the
majority of RTKs share similar structures (Karpov et al., 2015). Generally, an RTK
is comprised of an extracellular domain for ligand binding, a single α-helix
transmembrane domain, and an intracellular region that contains a juxtamembrane
domain, a tyrosine kinase domain (TKD), and a C-terminal (Lemmon &
Schlessinger, 2010). The extracellular domains of RTKs are quite diverse between
different subfamilies, which ensures the high specificity of each RTK to recognize
unique ligand(s) (Karpov et al., 2015). On the contrary, the intracellular regions are
relatively conserved between different subfamilies. The tyrosine kinase domain of
RTKs has an N-lobe and a C-lobe (Figure 5.A). The smaller N-lobe consists of a
five-stranded β-sheet and one α-helix, while the bigger C-lobe mainly consists of
α-helices (Huse & Kuriyan, 2002). Besides the big cleft between the two lobes that
forms a specific site for ATP binding, a phosphate-binding loop, which contains a
highly conserved Gly-rich (GXGXXG) motif, poses the γ-phosphate of ATP and
allows ATP to fit beneath the loop (Taylor & Kornev, 2011). Another highly
conserved construction, the activation loop, which usually contains around 20 to
35 residues and is the primary site of regulatory phosphorylation, starts at the
tripeptide Asp-Phe-Gly (DFG) motif and ends at another tripeptide Ala-Pro-Glu
45

motif (Svensson et al., 2016; Bayliss et al., 2015). The capacity of undergoing large
conformational change allows the activation loop to switch between inactive and
active states. In the inactive state, each TKD is stabilized in a unique auto-inhibition
configuration by several particular intramolecular interactions between the
juxtamembrane domain/C-terminal and the TKD (Lemmon & Schlessinger, 2010).
Though the structures of inactive TKDs differ from receptor to receptor, which
determines the diverse functions of RTKs, the active structures of all TKDs are
very similar to each other (Nolen et al., 2004). Upon activation of TKD by specific
ligands, the phosphorylated tyrosine residues in the activation loop then serve as
sites for assembly of signaling molecules that contain Src homology 2 (SH2) or
phosphor-tyrosine-binding (PTB) domains (Axel Ullrich & Schlessinger, 1990). The
phosphorylation of these signaling molecules can be triggered either directly by
phosphorylated RTKs themselves, or indirectly by docking proteins, which are
recruited and phosphorylated by activated RTKs (Schlessinger & Lemmon, 2003).
Then the recruited signaling molecules pass down the initial signal and regulate
cell survival, proliferation, and differentiation.

I.3

The

insulin

signaling

pathways:

the

essential

determinant

of

adipogenesis
The insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R)
belong to the IR subfamily of RTKs. Both IR and IGF-1R have differ affinities to
insulin and IGFs (IGF-1/-2), which are from the same structural-related insulinpeptide superfamily (De Meyts et al., 2000-2013). The insulin signaling pathways
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that are triggered by the activation of the IR and IGF-1R integrate the storage and
release of nutrients through human lives. The outlines of the insulins signaling
pathways have been well described, but many details of signal transduction still
need to be elucidated. The two well-established and most essential signaling
pathways been initiated by insulin/IGFs are the Erk1/2 signaling pathway and the
PI3K/Akt signaling pathway (Zarich et al., 2006). The effects of insulin signaling
pathways activation on adipocytes can be divided into three types: immediate
effects, mid-term effects, and long-term effects. Immediate effects, such as the
phosphorylation and dephosphorylation of specific enzymes and proteins, take
place within several seconds after IR activation. Mid-term effects include the upand down-regulated expression of specific proteins within 5-60 minutes after
insulin stimulation. Long-term effects, e.g., cell proliferation and cell differentiation,
will be detected from several hours to several days after insulin stimulation. Details
of the effects of the insulin signaling pathways on adipocytes will be discussed
later in this section.

I.3.1 Insulin receptor and its structure
The initiation of the insulin signaling pathways start with the binding of
insulin or IGFs to the IR or the IGF-1R. Between the two receptors, IR is the
primary site for insulin binding. The IR was first identified in 1971 by Cuatrecasas
on adipocytes (Cuatrecasas, 1971). Through decades of research, the IR is proved
to exist on the membrane of all types of mammalian cells with vary numbers from
~40 on erythrocytes to ~200~300 × 103 on adipocytes (Watanabe et al., 1998).
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Thus, dysregulation of cell metabolism happens when the IR is abnormally
expressed on the cell surface. For instance, increased expression of the IR is often
overserved in malignant cells. About 80% of the breast cancer cells have a
significant higher IR content than the normal breast tissue cells. Besides, a higher
level of IR expression predicts a poor survival in breast cancer patients (Vigneri et
al., 2016). The IR knockout mice only survived a few days after birth. The “fatspecific” IR knockout mice and adipocyte-specific IR knockout mice, though had a
reduced fat mass and were protected from obesity-associated glucose intolerance,
both suffered increased TAG accumulation in liver, hepatomegaly, and decreased
lifespan (M. Bluher et al., 2002; Eguchi et al., 2011; Joshi et al., 1996).
As a member of the RTKs, the IR contains an extracellular domain for ligand
binding, a transmembrane domain, and an intracellular region which includes a
juxtamembrane domain, a tyrosine kinase domain, and a C-terminal (Figure 7).
However, unlike the prototypical RTKs that exist as single-chain polypeptides, IR
exists as a covalently-linked tetramer consists of two α-subunits and two βsubunits (Weiss et al., 2014). The four subunits are disulfide-linked to form a ~350
kDa structure. The α-subunit and 194 residues of the β-subunit together form the
extracellular portion of the IR, while the rest of the β-subunit, which contains a
single transmembrane part and a cytoplasmic portion (IR-β-tail) that permits the
tyrosine kinase activity of the IR, is the intracellular portion (Belfiore et al., 2009).
Upon ligand binding, the α-subunits of the IR will inhibit the kinase activity of the
β-subunits by inducing a structural change of the IR molecule at first. Then, this
conformational change of the IR molecule will bring the two β-subunits close
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enough to each other to permit the kinase activity of the β-subunits (Boucher et al.,
2014). The activation of tyrosine kinase activity of the IR includes the
autophosphorylation of three tyrosine residues, which are Y1158, Y1162 and
Y1163 in the activation loop of the kinase domain (contains ~300 residues) (Figure
7). Among the three tyrosine residues, the Y1162 is hydrogen-bonded to the
catalytic loop that occludes the ATP-binding site in the absence of Mg2+-ATP and
will be the first to undergo autophosphorylation during IR activation, followed by
autophosphorylation of the other two residues (Wei et al., 1995). Mutations in these
three residues not only affected the kinase activity of the IR but also impaired the
biological function of the IR (Wilden et al., 1992). Besides the three tyrosine
residues that permit the catalytic kinase activity, some other tyrosine residues,
such as Y965 and Y972 in the juxtamembrane region (~35 residues; between the
transmembrane helix and the tyrosine kinase domain) and Y1328 and Y1334 in
the C-terminal (~70 residues) of the β-subunit, are also autophosphorylated upon
ligand binding (Figure 7). Mutations on the tyrosine sites leads to decreased
signaling transduction and/or diminished insulin sensitivity, glycogen synthesis,
and nutrients uptake (Table 2).
The IR has two isoforms: the IR isoform A (IR-A) without the exon 11, which
codes a 12-amino acid segment at the C-terminal of α-subunit, and the IR isoform
B (IR-B) with the exon 11 (Ebina et al., 1985; A. Ullrich et al., 1985). The two
isoforms exhibit vary distribution in a tissue-specific manner and distinct cellular
functional properties (Figure 7).
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Figure 7 The insulin signaling pathway.
Insulin receptor (IR) is activated upon insulin binding. The activation of IR leads to
the phosphorylation of several tyrosine kinases in the intracellular region of IR,
including Y972 in the juxtamembrane region, Y1158, Y1162 and Y1163 in the
tyrosine kinase domain and Y1328 and Y1334 in the C-terminal. The pY972 is
responsible for the activation of IRS-1 and Shc through the phosphotyrosinebinding domain (PTB domain), while Y1158, Y1162 and Y1163 activate IRS-2 after
phosphorylation. In the PI3K/Akt pathway showing on the right of the figure, the
activated IRS-1/2 can directly recruit the PI3K and eventually lead to the activation
of Akt. Glucose uptake, glycogen synthesis and Glut4 translocation are upregulated upon Akt activation. In the Erk1/2 signaling pathway showing on the left,
activated Shc recruits the Grb2-SOS complex, which mediates the GDP/GTP
exchange of Ras. At the end, Erk1/2 will be activated and anticipates in the
regulation of cell growth, gene expression and protein translation. (Cieniewicz et
al., 2016; Papich & Riviere, 2009; Youngren, 2007; Taguchi & White, 2008;
Boucher et al.; Hubbard, 2013).
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The IR-B has high affinity to insulin and is predominantly expressed in
differentiated tissues that contain a higher number of IRs on the cell surface and
have an inadequate response to IGF-2, such as liver, kidney, adipose tissue, and
muscle. In contrast, though the IR-A has similar affinity to insulin as the IR-B, it
exhibits high affinity to IGF-2. Besides, the IR-A is primarily expressed in fetal and
tumor tissues with comparatively greater rates of internalization and recycling than
the IR-B (Escribano et al., 2017). Because of these differences, the IR-A activation
is mainly associated with cell growth, cell proliferation, and cell survival, whereas
the IR-B activation favors regulation of metabolism and differentiation. In the 32D
cells, the IR-A preferentially sends mitogenic, antiapoptotic signals and translocate
insulin receptor substrates (IRS-1) to the nucleus more effectively while the IR-B
tends to send differentiation signals (Sciacca et al., 2003). In vascular smooth
muscle cells, the overexpression of IR-A confers a stronger migratory capability
(Beneit et al., 2016). The IR-A is also proved to be more efficient at increasing
glycogen synthesis and storage and promoting glucose uptake than the IR-B
(Diaz-Castroverde et al., 2016).
The activation of the IR will induce the recruitment of downstream proteins
that contain either a phosphotyrosine-binding domain (PTB domain) or an SH2
domain (Figure 7). E.g., IRS-1/-2 and Shc (Src homology and collagen protein)
have a PTB domain, while Shc and APS (adaptor protein with pleckstrin homology
and Src homology 2 domains) contain an SH2 domain (Boucher et al., 2014;
Taguchi & White, 2008). The PTB domain-containing proteins bind to pY972
(phosphorylated-Y972), which creates a lower affinity docking site for the PTB
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domain of IRS-1, but a much higher affinity docking site for the same domain of
Shc (Chaika et al., 1999; SawkaVerhelle et al., 1996). Interestingly, the Y972
belongs to the NPXY motif where the phosphorylation on the tyrosine site recruits
the AP2 complex. In addition, pY972 is also the recruiting site for IRS-2. However,
different from the IRS-1 that only interacts with the IR through one phosphorylated
tyrosine (the pY972), the IRS-2 also interacts with the three tyrosines that located
in the activation loop (Jensen & De Meyts, 2009; He et al., 1996). As
consequences of IR activation, two major signaling pathways are activated: the
Erk1/2 signaling pathway and the PI3K/Akt signaling pathway (Figure 7). The
specific function and regulation of the two pathways will be discussed later.

I.3.2 Insulin-like growth factor receptor 1 and its structure
The complementary DNA for human IGF-1R was cloned and sequenced in
1986 (A. Ullrich et al., 1986). It binds to IGF-1 with higher affinity than IGF-2 but
does not recognize insulin efficiently. The IGF-1R is widely expressed in many cell
types in fetal and postnatal tissues and plays a role in essential cellular processes,
including cell growth, cell differentiation, and apoptosis (Arcaro, 2013). Mice with
null mutants for the IGF-1R exhibit a severe growth deficiency (only 45% of normal
size) and die invariably at birth because of respiratory failure (JP Liu et al., 1993).
Non-malignant cells treated with IGF-1R nuclear translocation inhibitor or IGF-1R
inhibitor display a decreased proliferation and migration rate than the untreated
cells (Solomon-Zemler et al., 2017). In addition to the role of the IGF-1R during
development and cell proliferation, evidence also suggests a vital role of it in
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malignant transformation (Sachdev & Yee, 2007). For instance, data show that the
increased expression of the IGR-1R is associated with malignancy behavior in
familial pheochromocytomas and paragangliomas regardless of the age at
diagnosis and the genetic aetiology (Fernandez et al., 2013). Evidence also shows
that a disrupted activation of the IGF-1R results in inhibited growth and motility of
a wide range of cancer cells in vitro and in mouse models (Sachdev & Yee, 2007).
The IGF-1R and the IR are from the same subfamily of RTKs. Thus, the
IGF-1R is highly structural homologous to the IR, sharing 45% to 65% amino acid
identity in the ligand-binding domain, 65% to 85% identity in the tyrosine kinase
and substrate recruitment domains, and nearly absolute conservation in the ATP
binding pocket (Escribano et al., 2017). However, unlike the IR gene that is
alternatively spliced to produce two isoforms, the IGF-1R gene is assembled
without alternative splicing (Morris F. White, 2012). Similar to the IR, the IGF-1R is
a tetramer consists of two α-subunits and two β-subunits. One α subunit and one
β subunit form an αβ half-receptor monomer. Two monomers are assembled into
heterotetramer complex through disulfide bonds, which can be induced by
treatment of IGF-1 or Mn/MgATP in vitro (Treadway et al., 1989). Activation and
signaling transduction of the IGR-1R is also quite similar to those of the IR. The
three tyrosine residues locate on the activation loop of the tyrosine domain of IGF1R are Y1131, Y1135, and Y1136 (these three tyrosine residues resemble the
functions of Y1158, Y1162, and Y1163 on the IR). The Y950 locates on the NYXP
motif of the juxtamembrane domain of the IGF-1R has similar function as the Y972
of the IR (Table 2).
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Table 2. Locations and functions of essential amino acids on the β-subunit
of the IR and the IGF-1R.
A. Locations of essential amino acid residues on the β-subunit.
Receptor

Full
Length

Juxtamembrane
Domain

Tyrosine Kinase
Domain

IR-A1

1343

Y953, Y960

K1018, Y1146,
Y1150, Y1151

Y1316,
Y1322

IR-B2

1355

Y965, Y972

K1030, Y1158,
Y1162, Y1163

Y1328,
Y1334

IGF-1R3

1337

Y943, Y950

K1003, Y1131,
Y1135, Y1136

Y1316

C-Terminal

1

The numbering of amino acids of IR-A corresponds to the receptor of Ullrich et
al. (A. Ullrich et al., 1985).
2
The numbering of amino acids of IR-B corresponds to the receptor of Ebina et al.
(Ebina et al., 1985).
3
The numbering of amino acids of IGF-1R corresponds to the receptor of Ullrich
et al. (A. Ullrich et al., 1986).
B. Functions of essential amino acid residues on the β-subunit of the IR-B.
Amino acid
Y965

Y972

Function
IR autophosphorylation site
AP2 complex binding site15
IR autophosphorylation site
AP2 complex binding site9
PTB domain-containing protein binding site12
IRS-1/2 binding site5

K1030

ATP binding site6

Y1158, Y1162, Y1163

IR autophosphorylation sites
Essential tyrosine residues on the activation
loop14
IRS-2 binding site9

Y1328, Y1334

IR autophosphorylation sites

5

(He et al., 1996); 6(M. F. White et al., 1988); 9(Bonifacino & Traub, 2003);
12
(Chaika et al., 1999); 14(Cieniewicz et al., 2016); 15(Y Xu et al., 2011).
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C. Effects of essential amino acid residue mutants on the β-subunit of the
IR-B.

Mutant

Effects of Mutant

Y965F

No effect on IR internalization or IR auto-phosphorylation11

Y972F

No interaction with IRS-14,5
No effect on IRS-2 binding5
No effect on IR auto-phosphorylation11
Decreased insulin sensitivity6 and rate of glucose
transport12
Diminished glycogen synthesis and internalization8

Y965A

No effect on IRS-2 binding5
No effect on IR auto-phosphorylation11
Decreased IR internalization11

Y972A

No effect on IR auto-phosphorylation11
Decreased IR internalization11

△966-977

No effect on auto-phosphorylation of β-subunit8
Diminished downstream signaling, glycogen synthesis,
and IR internalization8

K1030A

No interaction with IRS-1/24,5
Decreased IR internalization13

K1030R

Diminished glycogen synthesis, insulin sensitivity, MAP
kinase activity,

Y1158F

No effect on IRS-2 binding5
Decreased IR internalization13

Y1158,
Y1162F,
Y1163F

Deduction of insulin-activated auto-phosphorylation16
Decreased IR internalization13
Diminished glucose uptake

△1312-1355

No significant influence on kinase activities7, 10
No significant effect on IR internalization13

4

(O’Neill et al., 1994); 5(He et al., 1996); 6(M. F. White et al., 1988); 7(Backer,
Schroeder, et al., 1992); 8(Backer et al., 1990); 9(Bonifacino & Traub, 2003);
10
(Myers et al., 1991); 11(Backer, Shoelson, et al., 1992); 12(Chaika et al., 1999);
13
(Carpentier et al., 1993); 14(Cieniewicz et al., 2016); 15(Y Xu et al., 2011); 16(Ellis
et al., 1986).
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I.3.3 Signaling transduction in adipocyte differentiation
Because of the important function in cellular signaling transduction, the
RTKs regulate several essential cellular processes such as proliferation,
differentiation, and tissue homeostasis (Lemmon & Schlessinger, 2010; F Liu &
Zhuang, 2016). For instance, RTKs regulate the liver regeneration through the
Erk1/2 signaling pathway (J Li et al., 2011). In liver, the proliferation of hepatocytes
(hepatocytes undergo two cell cycles) occur in the early 66 hours after partial
hepatectomy (L Xu et al., 2010). The RTK à SHC à GRB2/SOS à RAS à RAF
pathway is found to promote the progression of G1 phase during the proliferation,
while the RTK à PLCγ à PKC à SRC/PYK2 à GRB2/SOS à RAS à RAF
pathway participates in advancing the S phase and G2/M phase checkpoint (J Li
et al., 2011). RTKs also regulate the differentiation of mesenchymal stem cells
(MSCs) into neuronal cells (Tzeng et al., 2015). Upon the stimulation of growth
factors such as FGF-8 (fibroblast growth factor 8) and FGF-2 (fibroblast growth
factor 2), RTKs induce activation of both the Erk1/2 signaling pathway and the
PI3K/Akt signaling pathway in MSCs (Trzaska et al., 2007). On the one hand, the
phosphorylation of Erk in the former pathway phosphorylates the downstream
protein GREB (cAMP response element-binding protein) and then leads to the upregulation of TrkB (tyrosine receptor kinase B, the receptor of BDNF) and the
secretion of BDNF (brain-derived neurotrophic factor) (Tzeng et al., 2015). On the
other hand, the activation of the later pathway plays a critical role in cell survival
(Tzeng et al., 2015). Therefore, the importance of RTKs on intracellular trafficking
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and cellular signaling, and how these receptors regulate proliferation and
differentiation will allow us to understand the critical role of these receptors in the
process of adipogenesis.
Following up the functions of RTKs, the IR specifically activates two
essential signaling pathways: the Erk1/2 signaling pathway and the PI3K/Akt
signaling pathway (Figure 7). Through the two pathways, the activation of the IR
regulates multiple biological processes: gene expression, protein translation, and
cell growth via the Erk1/2 signaling pathway; and changes in metabolic function,
such as glucose uptake, glycogen synthesis, and expression of necessary
enzymes/proteins as acute metabolic response, through the PI3K/Akt signaling
pathway (Taniguchi et al., 2006; Jensen & De Meyts, 2009). On the one hand, Shc
is recruited and activated through the pY972 on the juxtamembrane domain of the
IR. Then Grb2 will be recruited via the interaction between its SH2 domain and
tyrosine phosphorylated Shc (Jameson et al., 2016). At last, SOS will be recruited
and interacts with the two SH3 domains of Grb2 to form the Grb2-SOS complex,
following the activation of RAS à RAF à MEK à Erk1/2 cascade (Zarich et al.,
2006). On the other hand, the phosphorylation on the Y972 recruits and activates
both IRS-1 and IRS-2 whereas the Y1158, Y1162, and Y1163 on the activation
loop of the IR are only responsible for IRS-2 recruitment and activation. Then PI3K
will be recruited and activated based on its SH2 domains following IRS-1/2
activation (Youngren, 2007). The activated PI3K finally leads to activation of Akt,
which ensures the IRS-1/2 à PI3K à Akt cascade.
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Besides the effects on normal cell processes, the IR signaling pathways are
essential for the differentiation of the pre-adipocytes in specific aspects. First, the
signaling pathway is triggered by activation of the IR and regulates the
differentiation, proliferation, and growth of the fat cells (adipocytes) by stimulating
the formation and storage of lipids in both pre-adipocytes and adipocytes (Saltiel
& Kahn, 2001). Second, the invagination of the IR complexes is activated through
the RME, which regulates the IR distribution on the plasma membrane, insulin
sensitivity, and density of the IR biological activities (Morcavallo et al., 2014).
Interestingly, the receptor signaling of IR complexes is not terminated after
invagination, on the opposite, it can be magnified (Vieira et al., 1996). Since the
internalized IR complexes are still active and continue triggering the downstream
signaling, the process of internalization is essential for the regulation of signal
transduction (Sorkin & Von Zastrow, 2002). As is discussed above, there are two
fates for these internalized vesicles: 1) to merge with lysosomes and be degraded;
2) to proceed to the recycling endosomes from where the IR is brought back to the
cell surface to be used again (Marsh, 2001). The transport and sorting of early
endosomes require the participation of Rab5 (Hunker et al., 2006).

I.4 Regulating the function of Rab5
I.4.1 The small GTPase Rab5: small but essential
Rab5 is a Ras-like small GTPase (small GTP-binding protein) that not only
shows a crucial regulatory role in controlling the RME of the IR but also plays a
rate-limited role in early endosome fusion (Barbieri et al., 2004). Like the other
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GTPases, Rab5 has two forms: the active form and the inactive form. The active
form is also the Rab5 GTP-bound form, while the inactive form is also the Rab5GDP-bound form (Figure 8). The converting of the Rab5 GTP-bound form to the
Rab5 GDP-bound form (inactivation of Rab5) is triggered by Rab5 GAPs while the
activation of Rab5 is catalyzed by Rab5 GEFs (Figure 8).

Figure 8. Rab5 regulation.
As other GTPases, Rab5 has two forms: the active form and the inactive form. The
active form is the Rab5 GTP-bound form while the inactive form is the Rab5 GDPbound form. The converting of the GTP-bound form to the GDP-bound form
(inactivation of Rab5) is triggered by GAPs while the converse activation process
of Rab5 is catalyzed by GEFs (Lundquist, 2006). The ribbon diagrams of
GTP/GDP-bound form of Rab5 are modified from Zhu et al. (Zhu et al., 2004). The
switch I/II (SW (I)/(II)) regions are shown in red and blue, respectively. GppNHp (a
nonhydrolyzable GTP analog), GDP, and metal ions are shown in brown sticks and
dots, respectively. (PL: phosphate-binding loop; GAP: GTPase activating protein;
GEF: guanine exchange factor; GppNHp: guanosine-5’(β,γ)-imidotriphosphate.)
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As the primary Rab protein to function in early endosome dynamics and
probably the one that has the best-characterized effectors in mammalian studies,
Rab5 presents on the plasma membrane and endocytic vesicles, but mainly
locates on sorting endosomes (Woodman, 2000). Rab5 is also a membraneassociated protein that undergoes a hydrophobic modification at the C-terminal
(Woodman, 2000). The isoprenylation of C-terminal cysteines allow Rab5 to
associate with the membrane of an organelle or transport vesicles in its GTPbound form (Pechlivanis & Kuhlmann, 2006). When in the Rab5-GDP binding form,
Rab5 can be maintained in a soluble state, transferred, and efficiently recruited in
the cytosol by forming a cytosolic complex with guanine nucleotide dissociation
inhibitor (GDI) (Woodman, 2000). The GDI displacement factors (GDFs), which
present on the membrane of the endocytic vesicles or the early endosome, then
catalyze the localization of Rab5 to these membrane compartments and mediate
the replacement of GDI (Blumer et al., 2013). A Rab5 GEF in the endosome
membrane will then activate Rab5 by exchanging GDP to GTP (Alberts et al.,
2007). The activated Rab5 can activate PI3K, which synthesizes PI3P
(phosphatidylinositol 3-phosphate). Together with PI3P, the activated Rab5 binds
to a variety of Rab5 effectors to perform the biological effects of Rab5 on
endosome fusion (Woodman, 2000). In addition, the activated Rab5 can recruit
more Rab5 GEFs, thus creating a positive feedback loop to further enhancing
Rab5 assembly. Interestingly, Rab5 is also reported to be required for the
interaction between IRS-1 and p85α and the activation of Akt upon insulin
stimulation (Su et al., 2006).
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In summary, Rab5 activity is regulated by several Rab5 specific GEFs and
GAPs, and more importantly, different Rab5 effectors are recruited by the GTPbound Rab5 to modulate particular intracellular pathways (Table 3).

Table 3. Rab5 regulators and effectors.
Regulator/Effector
RIN1/2/3
Rab5 GEF

Rabex-5
ALS2/Alsin
RAP6/GAPex-5/RME-6

Rab5 GAP

RN-Tre
RabGAP-5
Rabaptin-5
Vps34
Rabenosyn-5

Rab5 effectors

EEA1
APPL1/2
PI3K
Rabankyrin-5
Huntingtin

I.4.2 Guanine nucleotide exchange factors, GTPase-activating proteins,
and effectors of Rab5: working cooperatively
Rab5 GEFs, including Ras interference 1/2/3 (RIN1/2/3),

Rabaptin-5

associated exchange factor for Rab5 (Rabex-5), , amyotrophic lateral sclerosis 2
(ALS2/Alsin), GTPase activating protein and exchange factor for Rab5 (GAPex-5),
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and Ras interference-like (Rinl) are specialized by the highly conserved vacuolar
protein sorting-associated protein 9 (VPS9) domain through which the inactivated
Rab5 interacts with (Carney et al., 2006). The VPS9 domain-containing proteins
are widely conserved in eukaryotic cells of different species, such as Vps9p and
Muk1p from S. cerevisiae, RME-6, RABX-5, and CE23604 from Caenorhabditis
elegans (C. elegans) and at least nine proteins from the human beings (Carney et
al., 2006).
Functions of the Rab5 GEFs have been extensively studied in the past four
decades. The RIN family is composed of RIN1, RIN2, and RIN3. They are
multifunctional proteins that, besides the VPS9 domain, contain another three
domains: the RA (Ras association) domain, the PR (proline rich) domain, and the
SH2 domain. The RIN proteins share similar structure of all the domains but are
distinguished by the containing of a different number of the PH domain, which has
one/two/three repeats in RIN1, RIN2 and RIN3, respectively. The RIN proteins can
be activated by the IR through the SH2 domain and activate Rab5 through the
VPS9 domain upon IR activation. Activation of RIN proteins leads to the activation
of Rab5, thus promotes the early endosome fusion (Barbieri et al., 2004). The RA
domain of the RIN proteins is responsible for the interaction with Ras, indicating
RIN proteins to be Ras effectors that promote Rab5 activity. RIN1 is the most wellcharacterized protein in the RIN family, existing in both the cytoplasm and the
plasma membrane (Colicelli et al., 2012). Previous studies show that RIN1
promotes EGFR and TGF-β receptor internalization through Rab5 activation
(Barbieri et al., 2003; Colicelli et al., 2012). The expression of RIN1-SH2 domain,
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however, impairs the EGFR internalization without affecting cargo endocytic
receptors, such as transferrin (Barbieri et al., 2003). RIN1 also binds to 14-3-3
proteins through a sequence containing serine 351. The binding with 14-3-3
locates RIN1 to the cytoplasm and intracellular compartments whereas the
mutation S351A shifts RIN1 localization to the plasma membrane (Y Wang et al.,
2002). RIN1:R94A mutant, which locates in the SH2 domain, showed a decreased
interaction with EGFR upon EGFR activation (Barbieri et al., 2003). The
RIN1:Y561F mutant, which locates in the VPS9 domain of RIN1, showed defective
function in activation of Rab5 and dramatic inhibition of Rab5 function (Galvis et
al., 2009). In addition, RIN1 has been found to be a breast tumor suppressor gene
and undergoes a regulated expression in forebrain neurons and epithelial cells
(Dzudzor et al., 2010; Milstein et al., 2007). RIN2 and RIN3 display same
biochemical property as RIN1 that perform the guanine nucleotide exchange
activity. However, both RIN2 and RIN3 can bind to amphiphysin II, whereas RIN1
cannot. Besides this distinct interaction, RIN1 is dominantly expressed in brain and
pancreas, RIN2 has its highest expression in heart and kidney, and RIN3 exhibits
higher expression in human mast cells (Carney et al., 2006; Janson et al., 2012).
RIN3 also exhibits a unique intracellular localization as it locates on Rab5-positive
vesicles in the cytoplasm but does not colocalize with the essential early
endosome marker early endosome antigen 1 (EEA1) (Kajiho et al., 2003).
The Rinl was recently identified as a Rab5 GEF with high similarity to the
RIN proteins but without an RA domain (Kajiho et al., 2012). It is ubiquitously
expressed in all types of cells but with higher expression in lymphoid organs, such
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as thymus and spleen, and specifically accumulates at neuromuscular synapses
(Woller et al., 2011). It colocalizes with Rab5 in actin-rich membrane ruffles, which
indicates a novel role of Rinl to recruit Rab5 to the cytoskeleton (Woller et al., 2011).
Interestingly, the Rinl also activates Rab22 and even shows a higher catalytic
activity for Rab22 compared to Rab5.
The Rabex-5 protein structure is identified to be made up of an N-terminal
domain, a membrane binding domain, a helical bundle (HB) domain, a VPS9
domain, a coiled-coil (CC) domain, and a PR domain (Shin et al., 2012). The
Rabex-5 activates Rab5 and thus recruits Rabaptin-5 (a Rab5 effector), which then
binds to the GTP-bound Rab5 and recruits Rabex-5 in a positive loop. Interestingly,
the GTP exchange activity of Rabex-5 is much higher when in the Rabex-5Rabaptin5 complex (Delprato et al., 2004). Besides, the VPS9 domain of Rabex-5
alone shows a higher GTP exchange activity than the full-length Rabex-5 (Delprato
et al., 2004).
Alsin is a 183kDa protein that mainly expresses in brain. It is a
multifunctional protein that contains a Ran GEF RCC1 (RCC1-like) domain, a
tandem Dbl homology (DH) domain, a pleckstrin homology domain, several
membrane occupation and recognition nexus (MORN) motifs, and a VPS9 domain
(Carney et al., 2006). Alsin exhibits colocalization with Rab5 and its effector EEA1
on the early endosomes in Hela cells (Otomo et al., 2003). Overexpression of the
wild-type Alsin and the constitutive active form of Alsin both results in enlarged
endosomes in cultured neuronal cells through the activation of Rab5 (Otomo et al.,
2003). Besides, Alsin-deficient mice exhibit a disturbance in endosome
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transportation of IGF-1R but unaltered endocytosis of transferrin and dextran
(Devon et al., 2006).
Rab5-activating protein 6 (RAP6) is the human homolog of GAPex-5, which
is also known as receptor-mediated endocytosis protein 6 (RME-6) as the C.
elegans homolog, contains an N-terminal RasGAP domain and a C-terminal VPS9
domain. Unlike the other Rab5 GEF proteins that colocalize with Rab5 on the early
endosomes, RAP6 is primarily found on clathrin-coated pits (CCPs). In vivo, the
expression of the dominant-negative form of Rab5 (Rab5-S34N, this mutant will
be discussed later in other chapters) or small interfering RNA (siRNA)-mediated
depletion of RAP6, reduced the uncoating efficiency of AP2 complex on the CCPs
by increasing the steady-state levels of AP2 (Semerdjieva et al., 2008).
Another group of proteins that regulate the Rab5 function are the GAPs,
including the Rab5-specific GAP protein (RabGAP-5) and related to the N terminus
of tre oncogene (RN-tre), which solubilize Rab5 by inactivating Rab5 from the
acceptor membrane (Figure 6). The rate of GTP hydrolysis mediated by GAPs is
relatively high since the basal rate is intrinsically slow (~1 min) (Scheffzek et al.,
1998).
RN-tre localizes to Rab5-positive vesicles. Overexpression of RN-tre
inhibits the Rab5-dependent internalization of transferrin and EGF but does not
affect the membrane association of EEA1 (Haas et al., 2005; Palamidessi et al.,
2013). Removal of RN-tre increases the level of active Rab5 and significantly
improves the cell migration of mouse embryo fibroblasts in vitro (Palamidessi et
al., 2013).
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The overexpression of RabGAP-5 results in a loss of Rab5 effector EEA1
from early endosomes and impaired endocytosis (Haas et al., 2005). However,
depletion of RabGAP-5 leads to similar phenotype as the expression of the
constitutive active mutant of Rab5 (Rab5-S34N): level of endosome-localized
EEA1 is increased, endosomes become larger, and trafficking of EGF is disrupted
(Haas et al., 2005).
In the processes of vesicle formation and delivery, Rab5 is also regulated
by multiple Rab5 effectors. As one of the best studied Rab proteins to date, Rab5
has been found to interacts with as many as 30 different effector proteins (Pfeffer,
2005). For instance, EEA1, an important Rab5 effector that binds to Rab5-GTP
form, is the only effector that is necessarily required by minimal fusion and
mediates endosome docking (Christoforidis et al., 1999). Another Rab5 effector,
Rabaptin-5, is initially identified as an GTP-bound Rab5 effector through a yeast
2-hybrid screen (Stenmark et al., 1995). Rabaptin-5 is mostly found as a complex
with Rabex-5 in the cell (Horiuchi et al., 1997). Rabex-5 and Rabaptin-5 recruit
each other in a positive loop upon Rab5 activation and thus keep the membrane
Rab5-postive until the loop is interrupted by other recruited compartments (Kalin
et al., 2015). Deletion of the Rab5-binding domain of Rabaptin-5 results in giant
endosomes as well as impaired endocytosis process (Kalin et al., 2015).
In summary, the movement of intracellular vesicles mediated by RME is
related with Rab5 and its effectors due to their roles in regulating vesicle formation
and delivery.
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CHAPTER II
II. Role of Rab5 in the process of adipogenesis
II. 1 Introduction
As described in Chapter I, the in vitro differentiation of the mouse 3T3-L1
pre-adipocytes into mature adipocytes is an insulin-dependent ten-days process
that can be divided into a mitotic clonal expansion (MCE) phase and a terminal
differentiation phase (Tang & Lane, 2012). The pre-adipocytes undergo two cycles
of mitosis during the MCE phase maintaining their fibroblast-like cell characteristics.
However, the cells exhibit distinct morphological changes in the terminal
differentiation phase. Besides the alterations in the cell shape and size, the most
noticeable feature of the mature adipocytes is the formation and accumulation of
a large number of lipid droplets in the cytosol (Suzuki et al., 2011). The conversion
from pre-adipocytes into adipocytes, along with the remarkable changes in cell
morphology, is controlled by the insulin and IGF-1 signaling pathways and
numerous transcription factors. Much of what is known about the adipogenic
factors required for adipogenesis process is based on the in vitro studies of
adipogenic cell lines, such as the mouse 3T3-L1 and 3T3-F442A cell lines. The
essential transcription factors promoting the adipogenesis process are the
peroxisome proliferator-activated receptor γ (PPARγ) and the CCAAT/enhancerbinding protein (C/EBP) family (Rosen et al., 2002). These transcription factors
regulate the expression of most genes that define mature adipocytes, including the
insulin-sensitive glucose transporter isoform 4 (GLUT4), which is primarily
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expressed on the plasma membrane of adipocytes (James et al., 1988; Tamori et
al., 2002). The expression level of GLUT4 and the number of GLUT4 existing on
the plasma membrane is regulated through the insulin and IGF-1R signaling
pathways (Bryant et al., 2002; Czech & Buxton, 1993). Several Rab proteins are
involved in the trafficking of GLUT4 by participating in the insulin signaling
transduction process and the transportation of GLUT4 from intracellular GLUT4
storage vesicles (GSVs) to the plasma membrane (Sadacca et al., 2013). In
particular, three Rab proteins of the endosomal system (e.g., Rab5, Rab4, and
Rab11) participate at different steps of the GLUT4 trafficking process.
Rab5 is a key regulatory molecule directing in the early endocytic pathway
(Barbieri et al., 2004; Barbieri et al., 2000; Hoffenberg et al., 2000). Rab5 is
encoded as three differentially expressed isoforms, Rab5a, Rab5b, and Rab5c
(Chen et al., 2009). The mRNA expression profiling study shows distinct tissue
distributions of the Rab5 isoforms (Gurkan et al., 2005). A study shows that the
suppression of Rab5a or Rab5b undermines the degradation of EGFR, whereas
Rab5c shows limited effect (Chen et al., 2009). Another study suggested the
silencing of Rab5c, but not the other two isoforms, significantly reduced the focal
adhesion foci of Hela cells, indicating a particular role of Rab5c in cell migration
(Chen et al., 2014). However, the functional redundancy of the isoforms is
suggested as only the simultaneous knockdown of all three isoforms results in an
inhibition of the insulin-dependent Akt activation, whereas individual knockdown of
any single isoform does not affect Akt activation (Su et al., 2006).
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Mutational studies have shown that the Rab5:S34N, a Rab5 GTP-binding
defective mutant, inhibits transferrin and EGF endocytosis displaying a dominantnegative effect; whereas the Rab5:Q79L, a mutant with reduced GTPase activity,
behaves as a constitutively active Rab5 mutant stimulating internalization of
several ligands, such as EGF and insulin (Dinneen & Ceresa, 2004; Hunker et al.,
2006; Jozic et al., 2011; Jozic et al., 2012; Mendoza et al., 2013). The Q79 residue
of Rab5 locates on the GTPase domain (residues 15-184) of Rab5. Structural
study of Rab5 reveals that each GTPase domain of Rab5 binds to one GTP and
one Mg2+ ion and contains a central six-strand β-sheet (β1- β6) flanked by five αhelices (α1- α5) (Terzyan et al., 2003). Two switch regions, switch I (residues 4464) and switch II (residues 76-94) undergo structural changes between the GTPbound and GDP-bound forms (G Zhu et al., 2004). Several residues on Rab5 have
been reported to be responsible for the interaction and recruitment of specific Rab5
effectors. For instance, Y57A, W74A, Y82A, and Y89A based on the Rab5:Q79L
mutant showed significant decreased binding affinity with Rabaptin-5, whereas
K116E and R120E based on the Rab5:Q79L mutant had no effect on Rab5Rabaptin-5 binding (G Zhu et al., 2004). Moreover, Y57A, W74A, Y82A, and Y89A
are also found to be effector binding epitopes for EEA1 and Rabenosyn-5 based
on structural studies (Mishra et al., 2010).
Like the other small GTPases, the Rab5 cycle is regulated by several Rab5
GEFs (e.g., RIN1, Rabex-5, and Rinl) and Rab5 GAPs (e.g., RN-tre and RabGap5). Rab5 in its active form (the GTP-bound form) recruits several downstream
effectors onto the endosome membrane to support the endosomal fusion in the
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early endocytic pathway and the interaction of endosomes with microtubule
networks (Balaji et al., 2012; Sandri et al., 2012). Rab5 is also implicated in other
cellular processes such as receptor cell signaling and phagosome maturation
(Mustafi et al., 2013). Recently, Rab5 is also proved to participate in several
cellular functions, including endoplasmic reticulum (ER) reorganization, nuclear
Lamin disassembly, spindle assembly and stability during mitosis (Audhya et al.,
2007; Capalbo et al., 2011; Das et al., 2014). Furthermore, up-regulation of the
Rab5-GTP level upon addition of EGF requires the participation of one or more
Rab5 GEFs (Hunker et al., 2006; Jozic et al., 2011; Jozic et al., 2012). Interesting,
the addition of insulin to 3T3-L1 pre-adipocytes, but not the NIH-3T3 or the HepG2
cell lines, induced inactivation of Rab5 (Huang et al., 2001; Tessneer et al., 2014).
Thus, evidence regarding the regulation of Rab5 activity during adipogenesis
process and the understanding of the cellular mechanisms by which Rab5
modulates the differentiation of 3T3-L1 pre-adipocytes are lacking.
Besides Rab5, several Rab proteins (e.g., Rab4, Rab7, Rab22, and Rab31)
also have their particular roles in the endocytosis process. In vitro study of 3T3-L1
cells reveals an increased cytosolic Rab4 level upon insulin stimulation (Shisheva
& Czech, 1997). Rab4 is also proved to play a role in determining directional
vesicle mobility (Potokar et al., 2012). Similar as Rab5, the overexpression of the
dominant-negative mutant of Rab4 (Rab4:Q67L) results in enlarged endosomes
and diminished vesicle mobility in terms of vesicle track length (the total length that
the vesicle traveled during analysis), maximal displacement (maximal distance
between two positions in the track that the vesicle traveled during analysis), and
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speed (Potokar et al., 2012). Consistently, the overexpression of the dominantpositive mutant of Rab4 (Rab4:S22N), leads to dysfunctional vesicle directionality
(Potokar et al., 2012). If Rab5 is the key for homotypical early endosome fusion,
then Rab7, which controls the net movement of late endocytic elements, is the star
to govern the early to late endosome fusion (Lebrand et al., 2002). It is reported
that Rab7 colocalizes with the insulin-responsive GLUT4-containing intracellular
compartments, but its localization is not affected by the stimulation of insulin (Millar
et al., 1999). The deletion of Rab7 in Hela cells does not affect the trafficking of
the EGF-EGFR complex through the early endosome to the late endosome upon
EGF stimulation. However, the EGF-EGFR complex is sequestrated in the late
endosomes indicating a regulatory role of Rab7 in the receptor trafficking
(Vanlandingham & Ceresa, 2009). Rab11 is a master regulator to mediate the
transportation of intracellular vesicles towards the cell surface in the exocytosis
process (Takahashi et al., 2012). Depletion of Rab11 results in tubulated recycling
endosomes as well as the accumulation of recycling compartments containing
endocytosed transferrin and transferrin receptor beneath the plasma membrane
(Takahashi et al., 2012). Rab22 is from the same subfamily of small GTPases as
Rab5 and thus displays high sequence homology to Rab5 (Kauppi et al., 2002). A
previous study showed that Rab22 even perform a higher affinity to the Rab5 GEF,
Rabex-5, interacted with Rabex-5 to recruit the Rab5 effector, EEA1, and
promoted early endosome fusion (HP Zhu et al., 2009). The knockdown of Rab22
abrogates the membrane targeting of Rabex-5 in the body hamster kidney (BHK)21 cells as well as the NGF-induced TrkA endocytosis in the PC12 cells (Wang et
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al., 2011; HP Zhu et al., 2009). Rab31 is also a Rab5 subfamily GTPase that can
be activated by the Rab5 GEF, RAP6, and perform its function in trans-Golgi
Network-to-endosome trafficking (Lodhi et al., 2007). The overexpression of
Rab31 impairs the GLUT4 translocation from the intracellular compartments to the
cell surface whereas the knockdown of Rab31 potentiates both GLUT4
translocation and glucose uptake upon insulin stimulation (Lodhi et al., 2007).
Because of the essential role of Rab proteins in the regulation of
endocytosis as well as in trafficking of glucose, I hypothesized that Rab5 and other
Rab proteins participate in the 3T3-L1 pre-adipocytes adipogenesis process
positively.

II.2 Specific aims and research design
II.2.1 Specific aim 1: To examine the key determinants of Rab5 that are
required in adipogenesis.
Rab5 is a small GTPase required for several cellular processes, including
proliferation, migration, and invasion. It functions as a molecular switch as it cycles
between its GTP-bound form (the active form) and GDP-bound form (the inactive
form). The switch of Rab5 is controlled by guanine nucleotide exchange factors
(GEFs), which activate Rab5 by increasing the nucleotide status of Rab5 in the
GTP-bound form, and also by GTPase activating proteins (GAPs), which inactivate
Rab5 by accelerating the hydrolysis of GTP to GDP. Preliminary observations
indicated that the expression of Rab5-Wild-type (WT) affected adipogenesis.
Therefore, I determined
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1.a the effect of the Rab5 isoforms (Rab5A, Rab5B, and Rab5C) on adipogenesis.
1.b the nucleotide status of Rab5 during adipogenesis
1.c the effect of the deletion of the N-terminal or C-terminal of Rab5 on
adipogenesis.
1.d the effect of point mutants in the effector domain of Rab5 on adipogenesis.
1.e the particular role of Rab5 in the differentiation process in comparison with
other Rab5 family proteins.

II.2.2 Research design 1
Rab5 isoforms, and several point and deletion mutants of Rab5, as well as
several selected Rab proteins, were inserted into the pMX-puro vector at the EcoRI
and NotI restriction sites. Then the plasmid DNA were purified via the plasmid
purification assay. The purified DNA was transfected into the Plat-A cells using
Lipofectamine® 2000 reagent as specified by Invitrogen. After 48 hours, virus
suspension from the Plat-A cells was applied to the 3T3-L1 mouse pre-adipocyte
cell line for the expression of specific proteins. The transfected cells were then
selected with puromycin. siRNA for the Rab5 isoforms were designed and
synthesized by Ambion. The purchased specific siRNA was induced into the 3T3L1 cells by Lipofectamine® 2000 reagent as specified by Invitrogen. The siRNAtransfected or the selected pMX-puro vector-transfected 3T3-L1 cells were utilized
for several biological assays, including cell cycle testing, lipid accumulation testing
(ORO assay, only for differentiated cells), microscopy, and western blotting.

98

Cell lysates of the 3T3-L1 cells that have been transfected with GFP,
Rab5:WT, Rab5:Q79L, and Rab5:S34N were incubated with GST-labeled EEA1.
The bonded proteins were eluted and be used for immunoprecipitation analysis.

II.3 Material and Methods
II.3.1 Materials
The 3T3-L1 pre-adipocyte cell line was obtained from the Zen-Bio, Inc. (NC,
USA). The Platinum A (Plat-A) retroviral packaging cell line and the pMX-puro
retroviral vector were purchased from Cell Biolabs, Inc. (San Diego, CA, USA).
Primary antibodies, including the insulin receptor (IR), GLUT4, Akt1, p-Akt
(Ser473), PPARγ, C/EBPα, Erk1/2, p-Erk1/2, FABP4, FAS, ACC, GAPDH, and
Rab5, and secondary antibodies, including the anti-Rabbit IgG and anti-Mouse IgG,
were purchased from the Cell Signaling Technology (Boston, MA, USA). Fetal
bovine serum (FBS) was purchased from the RMBIO, Inc. (Missoula, MT, USA).
Other reagents and supplies, if not specifically described, were purchased from
Thermo Fisher Scientific (Weston, FL, USA).

II.3.2 cDNA Construction.
Complementary DNAs (cDNA) of green fluorescent protein (GFP), Rab5
isoforms,

Rab4:wild-type

(Rab4:WT),

Rab7:WT,

Rab11:WT,

Rab22:WT,

Rab31:WT, GFP-Rab5:WT, GFP-Rab5:S34N, and GFP-Rab5:Q79L were cloned
into the pMX-puro vector at the EcoRI and NotI restriction sites (Onishi et al., 1998).
GFP-Rab5:S34N,

GFP-Rab5:Q79L,

Rab5:S34N,
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Rab5:Q79L,

Rab4:S22N,

Rab4:Q67L, Rab7:S22N, Rab7:Q67L, Rab11:S22N, Rab11:Q70L, Rab22:S19N,
Rab11:Q64L, Rab31:S19N, and Rab31:Q64L on the pMX-puro vector were made
via the Q5® Site-Directed Mutagenesis Kit purchased from New England Biolabs,
Inc. (NEB, Ipswich, MA, USA). Rab5:Q79L-△C4, Rab5:Q79L-△N19, Rab5:S34N△C4, Rab5:S34N-△N19, and GFP-Rab5:Q79L double mutants (GFP-Rab5:Q79LW57A, Rab5:Q79L-W74A, Rab5:Q79L-Y82A, Rab5:Q79L-Y89A, Rab5:Q79LK116E, and Rab5:Q79L-R120E) on the pMX-puro vector were purchased from
GenScript, Inc. (Piscataway, NJ, USA).

II.3.3 Site-directed mutagenesis.
5’ and 3’ primers for specific mutant were designed via the online NEB
primer design software, NEBaseChangerTM, and obtained from Sigma-Aldrich, Inc.
(Raleiga, NC, USA). The site-directed mutagenesis process was done following
the protocol of the Q5® Site-Directed Mutagenesis Kit. Briefly, 0.5 μM of 5’ and 3’
primers were mixed with 25 ng of template vector DNA in the Q5 Hot Start HighFidelity 2X Master Mix reagent. 25 cycles of PCR were performed followed by the
kinase, ligase, and DpnI treatment for 5 minutes. The treated PCR mixture was
then used for bacteria transformation, which will be described later.

II.3.4 Bacteria transformation
The cDNA-containing vectors (either purchased or cloned) and the treated
PCR mixture generated via the site-directed mutagenesis were transformed into
the 5-alpha Competent E. coli purchased from NEB via the transformation protocol
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described on the company website. Briefly, the competent cells were thawed on
ice for 10 minutes. Then 100 ng of cDNA-containing vectors or 5 μl of the treated
PCR mixture was mixed with 50 μl of the competent cells in an Eppendorf tube
and incubated on ice for 30 minutes followed by a 30 seconds heat shock at 42°C.
Then the Eppendorf tube was placed on ice for 5 minutes before mixing with 950
μl of SOC media provided by the kit. After a one-hour incubation at 37°C with
shaking (250 rpm), the transformed competent cells were spread on Lysogeny
broth (LB) agar selection plates and incubated overnight at 37°C.

II.3.5 Vector DNA purification assay.
Colonies grown on the LB agar selection plates or the cDNA constructs
were grown in the LB media overnight at 37°C. Then vectors containing specific
cDNA constructs were collected according to the QIAprep Spin Miniprep Kit or
Qiagen Plasmid Plus kits obtained from Qiagen Sciences, Inc. (Germantown, MD,
USA). The optical density (OD) of vector DNA was tested and analyzed to ensure
a high concentration and purity of DNA that can be used for mammalian cell
transfection and yeast transformation.

II.3.6 Generation of stable cell lines
The cDNA containing vector was transfected into the Plat-A (80%~90%
confluence) monolayer using Lipofectamine® 2000 Transfection Reagent. The
Plat-A cells were grown in the Plat-A growth media (1% penicillin/streptomycin
(P/S), 1 µg/mL puromycin, 10 µg/mL blasticidin, and 10% FBS in Dulbecco’s
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modified Eagle’s medium (DMEM)) and incubated under a humid atmosphere
containing 5% CO2 under 37°C before and after transfection. 48 hours after
transfection, the supernatant of media from the transfected Plat-A cells was filtered
with 0.2 nm filter and applied to 90% confluent 3T3-L1 cells grown in the 3T3-L1
growth media (1% P/S, 1% L-glutamine, and 10% FBS in DMEM). After another
24-hour incubation, transfected 3T3-L1 cells were selected with the 3T3-L1
selection media (2µg/mL puromycin in 3T3-L1 growth media).

II.3.7 Cell culture and 3T3-L1 cell differentiation.
Non-transfected 3T3-L1 cells were grown to 100% confluence in the 3T3L1 growth media and incubated in a humid atmosphere containing 5% CO2 under
37°C. The differentiation of the 3T3-L1 pre-adipocytes took a total of 10 days. The
differentiation process was triggered by treatment of the 3T3-L1 differentiation
media (10 µg/ml insulin, 1 µg/ml DEX and 1µg/ml IBMX in the 3T3-L1 growth media
for day 1 to day 4 and 10 µg/ml insulin in the 3T3-L1 growth media for day 5 to day
10). Media was changed every 48 hours. The pMX-puro cDNA-containing vectortransfected 3T3-L1 cells were grown in the same conditions as the non-transfected
3T3-L1 cells except with an addition of 2µg/mL puromycin in all types of media.

II.3.8 Oil Red O (ORO) staining and quantification.
On the tenth day of differentiation, the 3T3-L1 cells were washed and fixed
with 10% formalin in phosphate buffer saline (PBS) for 5 minutes and 1 hour at
room temperature, respectively. The ORO stock solution (0.5 g of ORO in 100 ml
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of isopropanol) was diluted freshly with deionized (DI) water to make the ORO
working solution (60% of stock solution with 40% of DI water). The working solution
was filtered with a 0.2 nm filter before applying to the fixed 3T3-L1 cells. Then the
3T3-L1 cells were stained with the filtered ORO working solution for 15 minutes at
room temperature. Excessive ORO working solution was removed and the stained
3T3-L1 cells were washed with DI water. At last, 100% of isopropanol was used to
elute the ORO from fixed cells by incubating the cells in a 37°C water bath for 10
minutes. The quantification of lipids was done by measuring OD of eluted ORO
solution at 540 nm wavelength.

II.3.9 Bright-field microscopy, confocal microscopy, and live-cell
microscopy
For bright-field and confocal microscopy, the normal 3T3-L1 cells and the
transfected 3T3-L1 cells were seeded on glass coverslips at 1.0 × 105 per 3.8 cm2
well. The cells were incubated with different types of media and treatments as
required. After the ORO staining (as described above), the cells were observed
and taken image of under an inverted microscope at a 20X magnification objective
lens via the AmScopeX software for bright-field images. Or the cells were mounted
with DAPI and observed under the Olympus BX61 confocal microscope.
For live-cell microscopy, the normal/transfected 3T3-L1 cells were seeded
in the µ-Slide 4 Well chamber purchased from ibidi, Inc. (Fitchburg, WI, USA) with
required media and treatments. Then live-cell images were taken under the Delta
Vision Elite microscope.
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II.3.10 Lysate preparation, protein quantification, and Western blotting
II.3.10.1 Lysate preparation
To prepare whole cell lysates, 3T3-L1 cells were collected in ice-cold fresh
lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM
ethylenediaminetetraacetic acid (EDTA), 1% sodium deoxycholate (w/v), 0.1%
SDS, 1 mM Na3VO4, 10 mM NaF, 2 mM phenylmethane sulfonyl fluoride (PMSF),
and protease/phosphatase inhibitors purchased from Sigma-Aldrich, Inc.). 3T3-L1
cell lysates were then mixed with the 4X loading dye and heat-shocked at 100°C
for 10 minutes. Supernatant were collected after centrifugation (2 minutes in
13,000 rpm) for western blotting. To prepare the whole yeast lysates, the yeast
cells were first collected by centrifugation (5 minutes in 5000 rpm). After discarding
the supernatant, 3 times of freeze-thaw cycles (3 minutes in -20°C ethanol then 3
minutes in 37°C water bath) were applied. The cells were then mixed with the fresh
lysis buffer with addition of 5 mM of DTT for 30 minutes.

II.3.10.2 Protein quantification – the Pierce BCA Protein Assay
Protein contents of the cell lysates were tested using the Pierce BCA
Protein Assay Kit. Briefly, the working solution was made freshly by mixing the
reagent A and the reagent B in a ratio of 1:20. Gradient volumes of the standard
protein and same volume of sample proteins (preparation has been described
above) were mixed thoroughly and incubated at 30°C for 30 minutes. The ODs of
standards and samples were measured under an absorbance of 562 nm
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wavelength. Then the concentrations of sample proteins were calculated based on
the standard curve.

II.3.10.3 Western blotting
The tested cell lysates were mixed with the 4X loading dye and heatshocked in 95°C for 10 minutes. Supernatant was collected after centrifugation (2
minutes in 13,000rpm). Same amount of cell lysate proteins (cased on the BCA
assay) were resolved by 10% SDS-PAGE and transferred to nitrocellulose
membranes. The membranes were blocked overnight with specific primary
antibodies at 4°C in BSA-TBS-t (20 mM Tris-HCl, pH 7.4, 150mM NaCl, 0.1%
Tween 20, and 5% bovine serum albumin (BSA)). After washing of the primary
antibodies, specific secondary antibodies were applied and washed. Visualization
of results was achieved by exposing. To determine relative protein amounts, three
representative exposures for each sample were quantified using the Fiji software
(National Institutes of Health).

II.3.11 siRNA sequences and transfection.
RNA interference (RNAi) directed against:
mouse Rab5A [5'-AAGCACAGTCCTATGCAGATG-3'],
mouse Rab5B [5'-AATCCGTGTGTTTAGATGACA-3'], or
mouse Rab5C [5'-AAGCAGCCATTGTGGTCTATG-3'] were designed and
synthesized by Ambion (Austin, TX). A scrambled siRNA sequence was designed
as a control [5'-CACCUAAUCCGUGGUUCAA-3']. Prior to siRNA sequence
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transfection, cells were plated in growth medium without antibiotics at 70-80%
confluence. siRNA sequence (20 nM final concentration) transfection was
performed using LipofectamineTM 2000 as specified by Invitrogen (Invitrogen,
Carlsbad, CA). After transfection, cells were used for the indicated assay (e.g., for
immunoblotting, differentiation or pull-down assays).

II.3.12 Activation of Rab5 assay.
Cells were lysed using a buffer containing 20 mM HEPES (pH 7.5), 100 mM
NaCl, 1 mM DTT, 5 mM MgCl2, 5% glycerol and 1% Triton-X-100, supplemented
with 1 mM PMSF. Lysates were incubated with 100 mL glutathione beads
containing 10 μg of GST-EEA1, followed by rocking for 1 hour at 4°C. After
incubation, beads were washed three times with PBS. The pull-downs were
subjected to SDS-PAGE and analyzed by immunoblotting using Rab5 antibodies.
Relative levels of Rab5-GTP were determined using the ratio of Rab5- to totalRab5.

II.3.13 Statistical analysis
All experiments presented were repeated a minimum of three times. Normal
distributed data were represented in mean ± standard deviation (S.E.M.). The
difference between groups were determined by the Student t-test. Tests were
considered statistically significant if p-value were less than 0.05.
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II.4 Results
II.4.1 Nucleotide status of Rab5 is critical for the differentiation of 3T3-L1
pre-adipocytes
Rab5 is known to regulate membrane fusion during vesicular trafficking
where the Rab5:Q79L mutant, which has preferential affinity for GTP showed a
dominant-positive effect and promotes early endosome fusion (Barbieri et al.,
1996). In contrast, the Rab5:S34N mutant, which has preferential affinity for GDP
and shows a dominant-negative effect, induced the accumulation of very small
endocytic profile and inhibited transferrin endocytosis (Stenmark et al., 1994).

II.4.1.1 The induction of pMX-puro retroviral vector expression-system
did not alter the differentiation process
To access whether Rab5 plays a regulatory role in the 3T3-L1 preadipocytes differentiation, I used the pMX-puro retroviral vector expression-system
to induce the expression of a specific protein. The retroviral system is designed to
express a specific exogenous protein in mammalian cells permanently. To
establish that the transfection system will not affect the normal differentiation
process, I induced the green fluorescent protein (GFP) into the 3T3-L1 cells as a
control. In Figure 9.A, the overexpression of GFP alone did not affect the
accumulation of lipids as compared with the un-transfected 3T3-L1 cells. As
expected, the expression level of GAPDH, which served as the whole cell lysate
loading control, was similar in both GFP-transfected and un-transfected cells
before (day 1) and after (day 9) differentiation, respectively (Figure 9.B). Both cells
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expressed similar amount of PPARγ at day 9, suggesting that the usage of the
pMX-puro retroviral vector expression-system did not significantly alter the
differentiation process of the 3T3-L1 pre-adipocytes. Bright-field images of ORO
stained cells were taken at day 1 and day 9 after differentiation (Figure 9.C).
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Figure 9. Differentiation of un-transfected and GFP-overexpressing 3T3-L1
pre-adipocytes.
The un-transfected (3T3-L1) or GFP-overexpressing (GFP) 3T3-L1 pre-adipocytes
were differentiated into adipocytes in the absence or in the presence of induction
media, and the accumulation of lipid droplets was measured by the incorporation
of Oil Red O as described in Material and Methods. A. Relative lipid content of
3T3-L1 and GFP 3T3-L1 cells. Results were represented as relative lipid contents.
Data represent the mean ± S.E.M. of three independent experiments. B.
Representative Western blot of the content of GFP, PPARγ, and GAPDH proteins.
C. Bright-field images of ORO stained day 1 and day 9 cells under 20X objective
lens. ORO stained lipid droplets were shown as red color under the microscope.
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II.4.1.2 The overexpression or deletion of individual Rab5 isoforms
inhibited the differentiation of 3T3-L1 pre-adipocytes
For the purpose of understanding the role of different Rab5 isoforms during
adipogenesis, individual overexpression of the Rab5 isoforms (Rab5A, Rab5B,
and Rab5C) was prepared. As shown in Figure 10.A, all the Rab5 isoforms, Rab5A,
Rab5B, and Rab5C, showed a statistically inhibitory effect on the lipids
accumulation.

Specifically,

the

overexpression

of

Rab5A

inhibited

the

accumulation of lipids by 32±6%, while Rab5B and Rab5C inhibited the
accumulation by 25±6% and 21±5%, respectively. Then the depletion effect of
each Rab5 isoforms was done via the RNA interference to individually or
simultaneously knockdown the Rab5 isoforms. The accumulation of lipids in
differentiated 3T3-L1 cells was examined under the knockdown of Rab5 isoforms
by inducing specific siRNA. According to Figure 10.B, depletion of Rab5 was
accompanied by a reduction of the accumulation of lipids. Importantly, individual
removal of Rab5A isoform produced a small but statistically significant (24±6%)
inhibition on the accumulation of lipids as compared with scrambled siRNAinduced and siRNA-uninduced cells. Rab5B and Rab5C siRNA were also able to
block the accumulation of lipids, though not as noticeable as Rab5A, by 14±2%
and 16±4%, respectively, as compared with scrambled siRNA and non-siRNA
induced cells. Remarkably, combined depletion of all the Rab5 isoforms strongly
inhibited (84±5%) the accumulation of ORO (Figure 10.B).
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Figure 10. Selective effect of Rab5 isoforms on the differentiation of 3T3-L1
pre-adipocytes.
Results were represented as relative lipid contents. Data represent the mean ±
S.E.M. of three independent experiments. (*P<0.05 by Student's t-test). A. Relative
lipid content of cells expressing GFP or Rab isoforms. GFP or Rab5 isoformstransfected 3T3-L1 cells were differentiated into adipocytes in the presence of
induction media. B. Relative lipid content of differentiated 3T3-L1 cells with
depletion of the Rab5 isoforms. Non-transfected cells (Ctl), or cells transfected with
scramble RNAi (Scr), or individually RNAi against the Rab5 isoforms (siRab5a/b/c),
or RNAi’s against all Rab5 isoforms (siRab5abc) were differentiated as described
in Material and Methods.
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Since the Rab5A exhibited the most remarkable results in lipid formation
during adipogenesis of the 3T3-L1 pre-adipocytes, the rest of the experiments
were designed based on the Rab5A isoform. And in the rest of this section, Rab5
represents the Rab5A isoform if not specifically stated.

II.4.1.3 The GTP-bound Rab5 decreased during adipogenesis
As described above, Rab5 functions as a molecular switch that cycles
between the active GTP-bound form and the inactive GDP-bound form. The
overexpression and depletion of the three Rab5 isoforms individually exhibited
inhibitory role in the adipogenesis process of 3T3-L1 pre-adipocytes (Figure 10).
Thus, it is hypothesized that the nucleotide states of Rab5 may change during the
differentiation process and the states of Rab5 may play a regulatory role in
governing the adipogenesis process of 3T3-L1 cells.
In order to detect the endogenous nucleotide states of Rab5 during the
differentiation of 3T3-L1 pre-adipocytes, the 3T3-L1 cells overexpressing GFP
were differentiated into adipocytes in the absence (as the negative control) or in
the presence (as the positive control) of induction media. Endogenous GTP-bound
activated Rab5 was analyzed by Rab5 GST pull-down assay followed by
immunoblotting at specific days during the differentiation. In Figure 11, along with
the progression of adipogenic differentiation, the expression level of the adipocytespecific transcription factor, PPARγ, gradually elevated (Figure 11.A&B). In
contrast, the relative Rab5-GTP level gradually decreased over time during the
differentiation process (Figure 11.C&D).
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Figure 11. GTP levels of endogenous Rab5 in comparison with expression
of PPARγ during the differentiation of 3T3-L1 pre-adipocytes.
3T3-L1 pre-adipocytes overexpressing GFP were differentiated into adipocytes in
presence of induction media, and the endogenous GTP-bound activated Rab5 was
analyzed by GST pull-down assay followed by immunoblotting at specific day of
the differentiation as described in Material and Methods. A. Relative PPARγ
expression levels in comparison with GAPDH during differentiation. Data represent
the mean ± S.E.M. of three independent experiments. (*P<0.05 by Student's t-test).
B. Representative Western blot of the content of PPARγ and GAPDH. C. Relative
Rab5 GTP-bound levels as compared with total Rab5 loaded. Data represent the
mean ± S.E.M. of three independent experiments. (*P<0.05 by Student's t-test). D.
Representative immunoblots of samples probed with anti-Rab5 antibodies for total
Rab5 (T-Rab5) and active Rab5 (GTP-Rab5).
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II.4.1.4 Increase the Rab5-GTP level hampered the differentiation of
3T3-L1 pre-adipocytes
In order to address the role of Rab5 in the differentiation of 3T3-L1 preadipocytes, cell lines overexpressing GFP, Rab5:wild-type (WT), the GTP-bound
defective Rab5 mutant (Rab5:S34N), or the GTPase-defective, constitutively
activated Rab5 mutant (Rab5:Q79L) were prepared, and the accumulation of lipids
was measured via the oil red O (ORO) assay. To observe the localization of Rab5
and the two Rab5 mutants, the GFP conjugated Rab5:WT, Rab5:S34N, and
Rab5:Q79L were transfected into the 3T3-L1 cells. Then the day 1 and day 9 cells
were fixed for confocal microscopy and observed under the Olympus BX61
confocal microscope (Figure 13). As shown in Figure 12, the overexpression of
Rab5:Q79L mutant decreased the accumulation of lipids in 3T3-L1 pre-adipocytes
at day 9 of differentiation. Moreover, Rab5:WT decreased the accumulation of
lipids in less extent as compared with the Rab5:Q79L mutant but is statistically
significant in comparison with the GFP cells (Figure 12.A). Surprisingly, the
expression of Rab5:S34N mutant stimulated this differentiation process as the lipid
content increased by about 28% in comparison with the GFP cells (Figure 12). The
observation suggests that Rab5 inactivation improves the differentiation of 3T3-L1
pre-adipocytes, whereas constitutively activating Rab5 resulted in decreased lipid
accumulation.
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Figure 12. Selective effect of Rab5 constructs on the differentiation of 3T3L1 pre-adipocytes.
3T3-L1 pre-adipocytes expressing GFP or Rab5 constructs (Rab5:WT, Rab5S34N,
and Rab5:Q79L) were differentiated as described in Material and Methods. A.
Relative lipid content of 3T3-L1 cells overexpressing GFP, Rab5:WT, Rab5:Q79L,
and Rab5:S34N. Results were represented as relative lipid contents. Data
represent the mean ± S.E.M. of three independent experiments. (*P<0.05 by
Student's t-test). B. Representative Western blot of the content of GFP, Rab5, and
GAPDH proteins.
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Adipocyte differentiation can be also monitored by formation of intracellular
lipid droplets (Qi et al., 2017). Thus, with the overexpression of GFP-conjugated
Rab5 and Rab5 mutants, combining with the ORO staining assay, morphological
experiments were carried out to visualize the lipid droplets and the localization of
Rab5 or Rab5 mutants. Under the microscope, GFP and GFP-conjugated
constructs were visualized as green, ORO stained lipid droplets were observed as
red, whereas nucleus were stained with DAPI, which gave a color of blue under
the microscope. As described above, 3T3-L1 pre-adipocytes expressing GFP and
Rab5 constructs were cultivated and induced to differentiate into adipocytes with
induction media. At day 9, Oil Red O staining showed an abundant red round
structures in GFP- and Rab5:S34N-overexpressed 3T3-L1 cells, which suggested
a significant lipid accumulation in the GFP-control and the Rab5:S34N mutant cells.
However, lipid droplets were not observed in untreated non-differentiated day 1
cells (images in the left column of Figure 13). More importantly, formation of lipid
droplets was inhibited in the Rab5:Q79L mutant cells (Figure 13). In cells
overexpressing the Rab5:WT, lipid droplets were observed but in less amount in
comparison with the GFP-control cells (Figure 13). These observations were
further supported with the quantitative measurement of lipid content (Figure 12).
In addition, the overexpression of Rab5:Q79L mutant significantly inhibited
adipogenic morphology (e.g., the transition from a fibroblast-like shape to an
increasingly rounded-up appearance with an accumulation of cytoplasmic lipid
droplets), which can be confirmed by comparing the GFP-expressing cells with the
Rab5:Q79L-expressing cells at day 9 of differentiation.
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Cell line

Day 1 (GFP)

Day 9 (GFP, ORO, DAPI)

GFP

GFPRab5:WT

GFPRab5:Q79L

GFPRab5:S34N

Figure 13. Confocal images of 3T3-L1 cells overexpressing GFP and GFPconjugated Rab5 constructs.
GFP, lipid droplets, and nucleus were represented in green, red, and blue,
respectively. Morphological changes of 3T3-L1 pre-adipocytes were monitored by
a Olympus BX61 and photographed before (day 1) after 9 days from the onset of
differentiation.
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Figure 14. Effect of Rab5 constructs on the expression of PPARγ and CEB/Pα.
3T3-L1 pre-adipocytes overexpressing GFP or Rab5 constructs were
differentiated as described in Material and Methods, and the endogenous levels of
PPARγ, GEB/Pα and GAPDH proteins were analyzed with specific antibodies by
immunoblotting. Data represent the mean ± S.E.M. of three independent
experiments. (*P<0.05 by Student's t-test).
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Next, the 3T3-L1 pre-adipocytes overexpressing GFP, Rab5:WT and the
Rab5 mutants were differentiated and then harvested for immunoblotting analysis
with specific antibodies. With the overexpression of Rab5:S34N mutant, but not
the Rab5:Q79L mutant, the protein expression of the adipogenesis-associated
transcription factors, PPARγ and C/EBPα, were up-regulated as compared with
the GFP-overexpressing cells (Figure 14). The Rab5:WT affected the expression
of the two transcription factors in less extent in comparison with the Rab5:Q79L
mutant. Thus, these observations suggest that the nucleotide status of Rab5 is
critical for the differentiation process of 3T3-L1 pre-adipocytes. The effect of Rab5
nucleotide status on adipogenesis relies, at least partially, on its regulatory role
towards the two adipogenic transcription factors, PPARγ and C/EBPα.

II.4.2 The determinants of Rab5 in promoting adipogenesis.
In the previous section, Rab5:Q79L, the dominant-positive mutant of Rab5,
has demonstrated an inhibitory role in adipogenesis process. Since specific
residues, especially the Y57A, W74A, Y82A, and Y89A residues on the Rab5
GTPase domain affect the binding affinity of Rab5 with Rab5 effectors (e.g.
Rabaptin-5, Ranenosyn-5, and EEA1), several additional mutants (Y57A, W74A,
Y82A, Y89A, K116E, and R120E) were made based on the Rab5:Q79L mutant.
Then the Rab5:Q79L double mutants were transfected into the 3T3-L1 cells
through the pMX-puro vector system, respectively. Surprisingly, the Rab5:Q79LK116E double mutant, not the other mutants that showed positive role in effector
binding, advanced the lipid formation of differentiated 3T3-L1 cells, whereas the
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other double mutants exhibited similar inhibitory role in adipogenesis as the
Rab5:Q79L single mutant (Figure 15).

A

B
Rab5
GAPDH
GFP

WT

F57A

W74A

Y82A

Y89A

K116E R120

Rab5:Q79L
Figure 15. Selective effects of Rab5:Q79L double mutants on the
differentiation of 3T3-L1 pre-adipocytes.
3T3-L1 pre-adipocytes overexpressing GFP, Rab5:Q79L, or Rab5:Q79L double
mutants were differentiated into adipocytes in the presence of induction media,
and the accumulation of lipid droplets was measured by the incorporation of ORO
as described in Material and Methods. A. Relative lipid content of differentiated
3T3-L1 cells overespression GFP, Rab5:Q79L mutant, and Rab5:Q79L double
mutants. Data represent the mean ± S.E.M. of three independent experiments.
*P<0.05 by Student's t-test. B. Representative Western blot of the content of GFP,
Rab5 constructs, and GAPDH proteins.
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GFP

Differentiation Day 9
Rab5:Q79L

Rab5:Q79L-F57A

Rab5:Q79L-W74A

Rab5:Q79L-Y82A

Rab5:Q79L-Y89A

Rab5:Q79L-K116E

Rab5:Q79L-R120E

Figure 16. Bright-field images of 3T3-L1 cells overexpressing GFP,
Rab5:Q79L, or Rab5:Q79L double mutants.
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Bright-field images of the 3T3-L1 cells overexpressing GFP, Rab5:Q79L, or
Rab5:Q79L double mutants revealed parallel results in comparison with the
quantitative ORO results (Figure 15 &16).
To further examine the specific molecular requirement for the effect of Rab5
on the differentiation of 3T3-L1 pre-adipocytes, I investigated the effect of deletion
of the N-/C-terminal of Rab5 or the Rab5 mutants. These N-/C-terminal residues
are essential for Rab5 function. The N-terminal is critical for efficient
geranylgeranylation of the C-terminal of Rab5 (Sanford et al., 1995). The Cterminal contains a CCXX motif that is responsible for the post-transcriptional
modification, geranylgeranylation, of Rab5 (Farnsworth et al., 1994). The biological
activity of Rab5: △N19 and Rab5: △C4 deletion mutants were examined (Figure
17.A). In comparison with Rab5:S34N, the mutant Rab5:S34N-△N19 resulted in a
partial, though not significant, loss of differentiation of the 3T3-L1 pre-adipocytes.
For the C-terminal deletion, the elimination of the entire CCXX motif (Rab5:S34N△C4) completely abolished the effect of Rab5:S34N on the differentiation of 3T3L1 pre-adipocytes. In Figure 17, the introduction of the C-terminal deletion in
Rab5:Q79L mutant (Rab5:Q79L-△C4), but not the introduction of the N-terminal
deletion (Rab5:Q79L-△N19), reversed the inhibitory effect of Rab5:Q79L mutant
on differentiation of 3T3-L1 pre-adipocytes. These data suggest that posttranslational isoprenylation modifications of Rab5 are essential for its biological
function during differentiation of 3T3-L1 pre-adipocytes.
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S34N-△C4

S34N

Q79L-△N19
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GAPDH

Figure 17. Selective effect of Rab5 constructs on the differentiation of 3T3L1 pre-adipocytes.
3T3-L1 pre-adipocytes overexpressing GFP or Rab5 constructs (Rab5:S34N,
Rab5:S34N-△C4/△N19, Rab5:Q79L and Rab5:Q79L-△C4/△N19) were
differentiated as described in Material and Methods. A. Relative lipid content of
differentiated 3T3-L1 cells overespression GFP or Rab5 constructs. Results were
represented as relative lipid contents. Data represent the mean ± S.E.M. of three
independent experiments. (*P<0.05 by Student's t-test). B. Representative
Western blot of the content of GFP, Rab5 proteins.
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II.4.3 Rab5 plays an irreplaceable role in the regulation of adipogenesis
Based on the results collected so far, Rab5 played a regulatory role in
adipogenesis. Since the primary role of Rab5 is to promote early endosome fusion
in the membrane trafficking process and receptor-mediated endocytosis, I
questioned if the other Rab family proteins had their particular roles in the process
of adipogenesis. Thus, several small GTPases, including Rab4, Rab7, Rab11,
Rab22, and Rab31, as well as the dominant-negative forms (e.g., Rab4:Q67L,
Rab7:Q67L, Rab11:Q70L, Rab22:Q64L, Rab31:Q64L) and the dominant-positive
forms (e.g., Rab4:S22N, Rab7:S22N, Rab11:S25N, Rab22:S19N, Rab31:S19N)
were transfected into the 3T3-L1 pre-adipocytes, respectively. As introduced
above, each of these Rab GTPase proteins exhibits particular function in the
endocytic pathway, and the active/inactive form of these Rab proteins affect the
endocytic pathway in different manners.
In Figure 18, unlike the Rab5:Q79L, none of the Rab GTP-hydrolysis
defective mutants (the Rab:QL mutants) tested here inhibited the differentiation of
3T3-L1 pre-adipocytes. Furthermore, none of the Rab GTP-binding defective
mutant (the Rab:SN mutants) increased the accumulation of lipids. In addition, the
overexpression of Rab:WT proteins did not affect the differentiation process.
However, it is also important to note that the overexpression of Rab4:Q67L mutant
showed a modest but statistically significant increased accumulation of lipids, while
the overexpression of Rab4:S22N decreased it. These data suggest that
increasing the levels of Rab5 in the GTP-bound form by overexpressing the
Rab5:Q79L mutant and to some extent, overexpressing of Rab5:WT, has a
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detrimental and non-substitutable role on the differentiation of 3T3-L1 preadipocytes. Furthermore, the data suggest that the Rab5 GDP-bound form plays
a particular and significant role in the differentiation process.
A

*
*

B
Rabs
GAPDH
WT

S22N Q56L

WT S22N

Rab4

Q67L

Rab7

Rabs
GAPDH
WT

S22N Q70L
Rab11

WT

S19N
Rab22

Q64L

WT S19N

Q64L

Rab31

Figure 18. A. Selective effect of Rab proteins on the differentiation of 3T3-L1
pre-adipocytes.
3T3-L1 pre-adipocytes overexpression different Rab:WT, Rab:SN, and Rab:QL
were differentiated into adipocytes in the presence of induction media, and the
accumulation of lipid droplets was measured by the incorporation of ORO as
described in Material and Methods. Data represent the mean ± S.E.M. of three
independent experiments. (*P<0.05 by Student's t-test). B. Representative
Western blot of the content of GFP, Rab p, and GAPDH proteins.
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II.4.4 Rab5 performs its function via the insulin signaling pathway during
the adipogenesis process
Based on the observations above, Rab5, not the other Rab proteins (e.g.,
Rab7, Rab11, Rab22, and Rab 31), uniquely affects the expression of
adipogenesis-associated transcription factors. Then, I wondered what effect of
Rab5 constructs overexpression on the expression of other factors (e.g., insulin
receptor, GLUT4 and Akt) during adipogenesis would be. This is because the IR,
GLUT4, and Akt (the key protein in the PI3K/Akt signaling pathway triggered upon
insulin stimulation) have been showed to play a key role during the differentiation
of 3T3-L1 pre-adipocytes. Not surprisingly, the expression of the IR, GLUT4, and
Akt exhibited an increase in cells overexpressing the Rab5:S34N mutant (Figure
19, Figure 20, and Figure 21). These data further supported the increase of lipids
formation observed in this Rab5 mutant cell line (Figure 12). It is important to note
that not only the expression level of IR and GLUT4 were increased in Rab5:S34N
cell lines, but also the relative phosphorylated IR level was enhanced at day 9 of
differentiation (Figure 19, Figure 21). An increase in the phosphorylation of Akt,
but not the phosphorylation of Erk1/2 was also observed upon insulin stimulation
(Figure 20). Taken together, the data suggest that the overexpression of the
Rab5:S34N mutant, which constitutively inhibited the biological function of Rab5
selectively contribute to the up-regulation of expression as well as phosphorylation
of the IR by diminishing the internalization of the receptor. This impaired
internalization in turn augment the level of phosphorylated Akt and enhance the
translocation of GLUT4 to the plasma membrane. Therefore, it is possible to
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speculate that Rab5 GTP/GDP ratio has an essential role on differentiation of 3T3L1 pre-adipocytes.
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Figure 19. Effect of Rab5 and the Rab5 mutations on the expression and
phosphorylation of the IR.
3T3-L1 pre-adipocytes overexpressing GFP or Rab5 constructs were
differentiated as described in Material and Methods. The endogenous levels of IR,
phosphorylated-IR (p-IR), and GAPDH proteins were analyzed with specific
antibodies by immunoblotting as indicated in the figure upon insulin stimulation.
Data represent the mean ± S.E.M. of three independent experiments. Inset:
Representative Western blot of the content of IR, phospho-IR, and GAPDH
proteins. *P<0.05 by Student's t-test. A. Relative IR expression level (as compared
with GAPDH) of GFP- or Rab5 constructs-overexpressed 3T3-L1 cells. B. Relative
p-IR expression level (in comparison with IR) of GFP- or Rab5 constructsoverexpressed 3T3-L1 cells. C. Representative Western blot of the content of IR,
phospho-IR, and GAPDH proteins.
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Figure 20. Effect of Rab5 constructs on the activation of Akt and Erk1/2.
3T3-L1 pre-adipocytes overexpressing GFP or Rab5 constructs were
differentiated as described in Material and Methods. The activation of Akt and
Erk1/2 were analyzed with specific antibodies by immunoblotting as indicated in
the figure upon insulin stimulation. GAPDH served as loading control. Data
represent the mean ± S.E.M. of three independent experiments. *P<0.05 by
Student's t-test. A. Relative p-Akt level of 3T3-L1 cells expressing GFP or Rab5
constructs. B. Representative Western blot of the content of total Akt, phosphor
Akt (p-Akt), and GAPDH. C. Relative p-Erk1/2 level of 3T3-L1 cells expressing
GFP or Rab5 constructs. D. Representative Western blot of the content of total
Erk1/2, phosphor Erk1/2 (p-Erk1/2), and GAPDH.
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Figure 21. Effect of Rab5 and the Rab5 mutants on the expression of GLUT4.
3T3-L1 pre-adipocytes overexpressing GFP or Rab5 constructs were
differentiated as described in Material and Methods and the endogenous levels of
GLUT4 and GAPDH were analyzed with specific antibodies by immunoblotting as
indicated in the figure. A. Relative GLUT4 level in comparison with GFP cells. Data
represent the mean ± S.E.M. of three independent experiments. *P<0.05 by
Student's t-test. B. Representative Western blot of the content of GLUT4 and
GAPDH.

II.5 Discussion
In this Chapter, Rab5 has been established to play a detrimental role in the
process of adipogenesis with a decreased GTP-bound Rab5 level and without
affecting the total expression of Rab5 in the 3T3-L1 pre-adipocytes. Consistent
with these observations, I show that increasing the Rab5-GTP level is also
detrimental and irreplaceable for the differentiation of 3T3-L1 pre-adipocytes.
First, the expression of different Rab5 isoforms revealed a slight but
statistically significant decrease in the accumulation of lipids in the cytosol, which
was detected via the ORO staining assay (Figure 10). Interestingly, the deletion of
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individual Rab5 isoforms, as well as all three isoforms via RNA interference also
resulted in a decrease of lipids accumulation. The Rab5 isoforms exhibit different
roles in different cell types. For instance, the overexpression of Rab5B or Rab5A
hampered the degradation of EGFR as well as the progression of EGFR from early
to late endosomes upon EGF stimulation in Hela cells (Chen et al., 2009). Rab5A
is also found to regulate autophagosome formation in the U2OS cells (human bone
osteosarcoma epithelial cells). And Rab5C has been shown to enhance β-integrin
recycling in EGF-induced cancer cell invasion (Onodera et al., 2012). Since the
insulin receptor and the EGFR are both a member of the receptor tyrosine kinases,
these data suggest that Rab5 may affect the process of differentiation by impairing
the endocytosis process of the IR.
Second, the activated GTP-bound Rab5 has been demonstrated to undergo
a graduated decrease over the differentiation of 3T3-L1 cells (Figure 11). The
reduction of Rab5 GTP-bound form exhibited a negative relationship with the
accumulation of adipogenesis-associated transcription factor, PPARγ, which
served as the marker of adipogenesis process (Figure 11). In addition, the
decrease of Rab5 GTP-bound level during adipogenesis happened without any
changes in the total endogenous expression level of Rab5 (Figure 11.D). These
data suggest that the ratio of Rab5-GTP over total Rab5 may be important for the
differentiation of 3T3-L1 pre-adipocytes.
Third, two Rab5 mutants, the dominant-negative Rab5:S34N and the
dominant-positive Rab5:Q79L, exhibited opposite roles in the differentiation of
3T3-L1 cells, where the Rab5:Q79L inhibited this process whereas the Rab5:S34N
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promoted the process. In addition, the expression of the Rab5:Q79L mutant, but
not the Rab5:S34N mutant, blocked this process by inhibiting the expression of
PPARγ and C/EBPα in the 3T3-L1 pre-adipocytes. In previous studies, the
expression of Rab5:Q79L mutant results in enlarged endosomes in multiple cell
types, whereas the expression of Rab5:S34N inhibited the internalization of the
EGFR in Hela cells as well as phagosome formation and T. cruzi internalization in
the Raw 264.7 mouse macrophage cells (Dinneen & Ceresa, 2004; Galperin &
Sorkin, 2003; Li et al., 1994; Maganto-Garcia et al., 2008; Stenmark et al., 1994).
In the confocal images, enlarged endosomes can be observed in the Rab5-Q79Loverexpressed cells, which suggests that GTP-Rab5 may diminish the
accumulation of lipids by impairing the endocytosis process. Furthermore,
Rab5:Q79L-△C4, a mutant lacking CCXX (X refers to any amino acid) motif that is
required for isoprenylation, completely reversed the inhibitory effect of Rab5.
Previously, researchers show that the N-terminal is critical for efficient
geranylgeranylation of the C-terminal of Rab5, whereas the C-terminal contains a
CCXX motif that is responsible for the post-transcriptional modification of Rab5
(Farnsworth et al., 1994) (Sanford et al., 1995). My data suggest that the Cterminal is essential for the function of Rab5 in regulating the differentiation
process. Though the N-terminal supports the function of the C-terminal, deletion
of the N-terminal alone does not have a significant effect on the differentiation of
3T3-L1 pre-adipocytes.
Fourth, the overexpression of Rab5:Q79L-K116E, but not the other
Rab5:Q79L double mutants (Rab5:Q79L-Y57A, Rab5:Q79L-W74A, Rab5:Q79L130

Y82A, Rab5:Q79L-Y89A, or Rab5:Q79L-R120E), significantly promoted the
accumulation of lipids in the differentiated 3T3-L1 cells (Figure 15). Previously, the
Y57A, W74A, Y82A, and Y89A were predicted to be decisive binding epitopes for
EEA1 and Rabenosyn-5, and the Rab5:Q79L-Y57A, Rab5:Q79L-W74A,
Rab5:Q79L-Y82A, and Rab5:Q79L-Y89A mutants all showed reduced binding
affinity to Rab5 effector Rabaptin-5 (G Zhu et al., 2004; Mishra et al., 2010). The
K116 serves as a mono-ubiquitination site of Rab5 (Wagner et al., 2011). But the
Rab5:K116R mutant did not affect the recruitment of Rab5 effectors or alter the
GTP loading/GDP release activities of Rab5 (Shin et al., 2017). My data suggested
a novel role of the K116 residue in regulating the function of Rab5 in adipogenesis
process.
Fifth, several small GTPases (e.g., Rab4, Rab7, Rab11, Rab22, and Rab31)
were unable to affect this differentiation process as compared with Rab5. Though
each of the tested Rab proteins exhibits particular functions in different steps of
endocytosis (Frittoli et al., 2014; Lodhi et al., 2007; Takahashi et al., 2012;
Vanlandingham & Ceresa, 2009; HP Zhu et al., 2009). None of the chosen Rab5
proteins displayed a similar role as Rab5 in the differentiation process.
Sixth, both the expression levels of insulin receptor and GLUT4 were upregulated under the overexpression of Rab5:S34N and down-regulated under the
overexpression of Rab5:Q79L. Besides, the levels of phosphorylated Akt and
phosphorylated insulin receptor were increased in the Rab:S34N cells.
These observations can be explained, at least in part, by the fact that
Rab5:Q79L, but not Rab5:S34N mutant, increased internalization of the insulin
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receptor, thus, decreasing both cell surface localization as well as tyrosine
autophosphorylation of the insulin receptor at day 9 day of the differentiation
process. Consistent with this idea, internalized and less active insulin receptor will
not be able to fully activate Akt, a key molecule required for the activation of GLUT4.
These molecules have been implicated in the differentiation of 3T3-L1 preadipocytes.
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CHAPTER III
III. Role of Rab5 regulators and effectors in the process of adipogenesis
III.1 Introduction
Adipogenesis is a complicated process triggered by hormones and
governed by corresponding signaling pathways (Chi et al., 2017; Hinoi et al., 2014;
Nam et al., 2015; Wu et al., 2015). The insulin signaling pathway plays an essential
role in multiple cellular processes, including cell proliferation, cell migration, and
cell differentiation, in a wide range of cell types (Huttala et al., 2016; Shukla et al.,
2009; Yen et al., 2015). Specifically, insulin is proved to be the most potent
hormone to trigger the differentiation of the pre-adipocytes (Klemm et al., 2001).
The dominant effects of insulin on the pre-adipocytes coincide with the high
expression of IR on the plasma membrane of the pre-adipocytes, with a number
of about 200~300 × 103 per pre-adipocyte compared to ~40 per erythrocyte
(Watanabe et al.,

1998). The

binding of

insulin to

the

IR triggers

autophosphorylation of several tyrosine sites on the intracellular portion of the IR
β-subunit (Saltiel & Kahn, 2001). The insulin signaling pathway activated upon
insulin stimulation governs the body metabolism by affecting the rates of glucose
transport, glycogen synthesis, fatty acid synthesis, and enzyme/protein synthesis,
and the expression of adipocyte differentiation-associated proteins (Dimitriadis et
al., 2011). Under the stimulation of insulin, the IR undergoes a rapid internalization
process (t1/2 < 3 min) through the receptor-mediated endocytosis (RME), in which
the insulin-IR complex is engulfed into the cell with a region of the plasma
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membrane as a clathrin-coated pit (CCP) in an insulin concentration-dependent
manner (Jochen et al., 1989; Marshall, 1985). Internalized CCP is then delivered
through the intracellular membrane trafficking system, in which the CCP is
transport to the early endosome, the late endosome, and eventually the lysosome
to be degraded or the plasma membrane to be reused (Scheidel et al., 2015).
The small GTPase Rab5 is dynamically involved in several cellular
trafficking and signaling events, including receptor internalization, fusion of
endocytic vesicles with early endosomes, and signaling to the nucleus (Barbieri et
al., 2000; Bucci et al., 1992; GP Li et al., 1994). As is described in Chapter II, Rab5
regulate the adipogenic differentiation of the pre-adipocytes through the insulin
signaling pathway. Specifically, the overexpression of the GTP-binding defective
mutant of Rab5 (Rab5:S34N) increases differentiation of the 3T3-L1 preadipocytes, whereas the overexpression of the GTPase-defective mutant of Rab5
(Rab5:Q79L) improves differentiation of 3T3-L1 pre-adipocyte. Besides, previous
study shows that the formation of Rab5-positive endosomes and the activation of
Rab5 upon insulin in intact cells were both blocked by the treatment of a receptor
tyrosine kinase inhibitor (Jozic et al., 2011). In addition, the impaired Rab5
activation can be rescued by the overexpression of Rab5:Q79L, which parallels
with the fact that the formation of Rab5:Q79L mutant-positive endosomes is not
affected by the receptor tyrosine kinase inhibitor (Jozic et al., 2011).
Rab5 cycles between the active GTP-bound form and the inactive GDPbound form to serve as the molecular switch in the early endosome fusion process
(G Li, 2015). The activation of Rab5 is regulated by a number of guanine nucleotide
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exchange factors (GEFs). All these proteins contain a highly conserved VPS9
domain that catalyzes nucleotide exchange on GTP-bound form Rab5. The Rab5
GEFs include Rabex-5, Alsin, the RIN family proteins, RAP6 (which is also known
as RME-6 and GAPex-5), and Rinl (Han & Colicelli, 1995; Horiuchi et al., 1997;
Hunker, Galvis, et al., 2006; Kajiho et al., 2003; Otomo et al., 2003; Saito et al.,
2002; Woller et al., 2011). Furthermore, it seems that these Rab5 GEFs also
interact with several receptors via diverse mechanisms (Barbieri et al., 2003;
Deininger et al., 2008; Penengo et al., 2006; Su et al., 2007; Tall et al., 2001). The
GTPase activating proteins (GAPs) convert Rab5 to its GDP-bound form. Two
well-characterized Rab5 GAPs are RabGAP-5 and RN-tre. The deletion of
RabGAP-5 or RN-tre increase the level of active Rab5 in vitro (Haas et al., 2005;
Palamidessi et al., 2013).
One of the best-characterized Rab5 GEFs is RIN1 (Ras interference 1), a
multifunctional protein composed of several functional domains, including an SRC
homology 2 (SH2) domain, a proline-rich (PR) domain, a vacuolar protein sorting
9 (VPS9) domain, and a Ras association (RA) domain (Balaji et al., 2014).
Previous work suggested that RIN1 is an exchange factor for the small GTPase
Rab5, whose overexpression stimulates IR-mediated endocytosis. And it has
shown that deletion of the RIN1 N-terminal, which contains the SH2 domain and
PR domain of RIN1, blocked the insulin stimulated receptor-mediated endocytosis
(Hunker, Giambini, et al., 2006). Specific residues, such as RIN1:D537A and
RIN1:Y561F on the RIN1-VPS9 domain are critical for Rab5 activation, whereas
RIN1-R94A on the RIN1-SH2 domain is crucial for the interaction between EGFR
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and RIN1 upon EGF stimulation (Barbieri et al., 2003; Galvis, Balmaceda, et al.,
2009; Galvis, Giambini, et al., 2009). Thus, relationship of key residues required
for optimal RIN1 functionality is critical in order to understand the connection
between receptor signaling and trafficking.
The Rabex-5 protein structure is identified to be made up of an N-terminal
domain, a membrane binding domain, a helical bundle (HB) domain, a VPS9
domain, a coiled-coil (CC) domain, and a PR domain (Shin et al., 2012). Besides
the well-studied VPS9 domain to interact and activate Rab5, the HB domain has
been found to play a role in the association with early endosomes and activating
Rab5 in vivo (Zhu et al., 2007). The GEF activity of Rabex-5 is initially autoinhibited
by its CC domain, which binds weakly to the substrate-binding site of the VPS9
domain (Zhang et al., 2014). When the Rabex-5 activates Rab5 and recruits
Rabaptin-5 (a Rab5 effector), Rabaptin-5 will in turn bind to the GTP-bound Rab5
and recruits Rabex-5 in a positive loop. The binding with Rabaptin-5 displaces the
CC domain of Rabex-5 thus exposes a larger substrate-binding site for Rab5,
causing the release of the GEF activity (Zhang et al., 2014). The autoinhibition of
Rabex-5 explains why in comparison to other well-characterized small GTPases
and their corresponded GEFs, Rabex-5 exhibits a relatively lower affinity to Rab5
(Esters et al., 2001). The autoinhibition also gives a clue to why the GTP exchange
activity of Rabex-5 is much higher when in the Rabex-5-Rabaptin5 complex
(Delprato et al., 2004). Besides, the VPS9 domain of Rabex-5 alone also shows a
higher GTP exchange activity than the full-length Rabex-5 (Delprato et al., 2004).
Thus, Rabex-5 is involved in early endosome fusion as a Rab5 activator with
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regulated activity. Thus, the GTP exchange activity of Rabex-5 is much higher
when in the Rabex-5-Rabaptin5 complex (Delprato et al., 2004). A study has
shown that the Ras ubiquitination been mediated by Rabex-5 promoted Ras
endosomal localization and led to the suppression of Erk activation (Xu et al.,
2010). Interestingly, the VPS9 domain of Rabex-5 alone shows a higher GTP
exchange activity than the full-length Rabex-5 (Delprato et al., 2004).
In the processes of vesicle formation and delivery, Rab5 is also regulated
by multiple Rab5 effectors. As one of the best studied Rab proteins to date, Rab5
has been found to interacts with as many as 30 different effector proteins (Pfeffer,
2005). For instance, a novel Rab5 effector, VPS34, is classified as the Class III
enzyme of the phosphoinositide 3 kinase (PI3K) family and only uses
phosphatidylinositol as substrate to generate phosphoinositide (PI) at the 3position of the inositol ring, which is named the phosphatidylinositol 3-phosphate
(PI3P) (Backer, 2008). Since PI3P is required for the recruitment of EEA1 and
Rabenosyn-5 to the active form of Rab5, VPS34 plays a positive role in early
endosome fusion and the endocytosis process (Siddhanta et al., 1998)
(Christoforidis, Miaczynska, et al., 1999). EEA1, an important Rab5 effector that
binds to Rab5-GTP form, is the only effector that is necessarily required by minimal
fusion and mediates endosome docking (Christoforidis, McBride, et al., 1999).
Though Rabenosyn-5 is also recruited to the early endosome in a PI3P-dependent
manner, it does not bind to GTP-bound Rab5 directly but is required for fusion of
the plasma membrane-derived CCVs with early endosomes, as well as for
homotypical early endosome fusion (Nielsen et al., 2000). Another Rab5 effector,
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Rabaptin-5, was initially identified as an GTP-bound Rab5 effector through a yeast
2-hybrid screen (Stenmark et al., 1995). Rabaptin-5 is mostly found as a complex
with Rabex-5 in the cell (Horiuchi et al., 1997). Rabex-5 and Rabaptin-5 recruit
each other in a positive loop upon Rab5 activation and thus keep the membrane
Rab5-postive until the loop is interrupted by other recruited compartments (Kalin
et al., 2015). Deletion of the Rab5-binding domain of Rabaptin-5 results in giant
endosomes as well as impaired endocytosis process (Kalin et al., 2015).
In this project, I examined the effect of Rab5 GEFs (e.g., Rabex-5 and RIN1),
Rab5 GAPs (e.g., RN-tre), and Rab5 effector (e.g., VPS34) on adipogenesis. In
addition, I also elucidated the determinant residues and domains of RIN1 during
adipogenesis process. Based on the determined specific residues and domains of
RIN1 that are required for signal transduction during adipogenesis, and the in silico
docking analysis between the IR and RIN1, a model of RIN1 function on the insulin
signaling pathway during adipogenesis is proposed.

III.2 Specific aims and research design
III.2.1 Specific aim 2: To determine the effect of Rab5 regulators on
adipogenesis.
Rab5 effectors denote a set of proteins that interact with the GTP-bonded
Rab5. Each effector mediates a feature of Rab5 function and thus affects different
aspects of downstream signaling. For example, Rabaptin-5 is involved in
membrane fusion, it interacts with GTP-bonded Rab5 and stabilizes Rab5 in its
active form. VPS34 generates PI3P, which is required for the recruitment of EEA1
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and Rabenosyn-5 to the active form of Rab5. These recruitments allow both EEA1
and Rabenosyn-5 then take part in the molecular machinery of regulating
endosome fusion. The function of Rab5 dramatically depends on the recruitment
of different effectors to clear several downstream trafficking and signaling events.
One of the best-characterized Rab5 GEF is RIN1, which is required for the
activation of Rab5 upon ligand stimulation in several cellular processes. The
expression of RIN1:Wild-type, but not its depletion, affects the nucleotide status of
Rab5. Preliminary results indicated that RIN1 interacted with the activated insulin
receptor. Thus, I elucidated
2.a. whether the expression (or depletion) of Rab5 GAPs (RN-tre, RabGAP-5),
Rab5 GEFs (RIN1, Rabex-5, and RAP6), or Rab5 effector (VPS34) affected
adipogenesis.
2.b. the domains of Rab5 regulators required for adipogenesis.
2.c. the specific effect of the expression of RIN1 and its mutants on adipogenesis.
2.d. the key residues on RIN1 and the insulin receptor in the IR – RIN1 interaction.
2.e. a 3-dimensional model of the interaction between the VPS9-HB domain of
RIN1 and the IR cytoplasmic tail.

III.2.2 Research design 2
Cell lysates of the 3T3-L1 cells that have been transfected with GFP, RIN1,
Rabex-5, RAP6, RabGAP-5, and RN-tre were incubated with GST-labeled EEA1.
The bonded proteins were eluted and be used for immunoprecipitation analysis.
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Then the cDNA of RIN1:WT and RIN1 mutants were cloned into the pMXpuro vector at EcoRI and NotI restriction sites and plasmid DNA were purified via
the plasmid purification assay. The purified DNA was then transfected into the PlatA cells using Lipofectamine® 2000. After 48 hours, virus suspension from the PlatA cells were applied to the 3T3-L1 mouse pre-adipocyte cell line for the expression
of RIN1 or RIN1 mutants. The transfected cells were then selected with puromycin,
and used for several biological assays, including cell cycle testing, lipid
accumulation testing (ORO assay, only for differentiated cells) or western blotting.
The RIN1:WT, RIN1:VPS9, RIN1 mutants and RIN1:VPS9 mutants were
cloned into the pB42AD vector at the EcoRI and Xhol restriction sites. The insulin
receptor tail (IR-β) and the catalytic defective mutant of the insulin receptor were
cloned into the pLex-A vector at the EcoRI and BamHI restriction sites. All plasmids
were purified and transfected into the yeast EGY48 stain. One pLex-A plasmid was
combined with one pB42AD plasmid and co-transfected into the yeast cells. The
co-transfected yeast was used for yeast β-Galactosidase Assay to test the intensity
of protein-protein interaction. At last, the data were input into the software, i.e., the
SWISS MODEL serve and the PyMOL, to build the 3-dimensional structural model
of the interaction between the RIN1:VPS9 and the IR-tail.
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III.3 Materials and Methods
Methods that have been described in the previous chapter are not shown in
this section.

III.3.1 Materials
The 3T3-L1 pre-adipocyte cell line was obtained from the Zen-Bio, Inc. (NC,
USA). The Platinum A (Plat-A) retroviral packaging cell line and the pMX-puro
retroviral vector were purchased from Cell Biolabs, Inc. (San Diego, CA, USA).
The yeast Saccharomyces cerevisiae strain EGY48 was obtained from American
Type Culture Collection (ATCC, Manassas, CA, USA). The pLex-A and pB42AD
control vectors were purchased from Addgene (Cambridge, MA, USA). Yeast
minimal SD Agar base, yeast minimal SD base, yeast dropout supplements were
purchased from Takara Bio, Inc. (Mounting View, CA, USA). Primary antibodies,
including the Akt1, p-Akt (Ser473), PPARγ, C/EBPα, Erk1/2, p-Erk1/2, FABP4,
FAS, ACC, GAPDH, and Rab5, and secondary antibodies, including the antiRabbit IgG AND anti-Mouse IgG, were purchased from the Cell Signaling
Technology (Boston, MA, USA). Fetal bovine serum (FBS) was purchased from
the RMBIO, Inc. (Missoula, MT, USA). Other reagents and supplies, if not
specifically described, were purchased from Thermo Fisher Scientific (Weston, FL,
USA).
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III.3.2 cDNA Construction.
Complementary DNAs (cDNA) of green fluorescent protein (GFP), GFPRab5:wild-type (GFP-Rab5:WT), and RIN1:WT were cloned into the pMX-puro
vector at the EcoRI and NotI restriction sites (Onishi et al., 1998). cDNA of IR βsubunit intracellular tail (IR-β) was cloned into the pLex-A vector at the EcoRI and
BamHI restriction sites. cDNA of RIN1:WT and the C-terminal of RIN1 containing
both the VPS9 and RA domains (R3:WT) were cloned into the pB42AD vector at
the EcoRI and XhoI sites. RIN1-SH2 mutants (RIN1:W69F, RIN1:A76F,
RIN1:R94A, RIN1:H120F, RIN1:121F, RIN1:Y148F) conjugated the pB42AD
vector were purchased from GenScript, Inc. (Piscataway, NJ, USA). IR-kinase
dead (IR:KD, IR:K1030A) and IR-β mutants (IR:Y972F, IR:Y1158F, IR:Y1328F,
and IR:Y1334F) on the pLex-A vector, RIN1-SH2 mutants and RIN1-VPS9
mutants (RIN1:Y537F, RIN1:Y561F, RIN1:T580A) on the pMX-puro vector, and
R3 mutants (R3:Y506F, R3:Y523F, R3:Y537F, R3:P541A, R3:Y561F, R3:Y572F,
R3:Y577F, R3:Y578F, R3:T580A, R3Y:Y629F) on the pB42AD vector were made
via the Q5® Site-Directed Mutagenesis Kit purchased from New England Biolabs,
Inc. (NEB, Ipswich, MA, USA).

III.3.3 siRNA sequences and transfection.
RNA interference (RNAi) directed against:
mouse RIN1 [5'-UUAUACAUUUGCUUCACACCUAAGC-3'],
mouse Rabex-5 [5’-UUUAUAGAGACGCGUCAUGAUGUGC-3'],
mouse RAP6 [5'-AAGAATCGATTACCTATAGCA-3'],
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mouse Rn-tre [5'-TAGACAGTATAATCACGCA-3'],
or mouse RabGAP-5 [5'-GGACGACTCTGTGACAGAAGGAGTA-3'] and [5’
GAACATCAAGCAAACAGAGCTGGTA-3’] were designed and synthesized by
Ambion (Austin, TX). A scrambled siRNA sequence was designed as a control [5'CACCUAAUCCGUGGUUCAA-3']. Prior to siRNA sequence transfection, cells
were plated in growth medium without antibiotics at 70-80% confluence. siRNA
sequence (20 nM final concentration) transfection was performed using
Lipofectamine-2000 as specified by Invitrogen (Invitrogen, Carlsbad, CA). After
transfection, cells were used for the indicated assay (e.g., for immunoblotting,
diffenrentiation or pull-down assays).

III.3.4 Cell counting assay.
The 3T3-L1 pre-adipocytes under different treatment (e.g., with or without
treatment of the differentiation media) and at different time points during
differentiation (e.g., 0 h time point before the treatment of differentiation media, 15
minutes/24 hours/48 hours time points after the treatment of differentiation media)
were detached by trypsin and diluted with DMEM. 100 μl of the cell suspension will
be mixed with 100 μl of the Trypan Blue solution. 10μl of the mixture was applied
to a hemocytometer or a TC20™ Automated Cell Counter (Bio-Rad, Inc.) to be
counted.
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III.3.5 Yeast 2 hybrid system.
III.3.5.1 Yeast transformation
Protein-protein interactions were tested and analyzed by the yeast 2-hybrid
system (Y2H). The generation of cDNA-containing vectors were described above.
These pvectors were transformed into the yeast stain EGY48 containing a pSH1834 reporter vector. A cDNA-containing pB42AD vector and a cDNA-containing
pLexA vector were co-transformed into yeast cells by the Yeast Transformation Kit.
Transformed yeast cells were selected by SD agar plates that lack leucine (for
selection of pSH18-34), histidine (for selection of pLexA), tryptophan (for selection
of pB42AD) and uracil (for selection of yeast stain EGY48).

III.3.3.2 Yeast β-galactosidase Assay
The protein-protein interaction was quantified by the Yeast β-galactosidase
(β-gal) Assay. Yeast cells were collected in the log phase followed by three freezethaw cycles and lyased in 70 μl of Y-PER buffer (50 mM Tris-HCl, pH 8; 50 mM
NaCl; 5 mM MgCl2·6H2O; 5 mM DTT). The β-gal reaction was triggered by adding
70 μl of 2*β-gal buffer. Then samples were incubated in 37°C until an obvious
yellow color showed up. At last, 56 μl of stop solution was added and samples
were tested under 420 nm wavelength. The β-gal activity can be calculated by the
formula below:
#$$$∗&'

β-Gal activity= +∗,∗&' ()* (t=total incubation time, V=0.196 ml)
--*
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III.3.6 In silico Studies
The homology model of the VPS9 domain with N-terminal helical bundle of
RIN1 was built by the SWISS-MODEL (Arnold et al., 2006) using the crystal
structure of the VPS9 domain of Rabex-5 (Pdb Id:1TXU) as a template (Delprato
et al., 2004). The model was built from residue M350 to L612 of RIN1. The
sequence identity between the VPS9 domain of RIN1 and Rabex-5 is 30.0%. The
coordinate of Rab5 (1R2Q) was taken from the protein data bank (Terzyan et al.,
2003; Zhang et al., 2014). The RIN1:VPS9-Rab5 complex was built using the
crystal structure of the complex of Rab5 and Rabex-5 (Pdb Id: 4Q9U) (Zhang et
al., 2014). The RIN1:VPS9-Rab5 complex was minimized by using NAMED and
VMD (Humphrey et al., 1996; Phillips et al., 2005). The whole RIN1 model was
built by using RaptorX structure prediction server (Kallberg et al., 2012). The server
used the SH2 domain of human carboxyl-terminal Src kinase (Pdb Id: 3EAC) (Liu
& Cowburn, 2016), Rabex-5 (Pdb Id: 2OT3) (Delprato & Lambright, 2007) and the
RA domain (Pdb Id: 4K81) (Qamra & Hubbard, 2013) as templates. The molecular
model was drawn with PYMOL (Delano, 2001).

III.3.7 Statistical analysis
All experiments presented were repeated a minimum of three times. Normal
distributed data were represented in mean ± standard deviation (Wilfling et al.).
The difference between groups were determined by the Student t-test. Tests were
considered statistically significant if p-value were less than 0.05.
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III.4 Results
In chapter II, Rab5 has been established to play a detrimental role in the
process of adipogenesis with a decreased GTP-bound Rab5 level. However, the
total expression of Rab5 in the 3T3-L1 pre-adipocytes was not affected. The
overexpression of the Rab5:Q79L mutant, which increased GTP-bound Rab5 level
due to its low GTP hydrolysis rate, impaired the accumulation of cytosolic lipid
droplets in the 3T3-L1 differentiated cells. Whereas the overexpression of
Rab5:S34N, the GTP-binding defective mutant that maintained Rab5 in its inactive
form, promoted the formation of lipid droplets in the differentiated 3T3-L1 cells.
Besides, a gradient decrease of GTP-bound Rab5 was observed during the 3T3L1 cell differentiation process in a time-dependent manner. Thus, I questioned if
the Rab5 GEFs, Rab5 GAPs, and Rab5 effectors participate in the regulation of
Rab5 during the adipogenesis process.

III.4.1 Rab5 GEFs were down-regulated during the differentiation of 3T3L1 pre-adipocytes
In order to address whether the Rab5 GEFs participate in the differentiation
of adipocytes, cell lysates collected from 3T3-L1 pre-adipocytes at before (day 1)
and after (day 9) differentiation were prepared and utilized for immunoblotting, The
expression of several Rab5 GEFs, such as RAP6 and Rabex-5, and Rab5 GAPs,
such as RabGAP-5 and RN-tre, were analyzed. As described early, GAPDH
served as the whole cell lysate loading control. PPARγ, C/EBPα, acetyl-CoA
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carboxylase (ACC), fatty acid synthase (Kralisch & Fasshauer), GLUT4, and IR
were adipogenic markers indicating the extent of differentiation.

Rab5

ACC

Rabex5
FAS

RAP6
RabGAP5

PPARγ
p42

RN-tre
GLUT4

C/EBPα

IR

GAPDH
Day 1

p30

Day 1

Day 9

Day 9

Figure 22. Representative Western blot of the content of Rab5 GEPs, Rab5
GAPs, typical adipogenic markers, and GAPDH.
3T3-L1 pre-adipocytes expressing GFP were lysed before (day1) and after (day9)
of differentiation as described in Material and Methods.
In Figure 22, all adipogenic markers, including PPARγ, C/EBPα, ACC, FAS,
GLUT4, and IR exhibited an increased expression level at day 9 after
differentiation in comparison with day 1. The two Rab5 GEFs tested, Rabex-5 and
RAP6, showed a decreased expression in mature adipocytes (day 9). However,
the two Rab5 GAPs, RabGAP-5 and RN-tre, did not exhibit obvious changes
between day 1 and day 9 during differentiation. The results suggest an essential
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role of Rab5 GEFs in the regulation of Rab5 nucleotide states during the
differentiation process.

III.4.2 The Rab5 GEFs downregulated the accumulation of lipids in the
differentiated 3T3-L1 cells.
In order to address the specific role of different Rab5 GEFs (e.g., RIN1,
Rabex-5, and RAP6) and Rab5 GAPs (RN-tre and RabGAP-5) in the differentiation
of 3T3-L1 cells, the individual overexpression of specific Rab5 GEFs/GAPs in 3T3L1 cells was accomplished via the pMX-puro retroviral vector system that has been
described in the Materials and Methods. And to further explain the role of a specific
Rab5 GEF/GAP in regulating the Rab5 nucleotide states, I lysed the 3T3-L1 cells
overexpressing RIN1, Rabex-5, RAP6, RN-tre, or RabGAP-5 before (day1) and
after (day 9) differentiation. The cell lysates were incubated with GST-EEA1
(glutathione-S-transferase-EEA1) followed by GTP-Rab5 pull-down assay, and the
pull-downs were subjected to immunoblotting analysis to determine the ratio of
GTP-Rab5 (G-Rab5) to total Rab5 (T-Rab5). Besides, siRNA targeting specific
Rab5 GFF and Rab5 GAP, as well as scrambled siRNA as control, were designed
and induced into the 3T3-L1 cells to selectively silence a particular Rab5 GEF/GAP.
At last, 3T3-L1 cells overexpressing GFP or a specific Rab5 GEF/Rab5 GAP, and
3T3-L1 cells induced with scrambled siRNA or Rab5 GEF/GAP siRNA, were
stained with ORO followed by quantification of lipid content.
In Figure 23, I show that the overexpression of RabGAP-5 affected the
differentiation of 3T3-L1 pre-adipocytes as evidenced by the increase in the
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accumulation of cytosolic lipids. This increase in the accumulation of lipid droplets
was consistent with the decreased Rab5-GTP level in cells overexpressing
RabGAP-5 as compared with the GFP cells (Figure 23). Specifically, I also
observed statistically significant inhibition of the Rab5-GTP level in cell lines
expressing RabGAP-5 at both day 1 and 9 as compared with GFP-control cells.
Similarly, the overexpression of RN-tre increased adipogenesis (Figure 23). More
importantly, RabGAP-5 (137±4%) is more active than RN-tre (121±4%) during the
differentiation process (compare Figure 23.A with Figure 24.A) as well as in the
levels of GTP-bound Rab5 (compare Figure 23.C with Figure 24.C). Moreover, the
Rab5-GTP level was dramatically reduced in cells expressing Rab5 GAPs, and no
further reduction of the Rab5-GTP level was observed at day 9 of differentiation
(Figure 23.C and Figure 24.C). To further uncover the role of Rab5 GAPs in the
differentiation of 3T3-L1 pre-adipocytes, I utilized specific siRNA to induce the
deletion of specific Rab5 GAP in the 3T3-L1 pre-adipocytes. Individual removal of
Rab5 GAPs produced a significant inhibition on the accumulation of lipids (Figure
23.B and Figure 24.B). These observations suggest that the decrease of the GTPbound Rab5 induced by the two Rab5 GAPs has a positive effect on the
differentiation of 3T3-L1 pre-adipocytes.
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Figure 23. Selective effect of RabGAP-5 on the differentiation of 3T3-L1 preadipocytes.
Data represent the mean ± S.E.M. of three independent experiments. A. 3T3-L1
cells expressing GFP and RabGAP-5 were differentiated. The accumulation of lipid
droplets quantified via ORO assay and were represented as relative lipid contents.
Inset: Representative Western blot of content of RabGAP-5 and GAPDH proteins.
B. Non-transfected cells (Ctl), and cells transfected with scramble RNAi (Scr) or
RNAi against RabGAP-5 were differentiated as described. Results were
represented as relative lipid contents. Inset: Representative Western blot of
content of RabGAP-5, RIN1 and GAPDH proteins. C. Cell lysates of 3T3-L1 preadipocytes expressing GFP and RabGAP-5 were prepared at specific day (Day 1
and Day 9) of the differentiation, and the endogenous GTP-bound Rab5 was
analyzed by immunoblotting as indicated in the figure.
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Figure 24. Selective effect of RN-tre on the differentiation of 3T3-L1 preadipocytes.
Data represent the mean ± S.E.M. of three independent experiments. A. 3T3-L1
pre-adipocytes expressing GFP and RN-tre were differentiated. The accumulation
of lipid droplets quantified via ORO assay and were represented as relative lipid
contents. Inset: Representative Western blot of content of RN-tre and GAPDH
proteins. B. Non-transfected cells (Ctl), and cells transfected with scramble RNAi
(Scr) or RNAi against RN-tre were differentiated as described. Results were
represented as relative lipid contents. C. Cell lysates of 3T3-L1 pre-adipocytes
expressing GFP and RN-tre were prepared at specific day (Day 1 and Day 9) of
the differentiation, and the endogenous GTP-bound Rab5 was analyzed by
immunoblotting as indicated in the figure.
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To gain more information about the regulation of Rab5 cycle during
adipogenesis, I analyzed the effect of the expression of Rab5 GEFs (RIN1, Rabex6, and RAP6) on the differentiation of 3T3-L1 pre-adipocytes (Figure 25~27). In
Figure 25, the overexpression of RIN1 blocked the accumulation of lipids.
Consistent with this observation, the overexpression of RIN1 increased the Rab5GTP level as compared with GFP-control pre-adipocytes at day 1 and 9 of
differentiation (Figure 25.C). Interestingly, a decrease of the level of Rab5-GTP
was observed in RIN1-overexpressed cells at day 9 as compared with day 1 of
differentiation, but this reduction in the Rab5-GTP level was less significant as
compared with the GFP-control cells (e.g., Rab5-GTP level in GFP-control
exhibited a reduction of 75% whereas reduced by only 50% in the RIN1overexpressed cells) (Figure 25.C).
The effect of the overexpression of Rabex-5 and RAP6 on the differentiation
of 3T3-L1 pre-adipocytes were also examined (results are shown in Figure 26 and
Figure 27). In Figure 26.A and Figure 27.A, similar to the effect of RIN1overexpression, the individual overexpression of Rabex-5 and RAP6 blocked the
accumulation of ORO by 63±7% and 56±4%, respectively. Consistent with these
results, I observed that the individual overexpression of wither Rabex-5 or RAP6
statistically significant increased the Rab5-GTP level as compared with GFPcontrol pre-adipocytes at day 1 and 9 (Figure 26.C and Figure 27.C). Furthermore,
a statistically significant decrease in the level of Rab5-GTP was also observed in
the GFP-overexpressing cells when day 9 was compared with day 1 (a ~75%
reduction can be observed). A decrease of the level of Rab5-GTP can also be
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detected in Rabex-5- and RAP6-overexpressing cell lines at day 9 as compared
with day 1 of the differentiation process. But this reduction between day 9 and day
1 in the Rab5-GTP level was less significant as compared with GFP-control cells
(e.g., Rabex-5-cells showed a ~70% decrease whereas the RAP6-cells showed a
~50% decrease) (Figure 26.C and Figure 27.C).
Then the depletion effect of these Rab5 GEFs was examined by inducing
specific siRNA on the 3T3-L1 pre-adipocytes during the differentiation process.
The down-regulation of each one of the Rab5 GEFs was accompanied by an
increase of the accumulation of ORO as compared with control siRNA-induced
cells. Specifically, cells overexpressing RIN1 promoted the lipid formation by 26%,
Rabex-5 increased lipids accumulation by 20, while the overexpression of RAP6
increased lipids accumulation by 25 (Figure 26.A and Figure 27.A). 3T3-L1 preadipocytes differentiation process and also increased the levels of Rab5-GTP as
compared with GFP-control cells (data not shown). Taken together, these data
suggest that the overexpression or deletion of the specific Rab5 GFE (or the Rab5
GAPs) have essential effects on differentiation of 3T3-L1 pre-adipocytes. The
affected differentiation process by these Rab5 GEFs/GAPs were because, at least
partially, of their role in regulating the Rab5 nucleotide states.
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Figure 25. Selective effect of RIN1 on the differentiation of 3T3-L1 preadipocytes.
Data represent the mean ± S.E.M. of three independent experiments. A. 3T3-L1
pre-adipocytes expressing GFP and RIN1 were differentiated. The accumulation
of lipid droplets quantified via ORO assay and were represented as relative lipid
contents. Inset: Representative Western blot of content of RIN1 and GAPDH
proteins. B. Non-transfected cells (Ctl), and cells transfected with scramble RNAi
(Scr) or RNAi against RabGAP-5 were differentiated as described. Results were
represented as relative lipid contents. Inset: Representative Western blot of
content of RIN1, RIN1 and GAPDH proteins. C. Cell lysates of 3T3-L1 preadipocytes expressing GFP and RIN1 were prepared at specific day (Day 1 and
Day 9) of the differentiation, and the endogenous GTP-bound Rab5 was analyzed
by immunoblotting as indicated in the figure. Inset: Representative immunoblots of
samples probed with anti-Rab5 antibodies for total Rab5 (T-Rab5) and active Rab5
(G-Rab5) respectively.
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Figure 26. Selective effect of Rabex-5 on the differentiation of 3T3-L1 preadipocytes.
Data represent the mean ± S.E.M. of three independent experiments. A. 3T3-L1
pre-adipocytes expressing GFP and Rabex-5 were differentiated. The
accumulation of lipid droplets quantified via ORO assay and were represented as
relative lipid contents. Inset: Representative Western blot of content of Rabex-5
and GAPDH proteins. B. Non-transfected cells (Ctl), and cells transfected with
scramble RNAi (Scr) or RNAi against Rabex-5 were differentiated as described.
Results were represented as relative lipid contents. C. Cell lysates of 3T3-L1 preadipocytes expressing GFP and Rabex-5 were prepared at specific day (Day 1
and Day 9) of the differentiation, and the endogenous GTP-bound Rab5 was
analyzed by immunoblotting as indicated in the figure.
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Figure 27. Selective effect of RAP6 on the differentiation of 3T3-L1 preadipocytes.
Data represent the mean ± S.E.M. of three independent experiments. A. 3T3-L1
pre-adipocytes expressing GFP and RAP6 were differentiated. The accumulation
of lipid droplets quantified via ORO assay and were represented as relative lipid
contents. Inset: Representative Western blot of content of RAP6 and GAPDH
proteins. B. Non-transfected cells (Ctl), and cells transfected with scramble RNAi
(Scr) or RNAi against RAP6 were differentiated as described. Results were
represented as relative lipid contents. Inset: Representative Western blot of
content of RabGAP-5, RIN1 and GAPDH proteins. C. Cell lysates of 3T3-L1 preadipocytes expressing GFP and RAP6 were prepared at specific day (Day 1 and
Day 9) of the differentiation, and the endogenous GTP-bound Rab5 was analyzed
by immunoblotting as indicated in the figure. Inset: Representative immunoblots of
samples probed with anti-Rab5 antibodies for total Rab5 (T-Rab5) and active Rab5
(G-Rab5) respectively.
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III.4.3 Selective effect of RIN1 and its mutants on insulin signaling during
pre-adipocyte differentiation
III.4.3.1 RIN1 overexpression inhibited adipogenesis in vitro
Previous results showed that the adipogenic differentiation of Rab5overexpressed 3T3-L1 cells was promoted. Also, GTP-bound Rab5 were
progressively down-regulated over the process of differentiation. In addition, in the
previous section, I showed a regulatory role of Rab GEFs in the adipogenesis
process. Here, to further examine the effect of RIN1 on the differentiation of 3T3L1 pre-adipocytes, I overexpressed RIN1:wild-type (RIN1:WT) in the 3T3-L1 cells
and tested the effect of RIN1 overexpression on the adipogenic markers (results
shown in Figure 28 and Figure 29).
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*

GAPDH
GFP RIN1:WT

Figure 28. RIN1 effect on the differentiation of 3T3-L1 pre-adipocytes.
A. Relative lipid content of GFP (C+/C-, represent positive control and negative
control, respectively) or RIN1:WT transfected 3T3-L1 cells. Cells that were not
treated with hormone cocktail served as negative control. Data represent the mean
± S.E.M. of three independent experiments. *P<0.001 by Student's t-test compared
to differentiated GFP-overexpressed cells. S.E.M. = Standard error of the mean.
B. Representative Western blot results of RIN1:WT and GFP overexpressed cells.
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I used the Plat-A cells to transfer the RIN1:WT or the GFP-containing
retrovirus into 3T3-L1 pre-adipocytes. The transfected cells were treated with or
without hormone cocktail as was described in Materials and Methods. Then the
ORO staining and spectroscopy was used to quantify lipid accumulation in the
cytosol (Figure 28). Then the expression of adipogenic transcription factors,
PPARγ and C/EBPα, and adipogenic markers, ACC, FABP4 and FAS in
differentiated cells were tested to confirm the ORO results (Figure 29).

PPARγ
C/EBPα
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FAS
GAPDH
Hormone Inducers
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+
GFP
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Figure 29. Effect of RIN1:WT on transcription factors.
3T3-L3 cells overexpressing GFP or RIN1:WT were differentiated with (positive
control) or without hormone inducers.
In Figure 29, the expression level of PPARγ, C/EBPα, ACC, and FAS in
GFP- (cells were treated with or without hormone inducers, which represent the
positive control and the negative control, respectively) and RIN1:WT- (cells were
hormone treated) overexpressed 3T3-L1 cells were tested via Western blotting.
The differentiated GFP-overexpressed cells showed a significantly higher
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expression of the two adipogenic transcription factors, PPARγ and C/EBPα, and
the two adipogenic markers, ACC and FAS. However, the differentiated RIN1:WToverexpressed cells showed a decreased expression of all tested proteins (Figure
29).
These results, showing that RIN1:WT played an inhibitory role in preadipocyte differentiation, lead me to further examine the mechanism by which
RIN1 affects the adipogenesis process.
III.4.3.2 Two RIN1 selective mutants rescued the inhibitory effects of
RIN1 on adipogenesis
RIN1 performs multiple functions in cell metabolism due to its availability of
interacting with numerous proteins through different domains. Through its Src
homology 2 (SH2) domain, RIN1 interacts with several receptor tyrosine kinases,
such as epidermal growth factor receptor (EGFR) and insulin receptor (IR)
(Barbieri et al., 2003; Hunker et al., 2006b). Through its VPS9 domain, RIN1 can
activate Rab5, a small GTPase that is essential in early endosome fusion process
(Tall et al., 2001). Thus, I used two selective mutants, the RIN1:R94A and the
RIN1:Y561, to examine the inhibitory role of RIN1 in adipogenesis process. The
R94A mutation locates in the SH2 domain of RIN1 and leads a diminished
interaction between RIN1 and the IR (Barbieri et al., 2003). The Y561F mutant,
however, interferes with the activation of Rab5, resides in the VPS9 domain
(Mustafi and Barbieri, 2016).
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Again, the ORO staining and spectroscopy assay and the western blot
assay were used to quantify the lipid content and to qualify the maturity of
differentiated adipocytes, respectively. Interestingly, the overexpression of either
mutant could rescue the prohibited effects on adipogenesis caused by RIN1:WT
overexpression. In Figure 30, the ORO results presented that the RIN-R94A and
RIN1:Y561F mutant increased lipid content from 53% to 77% and 64%,
respectively in comparison to the RIN1:WT. The western blot analysis convinced
the ORO results where the cells overexpressing either RIN1:R94A or RIN1:Y561F
showed a higher expression of the adipogenic transcription factors, PPARγ and
C/EBPα, and two adipogenic markers, ACC and FAS (Figure 30).
Due to the fact that the function-declined RIN1 mutants, either in the SH2
domain or the VPS9 domain, could extricate adipogenesis of 3T3-L1 cells from
obstructed effects of RIN1:WT, I suspected that both the SH2 domain and the
VPS9 domain are necessary for RIN1 to complete its molecular function in
adipogenesis process. As described above, the two mutants are from different
domains of RIN1. Thus, the data here suggested that RIN1 affected the
adipogenesis process through at least two cellular processes, the endosome
pathway and the insulin signaling pathway.
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Figure 30. Effect of RIN1 selective mutants on adipogenesis.
A. Relative lipid content of GFP or RIN1:WT transfected 3T3-L1 cells. 3T3-L1 cells
overexpressing GFP, RIN1:WT, and RIN1 mutants were treated with or without
hormone cocktail as described in Materials and Methods. Cells that were not
treated with hormone cocktail served as negative control (C-). (Data represent the
mean ± S.E.M. of three independent experiments. *P<0.01 by Student's t-test
compared to differentiated RIN1:WT-overexpressed cells). S.E.M. = Standard
error of the mean. B. C. Western blot result of RIN1:WT, RIN1:R94A, RIN1:Y561F
and GFP overexpressed cells.
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III.4.3.3 RIN1 mutants recovered both Erk1/2 and Akt signaling in
compare with RIN1-WT
In the previous study, RIN1 showed co-localization with the IR on both cell
membrane and endosomes upon insulin stimulation, and the expression of RIN1WT blocks the activation of both Erk1/2 and Akt signaling pathway in cancer cells
in vitro (Hunker, Giambini, et al., 2006). Evidence also showed that both Akt and
Erk1/2 signaling reached their maximal level at 15 minutes upon insulin stimulation
in vitro (Zecchin et al., 2007). Because of the glaring effects of RIN1 and its
mutants on the process of adipogenesis and the regulatory role of RIN1 in insulin
signaling pathway, I examined the activation of Erk1/2 and Akt, two important
proteins in the MAPK and PI3K signaling pathways, respectively, at 15 minutes
after hormone treatment (Figure 31). The western blot analysis revealed that both
the MAPK and the PI3K signaling pathways were activated upon a 15-minutes
hormone treatment in all cell lines (Figure 31). Both activated Akt and Erk1/2
appeared to be downregulated in the RIN1-WT overexpressed cells upon hormone
treatment (Fig. 5A) However, the RIN1-R94A overexpressed cells attended to
reach a significantly higher signal than the RIN1-WT overexpressed cells at 15
minutes after and even before hormone treatment (Figure 31). Simultaneously, the
RIN1-Y561F overexpressed cells presented higher signal of activated Akt (p-Akt)
both before and 15 minutes after hormone treatment (Figure 31). The RIN-Y561F
mutant increased the Erk1/2 signal before hormone treatment and slightly higher
signal after hormone treatment (Figure 31).
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Figure 31. The activity of Akt and Erk1/2 before (0) and 15 minutes after
hormone treatment.
3T3-L1 cells overexpressing GFP, RIN1:WT, and RIN1 mutants were treated with
or without hormone cocktail as described in Materials and Methods. Cells that were
not treated with hormone cocktail served as negative control (C-). (Data represent
the mean ± S.E.M. of three independent experiments. *P<0.01 by Student's t-test
compared to differentiated RIN1:WT-overexpressed cells). S.E.M. = Standard
error of the mean. Representative Western blot of the content of p-Akt and pErk1/2 in comparison with GAPDH were shown.
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III.4.3.4 RIN1 mutants promote cell proliferation in clonal expansion
phase during adipogenesis
Proliferative 3T3-L1 pre-adipocytes were growth-arrested upon contact
inhibition before hormone treatment. Prior to terminal differentiation, the hormone
triggered growth-arrested cells re-entered cell cycle to perform 2 rounds of postconfluence mitosis, which is named as the clonal expansion phase. Establishing
that the RIN1:WT and RIN1 mutants had noticeable effects on the MAPK and PI3K
signaling pathways upon hormone treatment in the previous unit, I hypothesized
that the ultimate consequences of the protein overexpression would cause notable
effects on the clonal expansion phase. proliferation in the early stage of
adipogenesis.

*

Figure 32. Cell proliferation of GFP-, RIN1-, RIN1:R94A-, or RIN1:Y561Foverexpressed cells in the first 48h after hormone induction.
The results indicated a depressed cell growth rate of RIN1 expressed cells while
a rescue of cell proliferation when expressing the two selective mutants.
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Figure 33. Bright-field images of GFP-, RIN1-, RIN1:R94A-, or RIN1:Y561Foverexpressed cells in the first 48h after hormone induction.
Images were taken under bright-field microscope at 0h (before differentiation) and
48h (after differentiation) with the same magnification of 20X objective lens. The
results indicated a depressed cell growth rate of RIN1 expressed cells while a
rescue of cell proliferation when expressing the two selective mutants.
To address the effect of RIN1 and its mutants on adipogenesis, I used cell
counting assay, both manually and automatically, to intuitively investigate the
growth of transfected cells in the first 48 hours upon hormone treatment. In Figure
170

32 and 33, RIN1 inhibited cell proliferation whereas the two mutants of RIN1
rescued it during the clonal expansion phase of adipogenesis. The results suggest
that RIN1 plays an inhibitory role in adipogenesis by, at least partially, impairing
the cell mitotic clonal expansion phase of adipogenesis.

III.4.4

The

expression

of

Rab5

effector,

VPS34,

impaired

the

differentiation of 3T3-L1 preadipocytes.
Rab5 is regulated by Rab5 GAPs and GEFs, and eventually perform its
function by recruiting different Rab5 effectors. In order to investigate the effect of
VPS34, a Class III PI3K to generate PI3P upon recruitment by Rab5, I transfected
the 3T3-L1 pre-adipocytes with GFP-VPS34 via the pMX-puro retroviral vector
system. The transfected cells were treated with or without hormone cocktail as was
described in Materials and Methods. Then the ORO staining and spectroscopy
was used to quantify lipid accumulation in the cytosol (Figure 34). Then I tested
the effect of VPS34 on the insulin signaling pathway by analyzing the
phosphorylation levels of Akt and Erk1/2 in the cell lysates. The VPS34- and GFPtransfected cell lysates were collected before differentiation (0h) and 15 minutes
after hormone treatment (Figure 35). At last, live cell images were taken under the
inverted microscope at the same field of view to analyze the proliferation rate of
transfected cells (Figure 36 & 37). Bright-field images were taken at either before
differentiation(0h), 15 minutes, 24 hours, and 48 hours (48 hour time point is
considered as the end of the mitotic clonal expansion phase) after hormone
treatment.
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A

Figure 34. Differentiation of GFP and VPS34 overexpressed cells.
A. Relative lipid content of cells expressing GFP or GFP-VPS34. Data represent
the mean ± S.E.M. of three independent experiments. *P<0.05 by Student's ttest.B. Bright-field images of 3T3-L1 cells overexpressing GFP or GFP-VPS34. C.
Confocal images of 3T3-L1 cells overexpressing GFP or GFP-VPS4 before
differentiation.
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In Figure 34.A and B, the ORO quantification assay revealed a significant
decreased lipid content of VPS34 overexpressed cells as compared with the GFP
positive control (GFP+, cells were treated with hormone inducers during the 10day differentiation). Interestingly, the VPS34-transfected cells exhibited similar
lipid content as the GFP negative control cells which were not treated with
hormone inducers during the differentiation process. To my surprise, the size of
the VPS34-transfected cells was much bigger than the GFP-transfected cells,
which can be observed through both bright-field images and confocal images taken
under the same magnification (Figure 34.B & C).

Figure 35. The activity of Akt and Erk1/2 at 0h, 15 min 24h, and 48h after
hormone treatment.
3T3-L1 cells overexpressing GFP or GFP-VPS34 were treated with or without
hormone cocktail as described in Materials and Methods. Cells that were not
treated with hormone cocktail served as negative control. Representative Western
blot of the content of p-Akt and p-Erk1/2 in comparison with GAPDH were shown.
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In Figure 35, phosphorylated Akt and Erk1/2 were tested at 0h, 15min, 25h,
and 48h time points. Surprisingly, the VPS34-transfected cells had an increased
activity of both Akt and Erk1/2 as compared with the GFP cells at the same time
points. What is more, the VPS34 transfected cells even exhibited a higher
phosphorylation base line (compare the activity of both Akt and Erk1/2) and
experienced a higher increase at 15min after hormone induction.

*
Figure 36. The activity of Akt and Erk1/2 at 0h, 15 min 24h, and 48h after
hormone treatment.
3T3-L1 cells overexpressing GFP or GFP-VPS34 were treated with or without
hormone cocktail as described in Materials and Methods. Cells that were not
treated with hormone cocktail served as negative control. Representative Western
blot of the content of p-Akt and p-Erk1/2 in comparison with GAPDH were shown.
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Figure 37. Bright-field images of GFP and GFP-VPS34 overexpressed cells
in the first 48h after hormone induction.
Images were taken under bright-field microscope at 0h (before differentiation) and
48h (after differentiation) with the same magnification of 20X objective lens. The
results indicated a depressed cell growth rate of VPS34 expressed cells while a
rescue of cell proliferation when expressing the two selective mutants.
As described above, the Akt signaling pathway governs cell metabolism and
plays a positive role in 3T3-L1 pre-adipocyte differentiation whereas the Erk1/2
signaling pathway controls gene expression, protein translation, and plays a
negative role in promoting the adipogenesis process. Thus, it will be interesting to
investigate how the clonal expansion phase is affected during the differentiation
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process. In Figure 36 and 37, cell counting data revealed that the expression of
VPS34 in the 3T3-L1 cells not only enlarge the size of the pre-adipocytes, but also
decreased the cell proliferation rate in the first 48 hours of differentiation.

III.4.5 Selective association of IR with Rab5 GEFs
Based on my observations where the diminishing of the Rab5-GTP levels
during the differentiation process is linked to insulin stimulation together with the
differential effect of Rab5 GEFs, Rab5 GAPs, and Rab5 constructs on
differentiation of 3T3-L1 pre-adipocytes, I concluded that decreasing the Rab5GTP levels could be related to the inability of Rab5 GEFs and Rab5 GAPs to
regulate and/or access to Rab5 proteins during differentiation of 3T3-L1 preadipocytes.
To determine the possible cellular mechanism under the regulation of Rab5,
I examined whether the IR was associated with specific Rab5 GEFs and/or Rab5
GAPs. 3T3-L1 pre-adipocytes individually expressing each Rab5 GEF and Rab5
GAP were differentiated, and then cells at day 9 of the differentiation process were
incubated in the absence or in the presence of insulin for 5 min at 37°C. After the
incubation, cells were lysed, and IR was immunoprecipitated followed with
immunoblotting analysis with specific anti-Rab5 GEFs antibodies. In Figure 38, I
show that RIN1 (Figure 38.A), Rabex5 (Figure 38.B) and RAP6 (Figure 38.C) are
able to interact with the IR in the presence of insulin. Results were tested via
immunoprecipitation with anti-IR antibodies. In contrast, it was not possible to
immunoprecipitate these Rab5 GEFs with IR in the absence of insulin (Figure 38.A,
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B, and C). The SH2 domain of RIN1 has been established previously to interact
with activated insulin receptor tyrosine kinase domain, which is also confirmed in
Figure 38.D. The SH2 domain of RIN1 alone was able to interact with the activated
insulin receptor, whereas this domain was not able to interact with the catalytic
inactive mutant of the insulin receptor (IR:KD). Interestingly, besides the wellestablished SH2 domain, another domain of RIN1, the VPS9 domain showed
strong interaction with the IR-tail in the yeast two-hybrid system (Figure 38.D).
However, the domains that showed higher affinity to the activated IR did not show
any binding affinity to the catalytic inactive IR-tail. Taken together, these
observations suggest that, IR interacts with Rab5 GEFs only upon the stimulation
of insulin. These observations were not surprising for RIN1 since it contains an
SH2 domain. However, Rabex5 and RAP6 do not have an SH2 domain, even the
association of the latter molecules can be attributed to the requirement of
additional factors as it has been shown in the case of the interaction with EGFR.
Thus, is reasonable to consider that the VPS9 domain, which is a common domain
between these Rab5 GEFs, may be responsible for this interaction with the IR
upon insulin stimulation.
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C

B

D

Figure 38. Interaction of the IR-cytoplasmic tail and VPS9 containing proteins.
3T3-L1 preadipocytes expressing GFP, RIN1 (A), Rabex-5 (B), and RAP6 (C) were
differentiated into adipocytes in the absence (Control) or in the presence of insulin
at 37°C for 5 min. After the incubation, cells were lysed and analyzed by
immunoprecipitation followed by immunoblotting as described in the figure.
Results were represented as relative lipid contents. Data represent the mean ±
S.E.M. of three independent experiments. A./B./C. Representative Western blot of
the content of Rabex-5, RAP6, RIN1 constructs, IR, and phospho-IR proteins.
*P<0.05 by Student's t-test. D. Yeast cells were co-transformed with plasmids
pB42AD fused with Rab5 GEF constructs and plasmids pLexA fused with IRtail:WT/KD. Co-transformed cells were selected as described in Material and
Methods. Liquid cultures in selective media were also assayed for β-Galactosidase
(β-Gal) to verify and quantify two-hybrid interactions. The data are presented as
means ± SD of five independent experiments, n=5 *P<0.005. Each independent
experiment was performed in quintuplicate.
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To further investigate the specificity of the interaction between Rab5 GEFs
and IR, I then asked whether a specific domain of Rab5 GEFs was involved in the
interaction with the cytoplasmic tail of IR. To address this, I utilized a yeast twohybrid system to analyze the interaction of the cytoplasmic tail of IR:WT with the
following Rab5 GEFs constructs: a) RIN1:SH2, RIN1:VPS9 and RIN1:RA;
b) Rabex-5:Z-M (Z: zinc-finger, which displays Ub protein ligase (E3) activity and
binds Ub; M: MIU, a motif interacts with ubiquitin), Rabex-5:VPS9, Rabex-5:C-P
(Lee et al., 2006); c) RAP6:VPS9, RAP6:PH and RAP6:RGD (Figure 38). The
cytoplasmic tail of IR kinase-dead (IR:K1077M), as well as blank vectors that were
not conjugated with Rab5 GEF constructs, were used as negative controls.
Consistent with previous observations, I found that RIN1:SH2 domain interacted
with the cytoplasmic tail of IR (Figure 38.A). However, I also noticed that
RIN1:VPS9 domain, but not RIN1:RA domain, interacted with the cytoplasmic tail
of IR. Interestingly, the VPS9 domain of RAP6 and Rabex-5, but not other domains
from these Rab5 GEFs, also interacted with the cytoplasmic tail of IR (Figure 38.D).
These observations, indicates Rab5 GEFs interact with the cytoplasmic tail of IR
via VPS9 domain. For additional examination of this novel interaction between the
RIN1:VPS9 domain and with the cytoplasmic tail of IR, I built the in silico model of
the complex of RIN1:VPS9-HB and the cytoplasmic tail of IR using the X-ray crystal
structure of the IR and VPS9-HB of Rabex-5. In Figure 34, I show the model of the
interaction of VPS9-HB domain and IR-cytoplasmic tail. The molecular analysis of
the RIN1:VPS9-HB:IR cytoplasmic tail complex shows that there are 24 residues
in RIN1 VPS9-HB and 28 residues in IR-cytoplasmic tail are placed in the interface
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between them (Table 4). This complex is being stabilized by hydrogen bonds, van
der Walls, hydrophobic and ionic interactions at the interface, and it also predicts
that a number of exposed residues in the RIN1; VPS9-HB (Asp537, Pro541,
Tyr561, and Thr580) domain. Thr580 places in the αV6 helix on the VPS9 domain
and is conserved in hRabex-5, hRIN1, hAlsin, hVarp, but not in hRAP6 proteins. It
is placed in the interface, where the side chain of the Thr580 is almost buried into
the interface. The side chain of Thr580 in VPS9 domain makes the hydrogen bond
interaction with the backbone of Ser1096 of IR cytoplasmic tail. The distance
between OG1 atom of Thr580 and OG atom of Ser1096 of IR cytoplasmic tail is
nearly 4.5 Å, and it could also form the hydrogen bond between them (Figure 39).

Table 4. In silico analysis of the interaction between the VPS9-HB1 domain
of RIN1 and the IR-tail2
1 The numbering of amino acids of corresponds to the protein of Han and Colicelli
(Han & Colicelli, 1995).
2 The numbering of amino acids of IR-B differs from that of the receptor of Ebina
et al. by being 47 amino acids greater (Ebina et al., 1985).
Table 4.A Hydrophobic interactions between the VPS9-HB domain of RIN1
and the IR-tail
VPS9-HB Domain

IR-tail

Leu571

Trp1036

Pro599

Leu1085

Leu540

Ile1089, Leu1092

Pro541

Ile1089

Leu588

Ile1089, Leu1092

Ala584

Leu1092

Trp577

Val1097, Phe1175
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Table 4.B Cation-Pi interactions between the VPS9-HB domain of RIN1 and
the IR-tail within 6 Å
VPS9-HB Domain
Lys520

IR-tail
Tyr1205

Table 4.C Aromatic-aromatic Interactions between VPS9-HB and IR-tail
within 4.5 and 7 Å
VPS9-HB Domain
Tyr577

IR-tail
Phe1175

Table 4.D Ionic interactions between VPS9-HB and IR-tail within 6 Å
VPS9-HB Domain
Glu564
Asp537
Lys520
Glu532
Glu530
Glu538
Lys426
Glu574

IR-tail
Lys1067
Arg1086, Glu1090
Asp1203, Glu1206
Arg1211, Lys1212
Lys1212
Lys1212, Lys1215
Glu1327
Glu1328

Table 4.E Hydrogen bond interactions between VPS9-HB and IR-tail.
VPS9-HB
Domain

IR-tail

VPS9-HB
Domain

IR-tail

Leu571

Phe1101

Asp537

Arg1086, Arg1202

Ala536

Asn1093

Glu530

Lys1212, Lys 1215

Thr572

Lys1173

Glu538

Lys1212, Lys 1215

Glu532

Arg1211, Lys1212, Lyr1209

Lys426

Glu1327

Gly533

Lys1212

Lys520

Asp1203, Glu1206

Thr580

Ser1096

Ser563

Glu1035

Arg403

Lys1067, Thr1207

Tyr577

Asp1203

Tyr523

Asp1203
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Figure 39. Analysis of the interaction between the IR-cytoplasmic tail and the
RIN1:VPS9 mutants.
In silico docking analysis of the IR-cytoplasmic tail and the VPS9-HB domain of
RIN1. RIN1:VPS9 domain’s residues studied above are shown in magenta sticks
and their interactions are shown in separate panels (Inserts). The polar distance
less than 4.0 Å are shown in dotted lines. Residues Pro541 and Thr580 of the
VPS9 domain are buried in the interface of the complex. The Pro541 makes
hydrophobic interaction with Ile1089 of IR-cytoplasmic tail. The side chain of
Thr580 makes interaction with the main chain of Ser1096. These mutations of
Pro541 and Thr580 to alanine destabilize this complex. The activated IRcytoplasmic tail structure is taken from the protein data bank (Pdb Id: 4XLV) for
docking (Cabail et al., 2015). The homology model of VPS9-HB domain of RIN1
was built by SWISS-MODEL (Arnold et al., 2006) using the crystal structure of
Rabex-5 (Pdb id:1TXU) as a template (Delprato et al., 2004). The docking of the
IR-cytoplasmic tail and the VPA9-HB domain was done by the ZDOCK online
server. The docked model was minimized by using NAMED (Phillips et al., 2005)
and VMD (Humphrey et al., 1996). The molecular model was drawn with PYMOL
(Delano, 2001).
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Tyr561 is also conserved in hRabex-5, hRIN1, hGAPVD1, hVarp but not in
hAlsin proteins. It is placed in the αV5 helix, and the side chain is fully buried into
the interface between VPS9 and HB domain of RIN1. The hydroxyl group of Tyr561
makes hydrogen bonds with the backbone atom of Tyr506 and Arg455, placed in
αH4 (Figure 34). Tyr506 is only present in hRIN1 and it can make a hydrogen bond
with the backbone atom of tyr561. The mutation of Tyr561 and Tyr506 to
phenylalanine may lose the hydrogen bond. Based on these observations, I utilized
a two-hybrid system to analyze the interaction of the cytoplasmic tail of IR-WT with
the following Rab5:VPS9-HB mutants: (Y506F, Y523F, Y537F, P5431A, Y561F,
T572A, Y577F, Y578F, T580A) (Figure 39). I found that residues (Tyr506, P541,
Y561, and T580) play an important role in the interaction of RIN1:VPS9-HB with
the cytoplasmic tail of IR. As expected, the cytoplasmic tail of IR kinase-dead was
used as negative control. These observations indicate selective residues of the
VPS9-HB domain are required for the interaction of the cytoplasmic tail of IR, which
may represent a distinctive and original protein-protein interaction. Taken together,
these findings indicate that (a) Rab5 GEFs interact with the cytoplasmic tail of IR,
but not with its catalytic inactive mutant, (b) the Rab5 GEFs VPS9 domain is
sufficient for this interaction, and (c) Rab5 GAPs do not interact with the
cytoplasmic tail of IR. Furthermore, these results also strengthen the possibility
that interaction between VPS9 domain of Rab5 GEFs and the cytoplasmic tail of
IR, defining a novel and selective interaction between VPS9 domain and the IR
cytoplasmic tail.
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A

B

Figure 40. Analysis of interaction between the IR-cytoplasmic tail (IR-β) and
RIN1:VPS9 mutants or IR-β mutants and the RIN1:VPS9 domain.
Yeast cells were co-transformed with plasmids pLexA fused to the IR-β:WT/KD or
IR-β mutants (Y972F, IR:Y1158F, IR:Y1328F, and IR:Y1334F) and pB42AD fused
to the RIN1:VPS9 or RIN1:VPS9 mutant (Y506F, Y523F, D537A, P541A, Y561F,
Y572F, Y577F, Y578F, T580A). Co-transformed cells were spotted onto plates
containing selected media and incubated at 30°C as described in Material and
Methods. Liquid cultures in selective media were also assayed for β-Galactosidase
(β-Gal) to verify and quantify two-hybrid interactions. The data are presented as
means ± SD of five independent experiments, n=5 *P<0.05. Each independent
experiment was performed in quintuplicate.
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RIN1
Figure 41. Analysis of interaction between the IR-cytoplasmic tail (IR-β) and
RIN1:SH2 domain.
Yeast cells were co-transformed with plasmids pLexA fused to the IR-β:WT/KD
and pB42AD fused to the RIN1:SH2 or RIN1:SH2 mutants (RIN1:W69F,
RIN1:A76F, RIN1:R94A, RIN1:H120F, RIN1:121F, RIN1:Y148F). Co-transformed
cells were spotted onto plates containing selected media and incubated at 30°C
as described in Material and Methods. Liquid cultures in selective media were also
assayed for β-Galactosidase (β-Gal) to verify and quantify two-hybrid interactions.
The data are presented as means ± SD of five independent experiments, n=5
*P<0.05. Each independent experiment was performed in quintuplicate.
In order to further investigate the interaction between the IR and RIN1, I
insert RIN1-SH2:WT, RIN1:VPS9:WT, several RIN1-SH2/VPS9 mutants into the
pB42AD vector, and insert the IR-β and IR-β mutants into the pLex-A vector. Figure
40 showed the interaction between IR-cytoplasmic tail (IR-β) and RIN1:VPS9
mutants or IR-β mutants and RIN1:VPS9 domain whereas Figure 41 showed the
interaction between the IR-β and RIN1:SH2.
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III.5 Discussion
In this section, I show the cellular mechanism of the Rab GEFs and the Rab
GAPs in regulating Rab5 function during the differentiation of 3T3-L1 preadipocytes. My data indicate that Rab5 inactivation upon insulin stimulation is
directly linked to the interaction between the activated insulin receptor and the
VPS9 domain of the Rab5 GEFs. The interaction probably affects the availability
of Rab5 GEFs to activate Rab5. In addition, the VPS9-IR-tail interaction also
affected the recruitment of IRS-1 to the activated insulin receptor cytoplasmic tail.
The expression of Rab5 GEFs, which increased the Rab5-GTP levels,
reduced the differentiation of 3T3-L1 pre-adipocytes, while the expression of Rab5
GAPs, which decreased Rab5-GTP levels, improved adipogenesis. I also show
that the exposure of 3T3-L1 pre-adipocytes to insulin can stimulate the association
of Rab5 GEF via its VPS9 domain to the activated insulin receptor. This
observation strongly suggests a direct link between the Rab5 inactivation and the
insulin receptor trafficking and signaling.
Analysis of the Rab5-GTP levels reveals a significant decrease in the GTP
levels in an insulin-sensitive manner during 3T3-L1 pre-adipocytes differentiation
without any significant decrease of the total level of Rab5 (Figures 11). One striking
feature of the Rab5-GTP levels in cells expressing Rab5 GEFs is that not only an
increase of the GTP levels can be observed, but also a statistically significant
decrease in the Rab5-GTP levels is displayed by comparing the Rab5-GTP levels
between day 1 and day 9 during differentiation. In contrast, in cells expressing the
Rab5 GAPs, the Rab5-GTP levels were not further affected by the addition of
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insulin during the differentiation process. In this context, depletion of Rab5 GEFs
or Rab5 GAPs by siRNA showed a remarkable characteristic; silencing of Rab5
GEFs decrease Rab5-GTP levels, while depletion of Rab5 GAPs increase it.
These data suggest that regulation of these factors is critical to ensure and
maintain the Rab5-GTP level during the differentiation process. Taken together,
these results suggest a possible cellular mechanism of the regulation of Rab5
inactivation during adipogenesis, which is directly linked to the interaction of
activated insulin receptor with the Rab5 GEFs.
It is reasonable to propose that association of activated insulin receptor with
the Rab5 GEFs is specific and selective and will also affect the activation of Rab5.
In support of this possibility, it has been shown that RIN1 interacts with activated
insulin receptor via its SH2 domain (Hunker, Giambini, et al., 2006). Interestingly,
Rabex-5 and RIN1 are recruited by activated EGF-receptor tail via two different
mechanisms: RIN1 require tyrosine phosphorylation of the EGF-receptor, while
Rabex-5 requires ubiquitination. In addition, it has been also shown that a deletion
mutant of Rabex-5 containing the VPS9 domain is targeted to membrane without
Rabaptin-5 and the ubiquitination domain (Aikawa, 2012). Together, these data
suggest that Rab5 GEFs utilize several mechanisms to interact with the activated
receptor. However, in this study, I found that these Rab5 GEFs utilize one common
domain (the VPS9 domain) to interact with the activated insulin receptor, with the
exception of RIN1 that also utilizes the RIN1:SH2 domain to interact with the
activated insulin receptor (Figure 34).
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In addition, the VPS9 domain does not interact with insulin receptor catalytic
inactive mutant or with other receptors (e.g., EGF-, transferrin- and LDL-receptor
[data not shown]). However, the finding that the Rab5 GEFs VPS9 domain also
interacts with the IGF-1R (data not shown) further support the idea that Rab5 GEFs
VPS9 domain plays a critical function during the differentiation of pre-adipocytes
since both the IR and IGF-1R have been implicated in the regulation of adipocyte
differentiation and lipid accumulation in vitro (Boucher et al., 2010). It is also
important to mention that beside the VPS9 domain, other domains of the Rab5
GEFs may also play critical roles in the differentiation of pre-adipocytes. For
example, the Ras-binding domain found in both RIN1 and Rabex-5, as well as the
Ras-GAP domain described in RAP6, may also be involved in the differentiation of
pre-adipocytes since the expression of Ras GTP-hydrolysis defective mutant
(Ras:V12G) increases the differentiation of pre-adipocytes (Murholm et al., 2010).
These data suggest that Rab5 inactivation is a key and specific factor, yet not the
only one, that is crucial to trigger the differentiation of 3T3-L1 pre-adipocytes.
In summary, my data show that the exposure of 3T3-L1 pre-adipocytes to
insulin can stimulate the inactivation of Rab5, which strongly suggests a direct link
between the inactivation of Rab5 and the activation of the insulin receptor. One
explanation for this mechanism is lay on the association of Rab5 GEFs with the
activated insulin receptor and IGF-1R. In either case, the VPS9 domain of Rab5
GEFs mediates this interaction with the activated receptor, indicating a novel
cellular mechanism to regulate the activity of Rab5. This hypothesis is further
supported by the observation that only tyrosine-phosphorylated insulin receptor
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interacted with more than one Rab5 GEFs. Therefore, Rab5 cannot be activated
once the Rab4 GEFs were sequestered by the activated IR or IGF-1R. In
agreement with these observations, the addition of insulin down-regulates Rab5
activity in the initial phase, but Rab5 activity could be recovered later, which
coincides with activation and inactivation phases of the insulin receptor during the
receptor-mediated endocytosis. This lack of Rab5 activation will block insulin
receptor internalization allowing an increase of the tyrosine autophosphorylation
of the insulin receptor and activation of Akt followed by translocation of GLUT4 to
the plasma membrane. Another possibility is that decreasing the level of Rab5GTP is associated with diminishing the amount of Rab5 proteins during the
differentiation process. Thus, inadequate level of Rab5 proteins would affect their
activation by Rab5 GEFs. Moreover, it seems that it could be a case since the
expression of Rab5 is differentially altered during the 3T3-L1 pre-adipocytes
differentiation. However, it has been shown that the expression of Rab5 is not
altered during the 3T3-L1 pre-adipocytes differentiation (Figure 22 and Figure 11).
Additionally, secondary modification on Rab5 and/or Rab5 GEFs (e.g.,
phosphorylation, ubiquitination) would also be involved. Further investigation will
be needed to define the potential requirements of specific modifications of Rab5.
Additional explanations, such as how an increased GLUT4 internalization could be
induced by an inhibitory effect of the Rab5 activity cannot be ruled out (Figure 13).
Here, I provided function and cellular evidence that Rab5 may be
considered as a molecular switch on the cell fate determination of 3T3-L1 preadipocytes. Interestingly, Rab5 inactivation has been found to associate with
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neurite outgrowth and differentiation, where RabGAP-5 interacts with NGF-TrkA
receptor and regulates the NGF-TrkA receptor signaling (Tam et al., 2015).
Nevertheless, my studies indicate a finely orchestrated balance between
GTP/GDP ratio of Rab5, Rab5 GEFs, and tyrosine autophosphorylation of the
insulin receptor, and more importantly, demonstrate a fundamental role of Rab5
inactivation during the differentiation of 3T3-L1 pre-adipocytes.
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